primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Hypotension,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Infection,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Lethargy,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Mental status changes,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Myoclonus,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
101870933,10187093,15,C,Insulin glargine,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Toxicity to various agents,,2015,Q1,3,F,,20150212.0,20140522,20150226,EXP,,US-RANBAXY-2014US-79252,RANBAXY,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY-CURR. 2014;14:434-435",55.0,YR,,M,Y,,,20150226.0,N,OT,US,US,2015,Q1,Adult
1019966711,10199667,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q1,Colitis,,2015,Q1,11,F,20140514.0,20141222.0,20140527,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20797619,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,117.41,KG,20150106.0,N,CN,US,US,2015,Q1,Elderly
1019966711,10199667,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q1,Enterocolitis infectious,,2015,Q1,11,F,20140514.0,20141222.0,20140527,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20797619,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,117.41,KG,20150106.0,N,CN,US,US,2015,Q1,Elderly
1019966711,10199667,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q1,Pyrexia,,2015,Q1,11,F,20140514.0,20141222.0,20140527,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20797619,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,117.41,KG,20150106.0,N,CN,US,US,2015,Q1,Elderly
103094942,10309494,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Hyperglycaemia,,2015,Q1,2,F,,20140703.0,20140716,20140716,EXP,,IT-MYLANLABS-2014S1016135,MYLAN,"CHELUCI G, SIMONCELLI A, MOGGIO R. EFFECTS OF WARFARIN THERAPY ON GLUCOSE METABOLISM IN INSULIN TREATED DIABETES. ITALIAN-J-MED 2014; 8 (SUPPL. 2) 27-28",36.0,YR,A,M,Y,,,20140716.0,N,OT,IT,IT,2015,Q1,Adult
104726864,10472686,22,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Atrial fibrillation,,2015,Q1,4,F,20140908.0,20141223.0,20140922,20150102,EXP,,2014-US-011895,JAZZ,,66.0,YR,,M,N,101.6,KG,20141230.0,N,OT,US,,2015,Q1,Elderly
104726864,10472686,22,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Myocardial infarction,,2015,Q1,4,F,20140908.0,20141223.0,20140922,20150102,EXP,,2014-US-011895,JAZZ,,66.0,YR,,M,N,101.6,KG,20141230.0,N,OT,US,,2015,Q1,Elderly
104726864,10472686,22,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Pneumonia,,2015,Q1,4,F,20140908.0,20141223.0,20140922,20150102,EXP,,2014-US-011895,JAZZ,,66.0,YR,,M,N,101.6,KG,20141230.0,N,OT,US,,2015,Q1,Elderly
104726864,10472686,22,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Thrombosis,,2015,Q1,4,F,20140908.0,20141223.0,20140922,20150102,EXP,,2014-US-011895,JAZZ,,66.0,YR,,M,N,101.6,KG,20141230.0,N,OT,US,,2015,Q1,Elderly
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Abdominal pain lower,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Blood glucose increased,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Blood urea increased,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Condition aggravated,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Haemoglobin decreased,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
104727445,10472744,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q1,Osteoarthritis,,2015,Q1,5,F,20130512.0,20141223.0,20140924,20150106,EXP,,PHHY2013TR049009,NOVARTIS,,22.0,YR,,F,Y,50.0,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,TR,2015,Q1,Youth
1047570510,10475705,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRAMUSCULAR,"3 ML, UNK",,,,D,,,,3,ML,,,2015,Q1,Ventricular fibrillation,,2015,Q1,10,F,20140913.0,20150105.0,20140925,20150114,EXP,,US-ALEXION-A201403597,ALEXION,,67.0,YR,,F,Y,72.5,KG,20150114.0,N,MD,US,US,2015,Q1,Elderly
1047570510,10475705,131,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Ventricular fibrillation,,2015,Q1,10,F,20140913.0,20150105.0,20140925,20150114,EXP,,US-ALEXION-A201403597,ALEXION,,67.0,YR,,F,Y,72.5,KG,20150114.0,N,MD,US,US,2015,Q1,Elderly
105172792,10517279,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Acute respiratory failure,,2015,Q1,2,F,20140714.0,20141229.0,20141014,20150130,EXP,,US-GILEAD-2014-0117950,GILEAD,,80.0,YR,E,F,Y,,,20150130.0,N,MD,US,US,2015,Q1,Elderly
105172792,10517279,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Anaemia,,2015,Q1,2,F,20140714.0,20141229.0,20141014,20150130,EXP,,US-GILEAD-2014-0117950,GILEAD,,80.0,YR,E,F,Y,,,20150130.0,N,MD,US,US,2015,Q1,Elderly
105632153,10563215,17,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),,2,SUBCUTANEOUS,"12 UNK, QD",,,,D,,,,,,SOLUTION FOR INFUSION,QD,2015,Q1,Pyrexia,,2015,Q1,3,F,20130910.0,20150318.0,20141104,20150323,EXP,,JP-GSKJP-JP2014JPN012558AA,GLAXOSMITHKLINE,,82.0,YR,,M,Y,52.0,KG,20150323.0,N,CN,JP,JP,2015,Q1,Elderly
105632153,10563215,17,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),,2,SUBCUTANEOUS,"12 UNK, QD",,,,D,,,,,,SOLUTION FOR INFUSION,QD,2015,Q1,White blood cell count decreased,,2015,Q1,3,F,20130910.0,20150318.0,20141104,20150323,EXP,,JP-GSKJP-JP2014JPN012558AA,GLAXOSMITHKLINE,,82.0,YR,,M,Y,52.0,KG,20150323.0,N,CN,JP,JP,2015,Q1,Elderly
105798324,10579832,13,C,Insulin Glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Atrial fibrillation,,2015,Q1,4,F,20141005.0,20141114.0,20141112,20150121,EXP,,PL-CELGENE-POL-2014104044,CELGENE,,66.0,YR,,M,Y,87.0,KG,20150121.0,N,OT,PL,PL,2015,Q1,Elderly
105798324,10579832,13,C,Insulin Glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Sinus node dysfunction,,2015,Q1,4,F,20141005.0,20141114.0,20141112,20150121,EXP,,PL-CELGENE-POL-2014104044,CELGENE,,66.0,YR,,M,Y,87.0,KG,20150121.0,N,OT,PL,PL,2015,Q1,Elderly
105989232,10598923,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Dementia Alzheimer's type,,2015,Q1,2,F,2014.0,20141222.0,20141121,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21587910,BRISTOL MYERS SQUIBB,,68.0,YR,,F,Y,63.94,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
105989232,10598923,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Mental status changes,,2015,Q1,2,F,2014.0,20141222.0,20141121,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21587910,BRISTOL MYERS SQUIBB,,68.0,YR,,F,Y,63.94,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
105989232,10598923,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Urinary tract infection,,2015,Q1,2,F,2014.0,20141222.0,20141121,20150106,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21587910,BRISTOL MYERS SQUIBB,,68.0,YR,,F,Y,63.94,KG,20150106.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
106155622,10615562,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,UNK,,,,U,,,,,,,,2015,Q1,Anti-insulin antibody,,2015,Q1,2,F,,20150123.0,20141201,20150203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201411009692,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20150203.0,N,CN,JP,JP,2015,Q1,Adult
106155622,10615562,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,UNK,,,,U,,,,,,,,2015,Q1,Glycosylated haemoglobin increased,,2015,Q1,2,F,,20150123.0,20141201,20150203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201411009692,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20150203.0,N,CN,JP,JP,2015,Q1,Adult
106155622,10615562,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,UNK,,,,U,,,,,,,,2015,Q1,Hyperglycaemia,,2015,Q1,2,F,,20150123.0,20141201,20150203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201411009692,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20150203.0,N,CN,JP,JP,2015,Q1,Adult
106155622,10615562,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,UNK,,,,U,,,,,,,,2015,Q1,Hypoglycaemia,,2015,Q1,2,F,,20150123.0,20141201,20150203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201411009692,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20150203.0,N,CN,JP,JP,2015,Q1,Adult
106332442,10633244,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Acute respiratory failure,,2015,Q1,2,F,20140714.0,20150130.0,20141205,20150210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21503305,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20150210.0,N,CN,US,US,2015,Q1,Elderly
106332442,10633244,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Anaemia,,2015,Q1,2,F,20140714.0,20150130.0,20141205,20150210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21503305,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,,,20150210.0,N,CN,US,US,2015,Q1,Elderly
106538654,10653865,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Bronchitis,,2015,Q1,4,F,20141007.0,20150205.0,20141216,20150210,EXP,,JP-ROCHE-1473529,ROCHE,,48.0,YR,,F,Y,61.1,KG,20150210.0,N,MD,JP,JP,2015,Q1,Adult
106630822,10663082,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Diabetic metabolic decompensation,,2015,Q1,2,F,20140126.0,20150218.0,20141218,20150303,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-002112,BRISTOL MYERS SQUIBB,,85.0,YR,,M,Y,,,20150303.0,N,CN,IT,IT,2015,Q1,Elderly
106630822,10663082,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Drug ineffective,,2015,Q1,2,F,20140126.0,20150218.0,20141218,20150303,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-002112,BRISTOL MYERS SQUIBB,,85.0,YR,,M,Y,,,20150303.0,N,CN,IT,IT,2015,Q1,Elderly
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Acute kidney injury,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Acute myocardial infarction,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Anaemia,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Chronic kidney disease,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Hemiparesis,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Hyperkalaemia,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Swelling face,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106730812,10673081,8,C,INSULINE GLARGINE,,2,,UNK,,,,D,,,,,,,,2015,Q1,Vertigo,,2015,Q1,2,F,20141215.0,20150105.0,20141223,20150111,EXP,,US-AMGEN-USACT2014099808,AMGEN,,54.0,YR,A,M,Y,67.27,KG,20150111.0,N,MD,US,US,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Abdominal pain,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Asthenia,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Blood glucose increased,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Condition aggravated,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Decreased appetite,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Nausea,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Pancreatitis chronic,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106770452,10677045,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNK,,21081.0,22,IU,,QD,2015,Q1,Weight decreased,,2015,Q1,2,F,20140525.0,20141230.0,20141226,20150107,EXP,,CZ-SA-2014SA173954,AVENTIS,,60.0,YR,A,M,Y,68.0,KG,20150107.0,N,MD,CZ,CZ,2015,Q1,Adult
106807863,10680786,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Cerebral ischaemia,,2015,Q1,3,F,20140924.0,20141229.0,20141229,20150105,EXP,,PL-SA-2014SA176912,AVENTIS,,77.0,YR,E,F,Y,55.0,KG,20150105.0,N,MD,PL,PL,2015,Q1,Elderly
106807863,10680786,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Cerebral ischaemia,,2015,Q1,3,F,20140924.0,20141229.0,20141229,20150105,EXP,,PL-SA-2014SA176912,AVENTIS,,77.0,YR,E,F,Y,55.0,KG,20150105.0,N,MD,PL,PL,2015,Q1,Elderly
106837426,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Hyperglycaemia,,2015,Q1,6,F,20141213.0,20150313.0,20141230,20150325,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20150325.0,N,CN,US,US,2015,Q1,Adult
106837426,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Hypophysitis,,2015,Q1,6,F,20141213.0,20150313.0,20141230,20150325,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20150325.0,N,CN,US,US,2015,Q1,Adult
106837426,10683742,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Pulmonary embolism,,2015,Q1,6,F,20141213.0,20150313.0,20141230,20150325,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-001999,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,45.0,KG,20150325.0,N,CN,US,US,2015,Q1,Adult
106861892,10686189,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 U, HS",,,,D,,,,26,IU,,QD,2015,Q1,Hyperkalaemia,,2015,Q1,2,F,,20150216.0,20141231,20150219,EXP,,JP-BAYER-2014-189969,BAYER,"TSURUZOE K, YAMAMOTO A, HIRASHIMA Y, FUKUDA K, KAJIHARA N, NISHIDA S, ET.AL.. A CASE OF TYPE 2 DIABETES MELLITUS WITH SEVERE HYPERKALAEMIA FOLLOWING ADMINISTRATION OF A SGLA2 INHIBITOR. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2014;57(11):837-842",65.0,YR,E,M,Y,,,20150219.0,N,MD,JP,JP,2015,Q1,Elderly
106861892,10686189,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 U, HS",,,,D,,,,26,IU,,QD,2015,Q1,Ketosis,,2015,Q1,2,F,,20150216.0,20141231,20150219,EXP,,JP-BAYER-2014-189969,BAYER,"TSURUZOE K, YAMAMOTO A, HIRASHIMA Y, FUKUDA K, KAJIHARA N, NISHIDA S, ET.AL.. A CASE OF TYPE 2 DIABETES MELLITUS WITH SEVERE HYPERKALAEMIA FOLLOWING ADMINISTRATION OF A SGLA2 INHIBITOR. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2014;57(11):837-842",65.0,YR,E,M,Y,,,20150219.0,N,MD,JP,JP,2015,Q1,Elderly
106861892,10686189,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 U, HS",,,,D,,,,26,IU,,QD,2015,Q1,Metabolic acidosis,,2015,Q1,2,F,,20150216.0,20141231,20150219,EXP,,JP-BAYER-2014-189969,BAYER,"TSURUZOE K, YAMAMOTO A, HIRASHIMA Y, FUKUDA K, KAJIHARA N, NISHIDA S, ET.AL.. A CASE OF TYPE 2 DIABETES MELLITUS WITH SEVERE HYPERKALAEMIA FOLLOWING ADMINISTRATION OF A SGLA2 INHIBITOR. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2014;57(11):837-842",65.0,YR,E,M,Y,,,20150219.0,N,MD,JP,JP,2015,Q1,Elderly
106861892,10686189,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 U, HS",,,,D,,,,26,IU,,QD,2015,Q1,Rash generalised,,2015,Q1,2,F,,20150216.0,20141231,20150219,EXP,,JP-BAYER-2014-189969,BAYER,"TSURUZOE K, YAMAMOTO A, HIRASHIMA Y, FUKUDA K, KAJIHARA N, NISHIDA S, ET.AL.. A CASE OF TYPE 2 DIABETES MELLITUS WITH SEVERE HYPERKALAEMIA FOLLOWING ADMINISTRATION OF A SGLA2 INHIBITOR. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2014;57(11):837-842",65.0,YR,E,M,Y,,,20150219.0,N,MD,JP,JP,2015,Q1,Elderly
106861892,10686189,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 U, HS",,,,D,,,,26,IU,,QD,2015,Q1,Renal impairment,,2015,Q1,2,F,,20150216.0,20141231,20150219,EXP,,JP-BAYER-2014-189969,BAYER,"TSURUZOE K, YAMAMOTO A, HIRASHIMA Y, FUKUDA K, KAJIHARA N, NISHIDA S, ET.AL.. A CASE OF TYPE 2 DIABETES MELLITUS WITH SEVERE HYPERKALAEMIA FOLLOWING ADMINISTRATION OF A SGLA2 INHIBITOR. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2014;57(11):837-842",65.0,YR,E,M,Y,,,20150219.0,N,MD,JP,JP,2015,Q1,Elderly
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:32 UNIT(S),,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.001,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.01,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D, UNKNOWN,,21081.0,.1,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,INTRADERMALLY,,,,D,,,21081.0,1,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Abdominal distension,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Angioedema,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Blood immunoglobulin G increased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Body mass index decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Body temperature decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Dehydration,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Hyperhidrosis,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Local reaction,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Pallor,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Papule,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Polydipsia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Polyuria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Pruritus,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Pyrexia,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Rash pruritic,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Skin lesion,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Type I hypersensitivity,Type I hypersensitivity,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Urticaria,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Weight decreased,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106915321,10691532,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,INTRADERMAL,"INTRADERMALLY,",,,,D,,,21081.0,2,IU,,,2015,Q1,Wheezing,,2015,Q1,1,I,201210.0,20141226.0,20150105,20150105,EXP,,VE-SA-2014SA180562,AVENTIS,"ROJAS J, VILLALOBOS M, MARTINEZ MS, CHAVEZ-CASTILLO M, TORRES W, MEJIAS JC, ET AL. SUCCESSFUL MANAGEMENT OF INSULIN ALLERGY AND AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 4 WITH DESENSITIZATION THERAPY AND GLUCOCORTICOID TREATMENT: A CASE REPORT AND REVIEW OF THE LITERATURE. CASE REPORTS IN IMMUNOLOGY 2014. AVAILABLE FROM HTTP://DX.DOI.ORG/10.1155/2014/394754",17.0,YR,T,M,Y,,,20150105.0,N,OT,VE,VE,2015,Q1,Youth
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Condition aggravated,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Drug interaction,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Dysphagia,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Dystonia,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Extrapyramidal disorder,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Lethargy,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Parkinsonian gait,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Salivary hypersecretion,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
106924702,10692470,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Sedation,,2015,Q1,2,F,,20150107.0,20150106,20150109,EXP,,PHHY2014ES170250,NOVARTIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL.,. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORDIC JOURNAL OF PSYCHIATRY. 2014;69(1):79-80",68.0,YR,,F,Y,,,20150112.0,N,OT,ES,ES,2015,Q1,Elderly
107026832,10702683,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Anaemia,,2015,Q1,2,F,20140802.0,20150106.0,20150109,20150116,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,66.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107026832,10702683,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Gastrointestinal haemorrhage,,2015,Q1,2,F,20140802.0,20150106.0,20150109,20150116,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,66.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Atrioventricular block,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bradycardia,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Cerebral infarction,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Cerebral thrombosis,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Chills,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,General physical health deterioration,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Infection,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Pneumonia aspiration,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Pyrexia,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107062941,10706294,14,C,(INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Respiratory failure,,2015,Q1,1,I,20140429.0,20141229.0,20150109,20150109,EXP,,2693866,HOSPIRA,,73.0,YR,,M,N,,,20150108.0,N,OT,DE,,2015,Q1,Elderly
107078871,10707887,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,2,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20141224.0,20150107.0,20150113,20150113,EXP,,CO-BAXTER-2015BAX001139,BAXTER,,71.0,YR,,F,Y,78.4,KG,20150113.0,N,OT,CO,CO,2015,Q1,Elderly
107105711,10710571,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,60 U,,,,D,,,,60,IU,,QD,2015,Q1,Depression,,2015,Q1,1,I,20141207.0,20150109.0,20150114,20150114,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-01420UK",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,,,20150114.0,N,OT,GB,GB,2015,Q1,Adult
107105711,10710571,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,60 U,,,,D,,,,60,IU,,QD,2015,Q1,Suicidal ideation,,2015,Q1,1,I,20141207.0,20150109.0,20150114,20150114,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-01420UK",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,,,20150114.0,N,OT,GB,GB,2015,Q1,Adult
107130782,10713078,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"50 U, BID",,,,D,,,,50,DF,,BID,2015,Q1,Adenocarcinoma pancreas,,2015,Q1,2,F,20141016.0,20150320.0,20150115,20150331,EXP,,US-NOVOPROD-435032,NOVO NORDISK,,71.0,YR,E,M,Y,100.68,KG,20150331.0,N,MD,US,US,2015,Q1,Elderly
107240221,10724022,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10,IU,,,2015,Q1,Cardiac disorder,,2015,Q1,1,I,20150105.0,20150109.0,20150120,20150120,EXP,,CO-BAXTER-2015BAX001533,BAXTER,,36.0,YR,,M,Y,71.8,KG,20150120.0,N,OT,CO,CO,2015,Q1,Adult
107240221,10724022,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10,IU,,,2015,Q1,Cardio-respiratory arrest,,2015,Q1,1,I,20150105.0,20150109.0,20150120,20150120,EXP,,CO-BAXTER-2015BAX001533,BAXTER,,36.0,YR,,M,Y,71.8,KG,20150120.0,N,OT,CO,CO,2015,Q1,Adult
107240221,10724022,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,20150105.0,20150109.0,20150120,20150120,EXP,,CO-BAXTER-2015BAX001533,BAXTER,,36.0,YR,,M,Y,71.8,KG,20150120.0,N,OT,CO,CO,2015,Q1,Adult
107243061,10724306,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Atrial fibrillation,,2015,Q1,1,I,20141005.0,20141010.0,20150120,20150120,EXP,,PL-CELGENE-POL-2014105393,CELGENE,,66.0,YR,,M,Y,87.0,KG,20150120.0,N,OT,PL,PL,2015,Q1,Elderly
107243061,10724306,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Loss of consciousness,,2015,Q1,1,I,20141005.0,20141010.0,20150120,20150120,EXP,,PL-CELGENE-POL-2014105393,CELGENE,,66.0,YR,,M,Y,87.0,KG,20150120.0,N,OT,PL,PL,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Drug interaction,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Dysphagia,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Dystonia,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Parkinsonian gait,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Salivary hypersecretion,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265011,10726501,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Sedation,,2015,Q1,1,I,,20150112.0,20150121,20150121,EXP,,ES-TEVA-535112ISR,TEVA,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARCIA MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD-J-PSYCHIATRY 2015; 69(1) 79-80",68.0,YR,,F,Y,,,20150121.0,N,PH,ES,ES,2015,Q1,Elderly
107265501,10726550,22,C,INSULIN GLAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q1,Angina unstable,,2015,Q1,1,I,20141213.0,,20150120,20150120,DIR,,,,,61.0,YR,,F,N,119.5,KG,20150108.0,Y,MD,US,,2015,Q1,Adult
107336431,10733643,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Cough,,2015,Q1,1,I,,20150112.0,20150123,20150123,PER,,US-ASTRAZENECA-2015SE06208,ASTRAZENECA,,61.0,YR,,F,Y,,,20150123.0,N,CN,US,US,2015,Q1,Adult
107336431,10733643,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Functional gastrointestinal disorder,,2015,Q1,1,I,,20150112.0,20150123,20150123,PER,,US-ASTRAZENECA-2015SE06208,ASTRAZENECA,,61.0,YR,,F,Y,,,20150123.0,N,CN,US,US,2015,Q1,Adult
107370971,10737097,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Blood glucose increased,,2015,Q1,1,I,,20150115.0,20150126,20150126,PER,,US-ASTRAZENECA-2015SE07155,ASTRAZENECA,,66.0,YR,,M,Y,,,20150126.0,N,CN,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Anaemia,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Clostridium difficile infection,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Compression fracture,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Fatigue,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Platelet count decreased,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Thrombosis,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Tooth disorder,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107371362,10737136,16,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Viral upper respiratory tract infection,,2015,Q1,2,F,201406.0,20141120.0,20150126,20150126,PER,,US-CELGENEUS-USA-2014115427,CELGENE,,74.0,YR,,M,Y,83.6,KG,20150126.0,N,PH,US,US,2015,Q1,Elderly
107389111,10738911,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNKNOWN,,21081.0,20,IU,,,2015,Q1,Nephrolithiasis,,2015,Q1,1,I,,20150119.0,20150126,20150126,EXP,,EG-SA-2015SA008502,AVENTIS,,62.0,YR,A,F,Y,,,20150126.0,N,CN,EG,EG,2015,Q1,Adult
107414471,10741447,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,DF,,QD,2015,Q1,Fungal infection,,2015,Q1,1,I,20141119.0,20141215.0,20150127,20150127,PER,,US-ASTRAZENECA-2015SE08159,ASTRAZENECA,,51.0,YR,,F,Y,,,20150127.0,N,CN,US,US,2015,Q1,Adult
107414471,10741447,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,DF,,QD,2015,Q1,Hypersensitivity,,2015,Q1,1,I,20141119.0,20141215.0,20150127,20150127,PER,,US-ASTRAZENECA-2015SE08159,ASTRAZENECA,,51.0,YR,,F,Y,,,20150127.0,N,CN,US,US,2015,Q1,Adult
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Cough,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Decreased appetite,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Diarrhoea,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Dyspepsia,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Ear infection,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Eye infection,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Injection site mass,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107417981,10741798,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Nausea,,2015,Q1,1,I,201404.0,20140609.0,20150127,20150127,PER,,US-ASTRAZENECA-2014SE58207,ASTRAZENECA,,67.0,YR,,F,Y,85.3,KG,20150127.0,N,CN,US,US,2015,Q1,Elderly
107419311,10741931,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,14,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20141228.0,20150116.0,20150127,20150127,EXP,,CO-BAXTER-2015BAX002892,BAXTER,,48.0,YR,,F,Y,48.8,KG,20150127.0,N,OT,CO,CO,2015,Q1,Adult
107419311,10741931,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,14,IU,,QD,2015,Q1,Diarrhoea,,2015,Q1,1,I,20141228.0,20150116.0,20150127,20150127,EXP,,CO-BAXTER-2015BAX002892,BAXTER,,48.0,YR,,F,Y,48.8,KG,20150127.0,N,OT,CO,CO,2015,Q1,Adult
107419311,10741931,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,14,IU,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,20141228.0,20150116.0,20150127,20150127,EXP,,CO-BAXTER-2015BAX002892,BAXTER,,48.0,YR,,F,Y,48.8,KG,20150127.0,N,OT,CO,CO,2015,Q1,Adult
107420031,10742003,13,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,7,IU,,,2015,Q1,Disease complication,,2015,Q1,1,I,20141212.0,20150116.0,20150127,20150127,EXP,,CO-BAXTER-2015BAX002904,BAXTER,,79.0,YR,,F,Y,43.0,KG,20150127.0,N,OT,CO,CO,2015,Q1,Elderly
107420031,10742003,13,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,7,IU,,,2015,Q1,Pneumonia,,2015,Q1,1,I,20141212.0,20150116.0,20150127,20150127,EXP,,CO-BAXTER-2015BAX002904,BAXTER,,79.0,YR,,F,Y,43.0,KG,20150127.0,N,OT,CO,CO,2015,Q1,Elderly
107450831,10745083,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20150104.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003295,BAXTER,,44.0,YR,,M,Y,63.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Adult
107450831,10745083,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,20150104.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003295,BAXTER,,44.0,YR,,M,Y,63.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Adult
107451562,10745156,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,18,IU,,QD,2015,Q1,Acetonaemia,,2015,Q1,2,F,20141218.0,20150123.0,20150128,20150130,EXP,,US-ASTRAZENECA-2015SE00635,ASTRAZENECA,,84.0,YR,,F,Y,51.0,KG,20150130.0,N,CN,JP,JP,2015,Q1,Elderly
107451562,10745156,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,18,IU,,QD,2015,Q1,Diabetic hyperglycaemic coma,,2015,Q1,2,F,20141218.0,20150123.0,20150128,20150130,EXP,,US-ASTRAZENECA-2015SE00635,ASTRAZENECA,,84.0,YR,,F,Y,51.0,KG,20150130.0,N,CN,JP,JP,2015,Q1,Elderly
107451562,10745156,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,18,IU,,QD,2015,Q1,Malaise,,2015,Q1,2,F,20141218.0,20150123.0,20150128,20150130,EXP,,US-ASTRAZENECA-2015SE00635,ASTRAZENECA,,84.0,YR,,F,Y,51.0,KG,20150130.0,N,CN,JP,JP,2015,Q1,Elderly
107451921,10745192,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20141101.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003148,BAXTER,,79.0,YR,,M,Y,80.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Elderly
107451921,10745192,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,QD,2015,Q1,Gastrointestinal haemorrhage,,2015,Q1,1,I,20141101.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003148,BAXTER,,79.0,YR,,M,Y,80.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Elderly
107451921,10745192,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,QD,2015,Q1,Nervous system disorder,,2015,Q1,1,I,20141101.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003148,BAXTER,,79.0,YR,,M,Y,80.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Elderly
107451921,10745192,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,QD,2015,Q1,Peritonitis bacterial,,2015,Q1,1,I,20141101.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003148,BAXTER,,79.0,YR,,M,Y,80.0,KG,20150128.0,N,OT,CO,CO,2015,Q1,Elderly
107452191,10745219,8,C,INSULIN GLARGINE (INSULIN GLARGINE),INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Anaphylactic reaction,,2015,Q1,1,I,20131204.0,20131211.0,20150120,20150120,PER,,2013STP1000507,SIGMA TAU,,66.0,YR,,F,N,96.7,KG,20150109.0,N,MD,US,,2015,Q1,Elderly
107461751,10746175,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1 TIME PER DAY,,,,D,,,,12,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20141230.0,20150119.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003105,BAXTER,,72.0,YR,,F,Y,55.3,KG,20150128.0,N,OT,CO,CO,2015,Q1,Elderly
107461821,10746182,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,QD,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20150119.0,20150120.0,20150128,20150128,EXP,,CO-BAXTER-2015BAX003554,BAXTER,,61.0,YR,,M,Y,97.5,KG,20150128.0,N,OT,CO,CO,2015,Q1,Adult
107486121,10748612,10,C,Glargine INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,13,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20141227.0,20150120.0,20150129,20150129,EXP,,CO-BAXTER-2015BAX003563,BAXTER,,55.0,YR,,M,Y,93.0,KG,20150129.0,N,OT,CO,CO,2015,Q1,Adult
107486121,10748612,10,C,Glargine INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,13,IU,,,2015,Q1,Cardio-respiratory arrest,,2015,Q1,1,I,20141227.0,20150120.0,20150129,20150129,EXP,,CO-BAXTER-2015BAX003563,BAXTER,,55.0,YR,,M,Y,93.0,KG,20150129.0,N,OT,CO,CO,2015,Q1,Adult
107486571,10748657,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:40 UNIT(S),,,,D, 4F752A,,021081,,,,QD,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,20150102.0,20150121.0,20150129,20150129,EXP,,CO-SA-2015SA008369,AVENTIS,,52.0,YR,A,M,Y,,,20150129.0,N,CN,CO,CO,2015,Q1,Adult
107486571,10748657,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:40 UNIT(S),,,,D, 4F752A,,021081,,,,QD,2015,Q1,Pancreatitis,,2015,Q1,1,I,20150102.0,20150121.0,20150129,20150129,EXP,,CO-SA-2015SA008369,AVENTIS,,52.0,YR,A,M,Y,,,20150129.0,N,CN,CO,CO,2015,Q1,Adult
107502881,10750288,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Cataract,,2015,Q1,1,I,,20150114.0,20150129,20150129,EXP,,US-ASTRAZENECA-2015SE08907,ASTRAZENECA,,81.0,YR,,M,Y,,,20150130.0,N,CN,US,US,2015,Q1,Elderly
107502881,10750288,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Nervousness,,2015,Q1,1,I,,20150114.0,20150129,20150129,EXP,,US-ASTRAZENECA-2015SE08907,ASTRAZENECA,,81.0,YR,,M,Y,,,20150130.0,N,CN,US,US,2015,Q1,Elderly
107513721,10751372,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Drug-induced liver injury,,2015,Q1,1,I,,20141230.0,20150130,20150130,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-006857,BRISTOL MYERS SQUIBB,,41.0,YR,,M,Y,,,20150130.0,N,CN,DE,US,2015,Q1,Adult
107513951,10751395,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,021081,,,,,2015,Q1,Urinary tract infection,,2015,Q1,1,I,2014.0,20150121.0,20150130,20150130,EXP,,CO-SA-2015SA009068,AVENTIS,,87.0,YR,E,F,Y,,,20150130.0,N,CN,CO,CO,2015,Q1,Elderly
107513991,10751399,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,021081,,,,,2015,Q1,Myocardial infarction,,2015,Q1,1,I,20141222.0,20150121.0,20150130,20150130,EXP,,CO-SA-2015SA009338,AVENTIS,,76.0,YR,E,M,Y,,,20150130.0,N,CN,CO,CO,2015,Q1,Elderly
107545751,10754575,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:9 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q1,Abdominal discomfort,,2015,Q1,1,I,201501.0,20150123.0,20150202,20150202,EXP,,KR-SA-2015SA009174,AVENTIS,,63.0,YR,A,M,Y,70.0,KG,20150202.0,N,CN,KR,KR,2015,Q1,Adult
107545751,10754575,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,,,,,2015,Q1,Abdominal discomfort,,2015,Q1,1,I,201501.0,20150123.0,20150202,20150202,EXP,,KR-SA-2015SA009174,AVENTIS,,63.0,YR,A,M,Y,70.0,KG,20150202.0,N,CN,KR,KR,2015,Q1,Adult
107571281,10757128,6,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Rhabdomyolysis,,2015,Q1,1,I,,20140821.0,20150203,20150203,PER,,US-DRREDDYS-USA/USA/14/0042560,DR REDDYS,"RADOMSKI T, JASTI H. MAKING A LIST AND CHECKING IT TWICE: THE IMPORTANCE OF ACCURATE MEDICATION RECONCILIATION IN ESTABLISHING A LIFE-THREATENING DIAGNOSIS. J GEN INTERN MED. 2013;S357.",64.0,YR,,M,Y,,,20150203.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
107588571,10758857,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNKNOWN,,21081.0,,,,,2015,Q1,Neoplasm malignant,,2015,Q1,1,I,,20150126.0,20150203,20150203,EXP,,CO-SA-2015SA012186,AVENTIS,,84.0,YR,E,F,Y,,,20150203.0,N,CN,CO,CO,2015,Q1,Elderly
107616251,10761625,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,DOSE:45 UNIT(S),,,,D, 4F393A,,21081.0,,,,QD,2015,Q1,VIIth nerve paralysis,,2015,Q1,1,I,20150125.0,20150128.0,20150204,20150204,EXP,,CO-SA-2015SA012226,AVENTIS,,66.0,YR,E,F,Y,,,20150204.0,N,CN,CO,CO,2015,Q1,Elderly
107633401,10763340,6,C,Glargine insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,QD,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20150124.0,20150126.0,20150204,20150204,EXP,,CO-BAXTER-2015BAX004720,BAXTER,,56.0,YR,,F,Y,51.0,KG,20150204.0,N,OT,CO,CO,2015,Q1,Adult
107634022,10763402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Blood glucose increased,,2015,Q1,2,F,20150124.0,20150203.0,20150204,20150209,EXP,,AR-ELI_LILLY_AND_COMPANY-AR201502000232,ELI LILLY AND CO,,30.0,YR,,F,Y,,,20150209.0,N,CN,AR,AR,2015,Q1,Young Adult
107634022,10763402,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Drug dose omission,,2015,Q1,2,F,20150124.0,20150203.0,20150204,20150209,EXP,,AR-ELI_LILLY_AND_COMPANY-AR201502000232,ELI LILLY AND CO,,30.0,YR,,F,Y,,,20150209.0,N,CN,AR,AR,2015,Q1,Young Adult
107696481,10769648,12,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,22,IU,,,2015,Q1,Diabetes mellitus inadequate control,,2015,Q1,1,I,20150125.0,20150128.0,20150206,20150206,EXP,,CO-BAXTER-2015BAX005198,BAXTER,,22.0,YR,,M,Y,55.0,KG,20150206.0,N,OT,CO,CO,2015,Q1,Youth
107696481,10769648,12,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,22,IU,,,2015,Q1,Malaise,,2015,Q1,1,I,20150125.0,20150128.0,20150206,20150206,EXP,,CO-BAXTER-2015BAX005198,BAXTER,,22.0,YR,,M,Y,55.0,KG,20150206.0,N,OT,CO,CO,2015,Q1,Youth
107696481,10769648,12,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,22,IU,,,2015,Q1,Shock hypoglycaemic,,2015,Q1,1,I,20150125.0,20150128.0,20150206,20150206,EXP,,CO-BAXTER-2015BAX005198,BAXTER,,22.0,YR,,M,Y,55.0,KG,20150206.0,N,OT,CO,CO,2015,Q1,Youth
107696591,10769659,13,C,Glargine insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,14,IU,,,2015,Q1,Cardio-respiratory arrest,,2015,Q1,1,I,20150103.0,20150128.0,20150206,20150206,EXP,,CO-BAXTER-2015BAX005326,BAXTER,,68.0,YR,,F,Y,57.8,KG,20150206.0,N,OT,CO,CO,2015,Q1,Elderly
107703101,10770310,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q1,Death,,2015,Q1,1,I,20150108.0,20150203.0,20150206,20150206,EXP,,US-ASTELLAS-2015US003741,ASTELLAS,,71.0,YR,,M,Y,,,20150206.0,N,CN,GB,US,2015,Q1,Elderly
107703101,10770310,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q1,Rash,,2015,Q1,1,I,20150108.0,20150203.0,20150206,20150206,EXP,,US-ASTELLAS-2015US003741,ASTELLAS,,71.0,YR,,M,Y,,,20150206.0,N,CN,GB,US,2015,Q1,Elderly
107755912,10775591,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,DOSE:20 UNIT(S),,,,D, UNK,,21081.0,,,,,2015,Q1,Dehydration,,2015,Q1,2,F,,20150211.0,20150209,20150217,EXP,,LB-SA-2015SA014301,AVENTIS,,84.0,YR,E,F,Y,55.0,KG,20150217.0,N,MD,LB,LB,2015,Q1,Elderly
107755912,10775591,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,DOSE:20 UNIT(S),,,,D, UNK,,21081.0,,,,,2015,Q1,Dehydration,,2015,Q1,2,F,,20150211.0,20150209,20150217,EXP,,LB-SA-2015SA014301,AVENTIS,,84.0,YR,E,F,Y,55.0,KG,20150217.0,N,MD,LB,LB,2015,Q1,Elderly
107762961,10776296,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,U,,,,,,,,2015,Q1,Anticonvulsant drug level above therapeutic,,2015,Q1,1,I,,20150127.0,20150209,20150209,EXP,,US-ACTAVIS-2015-01239,ACTAVIS,"IMAM SH, LANDRY K, KAUL V, GAMBHIR H, JOHN D, KLOSS B. FREE PHENYTOIN TOXICITY. AM J EMERG MED. 2014;32(10):1301.E3-4",69.0,YR,,M,Y,,,20150209.0,N,MD,US,US,2015,Q1,Elderly
107762961,10776296,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,U,,,,,,,,2015,Q1,Gait disturbance,,2015,Q1,1,I,,20150127.0,20150209,20150209,EXP,,US-ACTAVIS-2015-01239,ACTAVIS,"IMAM SH, LANDRY K, KAUL V, GAMBHIR H, JOHN D, KLOSS B. FREE PHENYTOIN TOXICITY. AM J EMERG MED. 2014;32(10):1301.E3-4",69.0,YR,,M,Y,,,20150209.0,N,MD,US,US,2015,Q1,Elderly
107762961,10776296,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,U,,,,,,,,2015,Q1,Hepatic enzyme increased,,2015,Q1,1,I,,20150127.0,20150209,20150209,EXP,,US-ACTAVIS-2015-01239,ACTAVIS,"IMAM SH, LANDRY K, KAUL V, GAMBHIR H, JOHN D, KLOSS B. FREE PHENYTOIN TOXICITY. AM J EMERG MED. 2014;32(10):1301.E3-4",69.0,YR,,M,Y,,,20150209.0,N,MD,US,US,2015,Q1,Elderly
107762961,10776296,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,U,,,,,,,,2015,Q1,Mental disorder,,2015,Q1,1,I,,20150127.0,20150209,20150209,EXP,,US-ACTAVIS-2015-01239,ACTAVIS,"IMAM SH, LANDRY K, KAUL V, GAMBHIR H, JOHN D, KLOSS B. FREE PHENYTOIN TOXICITY. AM J EMERG MED. 2014;32(10):1301.E3-4",69.0,YR,,M,Y,,,20150209.0,N,MD,US,US,2015,Q1,Elderly
107762961,10776296,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,U,,,,,,,,2015,Q1,Somnolence,,2015,Q1,1,I,,20150127.0,20150209,20150209,EXP,,US-ACTAVIS-2015-01239,ACTAVIS,"IMAM SH, LANDRY K, KAUL V, GAMBHIR H, JOHN D, KLOSS B. FREE PHENYTOIN TOXICITY. AM J EMERG MED. 2014;32(10):1301.E3-4",69.0,YR,,M,Y,,,20150209.0,N,MD,US,US,2015,Q1,Elderly
107763811,10776381,23,C,INSULIN - GLARGINE,,2,,,,,,,,,,,,,,2015,Q1,Respiratory distress,,2015,Q1,1,I,20150128.0,,20150205,20150205,DIR,,,,,80.0,YR,,M,N,76.0,KG,20150204.0,N,PH,US,,2015,Q1,Elderly
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Anxiety,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Aphasia,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Chest pain,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Heart rate increased,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Presyncope,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107792511,10779251,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Psychomotor hyperactivity,,2015,Q1,1,I,20150202.0,,20150206,20150206,DIR,,,,,54.0,YR,,F,N,130.0,KG,20150205.0,N,PH,US,,2015,Q1,Adult
107795021,10779502,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Acute kidney injury,,2015,Q1,1,I,,20150127.0,20150210,20150210,EXP,,US-DRREDDYS-USA/USA/15/0045941,DR REDDYS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2015;.",76.0,YR,,F,Y,,,20150210.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
107795021,10779502,5,C,glargine insulin,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Crystal nephropathy,,2015,Q1,1,I,,20150127.0,20150210,20150210,EXP,,US-DRREDDYS-USA/USA/15/0045941,DR REDDYS,"BAIRD P, LEUNG S, HOANG H, BABALOLA O, DEVOE C, WANCHOO R, ET AL. A CASE OF ACUTE KIDNEY INJURY FROM CRYSTAL NEPHROPATHY SECONDARY TO POMALIDOMIDE AND LEVOFLOXACIN USE. J ONCOL PHARM PRACT. 2015;.",76.0,YR,,F,Y,,,20150210.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
107800051,10780005,10,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10,IU,,,2015,Q1,Pneumonia,,2015,Q1,1,I,20150103.0,20150107.0,20150210,20150210,EXP,,CO-BAXTER-2015BAX000759,BAXTER,,73.0,YR,,F,Y,44.7,KG,20150210.0,N,OT,CO,CO,2015,Q1,Elderly
107801161,10780116,11,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,,2015,Q1,Cardiovascular disorder,,2015,Q1,1,I,20141124.0,20150130.0,20150210,20150210,EXP,,CO-BAXTER-2015BAX005749,BAXTER,,80.0,YR,,F,Y,54.0,KG,20150210.0,N,OT,CO,CO,2015,Q1,Elderly
107801161,10780116,11,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,,2015,Q1,Diabetic complication,,2015,Q1,1,I,20141124.0,20150130.0,20150210,20150210,EXP,,CO-BAXTER-2015BAX005749,BAXTER,,80.0,YR,,F,Y,54.0,KG,20150210.0,N,OT,CO,CO,2015,Q1,Elderly
107801161,10780116,11,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,,2015,Q1,Diabetic foot,,2015,Q1,1,I,20141124.0,20150130.0,20150210,20150210,EXP,,CO-BAXTER-2015BAX005749,BAXTER,,80.0,YR,,F,Y,54.0,KG,20150210.0,N,OT,CO,CO,2015,Q1,Elderly
107801161,10780116,11,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,18,IU,,,2015,Q1,Diabetic vascular disorder,,2015,Q1,1,I,20141124.0,20150130.0,20150210,20150210,EXP,,CO-BAXTER-2015BAX005749,BAXTER,,80.0,YR,,F,Y,54.0,KG,20150210.0,N,OT,CO,CO,2015,Q1,Elderly
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Abdominal pain upper,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Acute kidney injury,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Blood pressure abnormal,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Cardiogenic shock,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Chills,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Diarrhoea,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Ischaemic hepatitis,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Leukocytosis,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Proctalgia,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Pyrexia,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107801184,10780118,15,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,25,IU,,BID,2015,Q1,Retching,,2015,Q1,4,F,201501.0,20150318.0,20150210,20150326,EXP,,US-BAXTER-2015BAX006863,BAXTER,,34.0,YR,,M,Y,90.8,KG,20150326.0,N,PH,US,US,2015,Q1,Young Adult
107804771,10780477,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Chills,,2015,Q1,1,I,20141107.0,,20150206,20150206,DIR,,,,,62.0,YR,,M,N,103.0,KG,20150205.0,N,,US,,2015,Q1,Adult
107815881,10781588,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Cellulitis,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,EXP,,US-CELGENE-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107815881,10781588,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Cough,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,EXP,,US-CELGENE-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107815881,10781588,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Neutropenia,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,EXP,,US-CELGENE-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107815881,10781588,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Pyrexia,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,EXP,,US-CELGENE-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107821081,10782108,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Cellulitis,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,PER,,US-CELGENEUS-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107821081,10782108,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Cough,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,PER,,US-CELGENEUS-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107821081,10782108,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Neutropenia,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,PER,,US-CELGENEUS-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107821081,10782108,32,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,40-60 U,,,,D,,,,,,INJECTION,BID,2015,Q1,Pyrexia,,2015,Q1,1,I,20150103.0,20150116.0,20150210,20150210,PER,,US-CELGENEUS-USA-2015014047,CELGENE,,54.0,YR,,M,Y,120.0,KG,20150210.0,N,MD,US,US,2015,Q1,Adult
107854261,10785426,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Benign prostatic hyperplasia,,2015,Q1,1,I,201404.0,20140409.0,20150211,20150211,EXP,,MX-ASTRAZENECA-2015SE13132,ASTRAZENECA,,74.0,YR,,M,Y,,,20150211.0,N,MD,MX,MX,2015,Q1,Elderly
107854261,10785426,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Haematuria,,2015,Q1,1,I,201404.0,20140409.0,20150211,20150211,EXP,,MX-ASTRAZENECA-2015SE13132,ASTRAZENECA,,74.0,YR,,M,Y,,,20150211.0,N,MD,MX,MX,2015,Q1,Elderly
107872193,10787219,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Bacteraemia,,2015,Q1,3,F,,20150225.0,20150211,20150303,EXP,,US-GILEAD-2015-0136181,GILEAD,,70.0,YR,E,M,Y,,,20150303.0,N,CN,US,US,2015,Q1,Elderly
107872193,10787219,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Renal impairment,,2015,Q1,3,F,,20150225.0,20150211,20150303,EXP,,US-GILEAD-2015-0136181,GILEAD,,70.0,YR,E,M,Y,,,20150303.0,N,CN,US,US,2015,Q1,Elderly
107872193,10787219,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Tumour lysis syndrome,,2015,Q1,3,F,,20150225.0,20150211,20150303,EXP,,US-GILEAD-2015-0136181,GILEAD,,70.0,YR,E,M,Y,,,20150303.0,N,CN,US,US,2015,Q1,Elderly
107875842,10787584,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,.02,ML,,QD,2015,Q1,Hyperkalaemia,,2015,Q1,2,F,20150103.0,20150219.0,20150212,20150224,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150224.0,N,MD,GB,GB,2015,Q1,Elderly
107875842,10787584,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,.02,ML,,QD,2015,Q1,Presyncope,,2015,Q1,2,F,20150103.0,20150219.0,20150212,20150224,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150224.0,N,MD,GB,GB,2015,Q1,Elderly
107875842,10787584,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,.02,ML,,QD,2015,Q1,Pseudomonas infection,,2015,Q1,2,F,20150103.0,20150219.0,20150212,20150224,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150224.0,N,MD,GB,GB,2015,Q1,Elderly
107909411,10790941,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,ORAL,FREQUENCY:1X1,,,,U,,,,,,,,2015,Q1,Epilepsy,,2015,Q1,1,I,20140624.0,20150205.0,20150212,20150212,EXP,,TR-MERCK-1502TUR003588,MERCK,,73.0,YR,,F,Y,65.0,KG,20150212.0,N,CN,TR,TR,2015,Q1,Elderly
107929203,10792920,14,C,INSULINE GLARGINE,,2,SUBCUTANEOUS,300 3ML,,,,D,,,,,,,,2015,Q1,Injection site erythema,,2015,Q1,3,F,20140827.0,20150211.0,20150213,20150220,EXP,,NL-ABBVIE-15P-114-1346030-00,ABBVIE,,77.0,YR,,M,Y,78.0,KG,20150220.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
107929203,10792920,14,C,INSULINE GLARGINE,,2,SUBCUTANEOUS,300 3ML,,,,D,,,,,,,,2015,Q1,Injection site swelling,,2015,Q1,3,F,20140827.0,20150211.0,20150213,20150220,EXP,,NL-ABBVIE-15P-114-1346030-00,ABBVIE,,77.0,YR,,M,Y,78.0,KG,20150220.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
107929203,10792920,14,C,INSULINE GLARGINE,,2,SUBCUTANEOUS,300 3ML,,,,D,,,,,,,,2015,Q1,Injection site warmth,,2015,Q1,3,F,20140827.0,20150211.0,20150213,20150220,EXP,,NL-ABBVIE-15P-114-1346030-00,ABBVIE,,77.0,YR,,M,Y,78.0,KG,20150220.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
107929203,10792920,14,C,INSULINE GLARGINE,,2,SUBCUTANEOUS,300 3ML,,,,D,,,,,,,,2015,Q1,Mood swings,,2015,Q1,3,F,20140827.0,20150211.0,20150213,20150220,EXP,,NL-ABBVIE-15P-114-1346030-00,ABBVIE,,77.0,YR,,M,Y,78.0,KG,20150220.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
107932421,10793242,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Ventricular fibrillation,,2015,Q1,1,I,20141206.0,,20150212,20150212,DIR,,,,,79.0,YR,,F,N,60.0,KG,20150211.0,N,PH,US,,2015,Q1,Elderly
107932421,10793242,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Ventricular tachycardia,,2015,Q1,1,I,20141206.0,,20150212,20150212,DIR,,,,,79.0,YR,,F,N,60.0,KG,20150211.0,N,PH,US,,2015,Q1,Elderly
107986451,10798645,6,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10.0,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20141231.0,20150205.0,20150216,20150216,EXP,,CO-BAXTER-2015BAX007278,BAXTER,,61.0,YR,,F,Y,57.0,KG,20150216.0,N,OT,CO,CO,2015,Q1,Adult
107986451,10798645,6,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10.0,IU,,,2015,Q1,Cardiovascular disorder,,2015,Q1,1,I,20141231.0,20150205.0,20150216,20150216,EXP,,CO-BAXTER-2015BAX007278,BAXTER,,61.0,YR,,F,Y,57.0,KG,20150216.0,N,OT,CO,CO,2015,Q1,Adult
107986451,10798645,6,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10.0,IU,,,2015,Q1,Cerebrovascular accident,,2015,Q1,1,I,20141231.0,20150205.0,20150216,20150216,EXP,,CO-BAXTER-2015BAX007278,BAXTER,,61.0,YR,,F,Y,57.0,KG,20150216.0,N,OT,CO,CO,2015,Q1,Adult
107986451,10798645,6,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10.0,IU,,,2015,Q1,Disease complication,,2015,Q1,1,I,20141231.0,20150205.0,20150216,20150216,EXP,,CO-BAXTER-2015BAX007278,BAXTER,,61.0,YR,,F,Y,57.0,KG,20150216.0,N,OT,CO,CO,2015,Q1,Adult
108027141,10802714,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,10.0,IU,,,2015,Q1,Death,,2015,Q1,1,I,201410.0,20150206.0,20150217,20150217,EXP,,CO-BAXTER-2015BAX007300,BAXTER,,80.0,YR,,F,Y,53.0,KG,20150217.0,N,OT,CO,CO,2015,Q1,Elderly
108027141,10802714,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,32.0,IU,,,2015,Q1,Death,,2015,Q1,1,I,201410.0,20150206.0,20150217,20150217,EXP,,CO-BAXTER-2015BAX007300,BAXTER,,80.0,YR,,F,Y,53.0,KG,20150217.0,N,OT,CO,CO,2015,Q1,Elderly
108119792,10811979,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Haemoptysis,,2015,Q1,2,F,20150121.0,20150219.0,20150212,20150304,EXP,,2733285,HOSPIRA,,77.0,YR,,F,N,50.6,KG,20150303.0,N,MD,JP,,2015,Q1,Elderly
108119792,10811979,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Interstitial lung disease,,2015,Q1,2,F,20150121.0,20150219.0,20150212,20150304,EXP,,2733285,HOSPIRA,,77.0,YR,,F,N,50.6,KG,20150303.0,N,MD,JP,,2015,Q1,Elderly
108119792,10811979,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Neutrophil count decreased,,2015,Q1,2,F,20150121.0,20150219.0,20150212,20150304,EXP,,2733285,HOSPIRA,,77.0,YR,,F,N,50.6,KG,20150303.0,N,MD,JP,,2015,Q1,Elderly
108119792,10811979,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Platelet count decreased,,2015,Q1,2,F,20150121.0,20150219.0,20150212,20150304,EXP,,2733285,HOSPIRA,,77.0,YR,,F,N,50.6,KG,20150303.0,N,MD,JP,,2015,Q1,Elderly
108119792,10811979,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Rash,,2015,Q1,2,F,20150121.0,20150219.0,20150212,20150304,EXP,,2733285,HOSPIRA,,77.0,YR,,F,N,50.6,KG,20150303.0,N,MD,JP,,2015,Q1,Elderly
108310181,10831018,8,C,Insulin Glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,34.0,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20150207.0,20150210.0,20150219,20150219,EXP,,CO-BAXTER-2015BAX008045,BAXTER,,77.0,YR,,M,Y,81.0,KG,20150219.0,N,OT,CO,CO,2015,Q1,Elderly
108342971,10834297,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,25.0,DF,,QD,2015,Q1,Injection site haemorrhage,,2015,Q1,1,I,20140201.0,20140304.0,20150219,20150219,PER,,US-ABBVIE-14P-163-1210301-00,ABBVIE,,66.0,YR,,M,Y,,,20150219.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
108342971,10834297,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,25.0,DF,,QD,2015,Q1,Injection site pain,,2015,Q1,1,I,20140201.0,20140304.0,20150219,20150219,PER,,US-ABBVIE-14P-163-1210301-00,ABBVIE,,66.0,YR,,M,Y,,,20150219.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
108342971,10834297,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,25.0,DF,,QD,2015,Q1,Injection site swelling,,2015,Q1,1,I,20140201.0,20140304.0,20150219,20150219,PER,,US-ABBVIE-14P-163-1210301-00,ABBVIE,,66.0,YR,,M,Y,,,20150219.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
108358261,10835826,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,25,DF,,QD,2015,Q1,Nasopharyngitis,,2015,Q1,1,I,20140207.0,20140211.0,20150219,20150219,PER,,US-ABBVIE-14P-163-1201793-00,ABBVIE,,66.0,YR,,M,Y,,,20150219.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
108358261,10835826,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,25,DF,,QD,2015,Q1,Pyrexia,,2015,Q1,1,I,20140207.0,20140211.0,20150219,20150219,PER,,US-ABBVIE-14P-163-1201793-00,ABBVIE,,66.0,YR,,M,Y,,,20150219.0,N,CN,COUNTRY NOT SPECIFIED,US,2015,Q1,Elderly
108501322,10850132,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Dehydration,,2015,Q1,2,F,20130214.0,20150226.0,20150221,20150304,EXP,IT-MINISAL02-293216,IT-TEVA-541347ACC,TEVA,,89.0,YR,,M,Y,,,20150304.0,N,MD,IT,IT,2015,Q1,Elderly
108501322,10850132,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Hyperkalaemia,,2015,Q1,2,F,20130214.0,20150226.0,20150221,20150304,EXP,IT-MINISAL02-293216,IT-TEVA-541347ACC,TEVA,,89.0,YR,,M,Y,,,20150304.0,N,MD,IT,IT,2015,Q1,Elderly
108501322,10850132,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Hypoglycaemia,,2015,Q1,2,F,20130214.0,20150226.0,20150221,20150304,EXP,IT-MINISAL02-293216,IT-TEVA-541347ACC,TEVA,,89.0,YR,,M,Y,,,20150304.0,N,MD,IT,IT,2015,Q1,Elderly
108536182,10853618,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,7,IU,UNSPECIFIED,,2015,Q1,Anaemia,,2015,Q1,2,F,20140727.0,20150219.0,20150223,20150305,PER,,CO-JNJFOC-20150208518,JANSSEN,,84.0,YR,E,F,Y,55.0,KG,20150305.0,N,OT,CO,CO,2015,Q1,Elderly
108536182,10853618,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,7,IU,UNSPECIFIED,,2015,Q1,Platelet count decreased,,2015,Q1,2,F,20140727.0,20150219.0,20150223,20150305,PER,,CO-JNJFOC-20150208518,JANSSEN,,84.0,YR,E,F,Y,55.0,KG,20150305.0,N,OT,CO,CO,2015,Q1,Elderly
108553431,10855343,5,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2015,Q1,Infection,,2015,Q1,1,I,201410.0,20141202.0,20150223,20150223,PER,,US-CELGENEUS-USA-2014121632,CELGENE,,83.0,YR,,M,Y,77.63,KG,20150222.0,N,MD,US,US,2015,Q1,Elderly
108555341,10855534,13,C,Glargine Insulin,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20141203.0,20150216.0,20150223,20150223,EXP,,CO-BAXTER-2015BAX008923,BAXTER,,60.0,YR,,M,Y,84.6,KG,20150223.0,N,OT,CO,CO,2015,Q1,Adult
108587991,10858799,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,100UNITS/ML  20 UNITS,,,,D,,,,,,INJECTION,QD,2015,Q1,Pneumonia,,2015,Q1,1,I,20140503.0,20140604.0,20150223,20150223,PER,,US-CELGENEUS-163-21880-14060880,CELGENE,,80.0,YR,,M,Y,,,20150221.0,N,MD,US,US,2015,Q1,Elderly
108611971,10861197,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Chronic obstructive pulmonary disease,,2015,Q1,1,I,20150206.0,,20150218,20150218,DIR,,,,,88.0,YR,,M,N,156.0,LBS,20150213.0,N,PH,US,,2015,Q1,Elderly
108611971,10861197,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Decreased appetite,,2015,Q1,1,I,20150206.0,,20150218,20150218,DIR,,,,,88.0,YR,,M,N,156.0,LBS,20150213.0,N,PH,US,,2015,Q1,Elderly
108611971,10861197,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Weight decreased,,2015,Q1,1,I,20150206.0,,20150218,20150218,DIR,,,,,88.0,YR,,M,N,156.0,LBS,20150213.0,N,PH,US,,2015,Q1,Elderly
108617722,10861772,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"91 IU, QD",,,,D,,,,91,IU,,QD,2015,Q1,Viral infection,,2015,Q1,2,F,20150212.0,20150317.0,20150224,20150326,EXP,,CO-NOVOPROD-439532,NOVO NORDISK,,30.0,YR,A,M,Y,104.0,KG,20150326.0,N,CN,CO,CO,2015,Q1,Young Adult
108677702,10867770,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Blood glucose increased,,2015,Q1,2,F,,20150305.0,20150225,20150317,EXP,,CO-ELI_LILLY_AND_COMPANY-CO201502006691,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20150316.0,N,CN,CO,CO,2015,Q1,Elderly
108689071,10868907,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,12,IU,,QD,2015,Q1,Anaphylactic reaction,,2015,Q1,1,I,20131030.0,20140411.0,20150225,20150225,EXP,,US-MYLANLABS-2014SP002236,MYLAN,,59.0,YR,,F,Y,,,20150225.0,N,CN,US,US,2015,Q1,Adult
108689071,10868907,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,12,IU,,QD,2015,Q1,Rash,,2015,Q1,1,I,20131030.0,20140411.0,20150225,20150225,EXP,,US-MYLANLABS-2014SP002236,MYLAN,,59.0,YR,,F,Y,,,20150225.0,N,CN,US,US,2015,Q1,Adult
108689071,10868907,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,12,IU,,QD,2015,Q1,Urticaria,,2015,Q1,1,I,20131030.0,20140411.0,20150225,20150225,EXP,,US-MYLANLABS-2014SP002236,MYLAN,,59.0,YR,,F,Y,,,20150225.0,N,CN,US,US,2015,Q1,Adult
108694471,10869447,12,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Drug interaction,,2015,Q1,1,I,,20141203.0,20150226,20150226,PER,,US-DRREDDYS-USA/USA/14/0044760,DR REDDYS,"BAIN E, BIRHIRAY R, REEVES D. DRUG-DRUG INTERACTION BETWEEN METHOTREXATE AND LEVETIRACETAM RESULTING IN DELAYED METHOTREXATE ELIMINATION. ANN PHARMACOTHER. 2014;48(2):292-6.",46.0,YR,,M,Y,80.0,KG,20150226.0,N,PH,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
108694471,10869447,12,C,insulin glargine,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Drug level increased,,2015,Q1,1,I,,20141203.0,20150226,20150226,PER,,US-DRREDDYS-USA/USA/14/0044760,DR REDDYS,"BAIN E, BIRHIRAY R, REEVES D. DRUG-DRUG INTERACTION BETWEEN METHOTREXATE AND LEVETIRACETAM RESULTING IN DELAYED METHOTREXATE ELIMINATION. ANN PHARMACOTHER. 2014;48(2):292-6.",46.0,YR,,M,Y,80.0,KG,20150226.0,N,PH,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
108704731,10870473,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D, UNKNOWN,,,10,DF,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108704731,10870473,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D, UNKNOWN,,,10,DF,,QD,2015,Q1,Ovarian cancer stage I,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108704731,10870473,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"5 U, QD",,,,D, UNKNOWN,,,5,DF,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108704731,10870473,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"5 U, QD",,,,D, UNKNOWN,,,5,DF,,QD,2015,Q1,Ovarian cancer stage I,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108704731,10870473,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D, UNKNOWN,,,10,DF,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108704731,10870473,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,"10 U, QD",,,,D, UNKNOWN,,,10,DF,,QD,2015,Q1,Ovarian cancer stage I,,2015,Q1,1,I,,20150217.0,20150226,20150226,EXP,,JP-NOVOPROD-439665,NOVO NORDISK,"GO YOSHIMICHI, ET.AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH GIANT OVARIAN CANCER. CLINICAL ENDOCRINOLOGY. 2013;61(4):331-333",53.0,YR,A,F,Y,51.0,KG,20150226.0,N,MD,JP,JP,2015,Q1,Adult
108708412,10870841,7,C,INSULINE GLARGINE,,2,,INJVLST 100E/ML PATR 3ML,,,,D,,,,,,,,2015,Q1,Cerebral infarction,,2015,Q1,2,F,2014.0,20150226.0,20150226,20150303,EXP,,NL-ABBVIE-15P-114-1350479-00,ABBVIE,,65.0,YR,,M,Y,,,20150303.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
108708412,10870841,7,C,INSULINE GLARGINE,,2,,INJVLST 100E/ML PATR 3ML,,,,D,,,,,,,,2015,Q1,Metastases to spine,,2015,Q1,2,F,2014.0,20150226.0,20150226,20150303,EXP,,NL-ABBVIE-15P-114-1350479-00,ABBVIE,,65.0,YR,,M,Y,,,20150303.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
108708412,10870841,7,C,INSULINE GLARGINE,,2,,INJVLST 100E/ML PATR 3ML,,,,D,,,,,,,,2015,Q1,Pain,,2015,Q1,2,F,2014.0,20150226.0,20150226,20150303,EXP,,NL-ABBVIE-15P-114-1350479-00,ABBVIE,,65.0,YR,,M,Y,,,20150303.0,N,CN,COUNTRY NOT SPECIFIED,NL,2015,Q1,Elderly
108723271,10872327,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,20150130.0,20150224.0,20150226,20150226,EXP,,CO-ABBVIE-15P-036-1352699-00,ABBVIE,,63.0,YR,,F,Y,59.5,KG,20150226.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q1,Adult
108723271,10872327,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Device related infection,,2015,Q1,1,I,20150130.0,20150224.0,20150226,20150226,EXP,,CO-ABBVIE-15P-036-1352699-00,ABBVIE,,63.0,YR,,F,Y,59.5,KG,20150226.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q1,Adult
108723271,10872327,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Diarrhoea,,2015,Q1,1,I,20150130.0,20150224.0,20150226,20150226,EXP,,CO-ABBVIE-15P-036-1352699-00,ABBVIE,,63.0,YR,,F,Y,59.5,KG,20150226.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q1,Adult
108723271,10872327,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Malaise,,2015,Q1,1,I,20150130.0,20150224.0,20150226,20150226,EXP,,CO-ABBVIE-15P-036-1352699-00,ABBVIE,,63.0,YR,,F,Y,59.5,KG,20150226.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Confusional state,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Hypotension,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Lethargy,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Localised infection,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Mental status changes,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Myoclonus,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Toxicity to various agents,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108725811,10872581,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Tremor,,2015,Q1,1,I,,20150216.0,20150227,20150227,EXP,,US-ALKEM-000884,ALKEM,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY BEHAV CASE REP. 2013 DEC 29;2:8-10.",55.0,YR,,M,Y,,,20150227.0,N,OT,US,US,2015,Q1,Adult
108737632,10873763,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Pneumonia fungal,,2015,Q1,2,F,20150216.0,20150313.0,20150227,20150325,EXP,,US-ALEXION PHARMACEUTICALS INC.-A201500587,ALEXION,,72.0,YR,,F,Y,88.3,KG,20150325.0,N,MD,US,US,2015,Q1,Elderly
108764961,10876496,6,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q1,Gastric disorder,,2015,Q1,1,I,20141223.0,20150217.0,20150228,20150228,EXP,,US-BIOGENIDEC-2015BI022614,BIOGEN,,53.0,YR,,F,Y,77.0,KG,20150228.0,N,CN,US,US,2015,Q1,Adult
108764961,10876496,6,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q1,Headache,,2015,Q1,1,I,20141223.0,20150217.0,20150228,20150228,EXP,,US-BIOGENIDEC-2015BI022614,BIOGEN,,53.0,YR,,F,Y,77.0,KG,20150228.0,N,CN,US,US,2015,Q1,Adult
108764961,10876496,6,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q1,Kidney infection,,2015,Q1,1,I,20141223.0,20150217.0,20150228,20150228,EXP,,US-BIOGENIDEC-2015BI022614,BIOGEN,,53.0,YR,,F,Y,77.0,KG,20150228.0,N,CN,US,US,2015,Q1,Adult
108764961,10876496,6,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q1,Nausea,,2015,Q1,1,I,20141223.0,20150217.0,20150228,20150228,EXP,,US-BIOGENIDEC-2015BI022614,BIOGEN,,53.0,YR,,F,Y,77.0,KG,20150228.0,N,CN,US,US,2015,Q1,Adult
108777441,10877744,6,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,32,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20150220.0,20150223.0,20150302,20150302,EXP,,CO-BAXTER-2015BAX010404,BAXTER,,80.0,YR,,M,Y,63.0,KG,20150302.0,N,OT,CO,CO,2015,Q1,Elderly
108777441,10877744,6,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,32,IU,,QD,2015,Q1,Diabetic foot,,2015,Q1,1,I,20150220.0,20150223.0,20150302,20150302,EXP,,CO-BAXTER-2015BAX010404,BAXTER,,80.0,YR,,M,Y,63.0,KG,20150302.0,N,OT,CO,CO,2015,Q1,Elderly
108777441,10877744,6,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,32,IU,,QD,2015,Q1,Oesophageal obstruction,,2015,Q1,1,I,20150220.0,20150223.0,20150302,20150302,EXP,,CO-BAXTER-2015BAX010404,BAXTER,,80.0,YR,,M,Y,63.0,KG,20150302.0,N,OT,CO,CO,2015,Q1,Elderly
108820681,10882068,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Cardiac failure,,2015,Q1,1,I,20150105.0,20150224.0,20150303,20150303,EXP,,CO-BAXTER-2015BAX010794,BAXTER,,72.0,YR,,F,Y,65.0,KG,20150303.0,N,OT,CO,CO,2015,Q1,Elderly
108820681,10882068,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Death,,2015,Q1,1,I,20150105.0,20150224.0,20150303,20150303,EXP,,CO-BAXTER-2015BAX010794,BAXTER,,72.0,YR,,F,Y,65.0,KG,20150303.0,N,OT,CO,CO,2015,Q1,Elderly
108820681,10882068,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,20150105.0,20150224.0,20150303,20150303,EXP,,CO-BAXTER-2015BAX010794,BAXTER,,72.0,YR,,F,Y,65.0,KG,20150303.0,N,OT,CO,CO,2015,Q1,Elderly
108850341,10885034,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,12-16 UNITS ON MORNING,,,,D, UNK,,21081.0,,,INJECTION,,2015,Q1,Amyloidosis,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108850341,10885034,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,12-16 UNITS ON MORNING,,,,D, UNK,,21081.0,,,INJECTION,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108850341,10885034,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,MORNING DOSE:20 UNIT(S),,,,D, UNK,,21081.0,,,INJECTION,QD,2015,Q1,Amyloidosis,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108850341,10885034,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,MORNING DOSE:20 UNIT(S),,,,D, UNK,,21081.0,,,INJECTION,QD,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108850341,10885034,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,DOSE:12 UNIT(S),,,,D, UNK,,21081.0,,,INJECTION,QD,2015,Q1,Amyloidosis,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108850341,10885034,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,DOSE:12 UNIT(S),,,,D, UNK,,21081.0,,,INJECTION,QD,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150225.0,20150304,20150304,EXP,,JP-SA-2015SA025123,AVENTIS,"YABE S, MORI T, IKAWA H, KUDO H, MATSUMOTO A, BENIKO M, ET AL. A CASE OF TYPE 1 DIABETES MELLITUS WITH MARKED POOR GLYCEMIC CONTROL CAUSED BY INSULIN-DERIVED AMYLOIDOSIS AT THE SITE OF REPEATED INSULIN INJECTIONS. JOURNAL OF THE JAPANESE DIABETIC SOCIETY. 2015 JAN;58(1):34-40.",62.0,YR,A,M,Y,57.4,KG,20150304.0,N,OT,JP,JP,2015,Q1,Adult
108852991,10885299,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,10 IU,,,,D,,,,10,IU,,,2015,Q1,Pancreatitis acute,,2015,Q1,1,I,20140415.0,20150226.0,20150304,20150304,EXP,,PHHY2015ES023308,NOVARTIS,,78.0,YR,,M,Y,,,20150304.0,N,OT,ES,ES,2015,Q1,Elderly
108853901,10885390,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,100 U/ML 3 ML SOLOST INJECTS 25 UNITS SQ QAM,,,,D,,,,,,INJECTION,,2015,Q1,Deep vein thrombosis,,2015,Q1,1,I,20150214.0,20150218.0,20150304,20150304,EXP,,PHHO2015US002756,NOVARTIS,,80.0,YR,,F,Y,83.4,KG,20150304.0,N,MD,US,US,2015,Q1,Elderly
108885091,10888509,10,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,General physical health deterioration,,2015,Q1,1,I,20150211.0,20150225.0,20150305,20150305,EXP,,CO-BAXTER-2015BAX011080,BAXTER,,80.0,YR,,M,Y,100.0,KG,20150305.0,N,OT,CO,CO,2015,Q1,Elderly
108885091,10888509,10,C,Insulin Glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,20,IU,,QD,2015,Q1,Soft tissue infection,,2015,Q1,1,I,20150211.0,20150225.0,20150305,20150305,EXP,,CO-BAXTER-2015BAX011080,BAXTER,,80.0,YR,,M,Y,100.0,KG,20150305.0,N,OT,CO,CO,2015,Q1,Elderly
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Anaphylactic shock,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Angioedema,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Blood pressure increased,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Body mass index increased,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Drug hypersensitivity,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Injection site induration,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Injection site pain,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Injection site papule,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108887851,10888785,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q1,Rash,,2015,Q1,1,I,,20150222.0,20150305,20150305,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201502009043,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20150227.0,N,OT,BR,BR,2015,Q1,Adult
108966681,10896668,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Drug ineffective,,2015,Q1,1,I,20150227.0,,20150302,20150302,DIR,,,,,51.0,YR,,F,N,,,20150227.0,N,PH,US,,2015,Q1,Adult
108966681,10896668,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Urinary tract infection,,2015,Q1,1,I,20150227.0,,20150302,20150302,DIR,,,,,51.0,YR,,F,N,,,20150227.0,N,PH,US,,2015,Q1,Adult
108969591,10896959,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Chest pain,,2015,Q1,1,I,20150205.0,,20150302,20150302,DIR,,,,,61.0,YR,,M,N,,,20150228.0,N,PH,US,,2015,Q1,Adult
108969591,10896959,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Costochondritis,,2015,Q1,1,I,20150205.0,,20150302,20150302,DIR,,,,,61.0,YR,,M,N,,,20150228.0,N,PH,US,,2015,Q1,Adult
108969591,10896959,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Disease recurrence,,2015,Q1,1,I,20150205.0,,20150302,20150302,DIR,,,,,61.0,YR,,M,N,,,20150228.0,N,PH,US,,2015,Q1,Adult
108969591,10896959,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Ventricular tachycardia,,2015,Q1,1,I,20150205.0,,20150302,20150302,DIR,,,,,61.0,YR,,M,N,,,20150228.0,N,PH,US,,2015,Q1,Adult
109072201,10907220,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Transaminases increased,,2015,Q1,1,I,20150223.0,,20150309,20150309,DIR,,,,,58.0,YR,,F,N,92.7,KG,20150304.0,N,OT,US,,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Confusional state,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Hypotension,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Lethargy,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Localised infection,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Mental status changes,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Myoclonus,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Renal impairment,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Toxicity to various agents,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109128101,10912810,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q1,Tremor,,2015,Q1,1,I,,20150227.0,20150313,20150313,EXP,,US-GLENMARK GENERICS (EUROPE) LTD-2015GMK014684,GLENMARK,"KAUFMAN KR, PARIKH A, CHAN L, BRIDGEMAN M, SHAH M. MYOCLONUS IN RENAL FAILURE: TWO CASES OF GABAPENTIN TOXICITY. EPILEPSY AND BEHAVIOR CASE REPORTS. 2014;2:8-10",55.0,YR,,M,Y,,,20150313.0,N,OT,US,US,2015,Q1,Adult
109155271,10915527,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG DAILY,,,,D,,,,,,,,2015,Q1,Babesiosis,,2015,Q1,1,I,,20150309.0,20150316,20150316,EXP,,US-TEVA-546740USA,TEVA,"MECCHELLA J,RIGBY W,ZBEHLIK A.",53.0,YR,,M,Y,,,20150316.0,N,OT,US,US,2015,Q1,Adult
109155271,10915527,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG DAILY,,,,D,,,,,,,,2015,Q1,Histiocytosis haematophagic,,2015,Q1,1,I,,20150309.0,20150316,20150316,EXP,,US-TEVA-546740USA,TEVA,"MECCHELLA J,RIGBY W,ZBEHLIK A.",53.0,YR,,M,Y,,,20150316.0,N,OT,US,US,2015,Q1,Adult
109155271,10915527,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG DAILY,,,,D,,,,,,,,2015,Q1,Pancytopenia,,2015,Q1,1,I,,20150309.0,20150316,20150316,EXP,,US-TEVA-546740USA,TEVA,"MECCHELLA J,RIGBY W,ZBEHLIK A.",53.0,YR,,M,Y,,,20150316.0,N,OT,US,US,2015,Q1,Adult
109242431,10924243,2,C,LANTUS (INSULIN GLARGINE) INJECTION,,2,,,,,,,,,,,,,,2015,Q1,Generalised tonic-clonic seizure,,2015,Q1,1,I,20140313.0,20140508.0,20150129,20150129,PER,,115424U,UCB,,80.0,YR,,F,N,65.7,KG,20150116.0,N,CN,US,,2015,Q1,Elderly
109242431,10924243,2,C,LANTUS (INSULIN GLARGINE) INJECTION,,2,,,,,,,,,,,,,,2015,Q1,Inappropriate schedule of drug administration,,2015,Q1,1,I,20140313.0,20140508.0,20150129,20150129,PER,,115424U,UCB,,80.0,YR,,F,N,65.7,KG,20150116.0,N,CN,US,,2015,Q1,Elderly
109242431,10924243,2,C,LANTUS (INSULIN GLARGINE) INJECTION,,2,,,,,,,,,,,,,,2015,Q1,Seizure,,2015,Q1,1,I,20140313.0,20140508.0,20150129,20150129,PER,,115424U,UCB,,80.0,YR,,F,N,65.7,KG,20150116.0,N,CN,US,,2015,Q1,Elderly
109328851,10932885,8,C,INSULINE GLARGINE,,2,UNKNOWN,"10 MG, DAILY",,,,U,,,,10,MG,,,2015,Q1,Arthralgia,,2015,Q1,1,I,,20150224.0,20150320,20150320,EXP,,US-APOTEX-2015AP007417,APOTEX,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ.. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS.. ARTHRITIS-CARE-RES-(HOBOKEN) 2014. 2014;66(10):1587-90",53.0,YR,,M,Y,,,20150320.0,N,OT,US,US,2015,Q1,Adult
109328851,10932885,8,C,INSULINE GLARGINE,,2,UNKNOWN,"10 MG, DAILY",,,,U,,,,10,MG,,,2015,Q1,Leukopenia,,2015,Q1,1,I,,20150224.0,20150320,20150320,EXP,,US-APOTEX-2015AP007417,APOTEX,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ.. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS.. ARTHRITIS-CARE-RES-(HOBOKEN) 2014. 2014;66(10):1587-90",53.0,YR,,M,Y,,,20150320.0,N,OT,US,US,2015,Q1,Adult
109480701,10948070,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Anaemia,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,PER,,US-CELGENEUS-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109480701,10948070,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Gastrointestinal haemorrhage,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,PER,,US-CELGENEUS-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109480701,10948070,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Pancreatic carcinoma,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,PER,,US-CELGENEUS-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109490481,10949048,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Anaemia,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,EXP,,US-CELGENE-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109490481,10949048,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Gastrointestinal haemorrhage,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,EXP,,US-CELGENE-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109490481,10949048,12,C,Insulin glargine,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,15,IU,UNKNOWN,QD,2015,Q1,Pancreatic carcinoma,,2015,Q1,1,I,20120802.0,20150312.0,20150324,20150324,EXP,,US-CELGENE-USA-2015034150,CELGENE,,50.0,YR,,M,Y,,,20150324.0,N,OT,US,US,2015,Q1,Adult
109509641,10950964,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109509641,10950964,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Depression,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109509641,10950964,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Urinary retention,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109537661,10953766,11,C,LANTUS (INSULIN GLARGINE) ?,,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,201004.0,20120730.0,20150226,20150226,PER,,TPA2012A01730,TAKEDA,,70.0,YR,,M,N,,,20120918.0,N,,US,,2015,Q1,Elderly
109537661,10953766,11,C,LANTUS (INSULIN GLARGINE) ?,,2,,,,,,,,,,,,,,2015,Q1,Cystitis,,2015,Q1,1,I,201004.0,20120730.0,20150226,20150226,PER,,TPA2012A01730,TAKEDA,,70.0,YR,,M,N,,,20120918.0,N,,US,,2015,Q1,Elderly
109539571,10953957,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,2010.0,20120728.0,20150226,20150226,PER,,TPA2012A05469,TAKEDA,,53.0,YR,,F,N,,,20120919.0,N,CN,US,,2015,Q1,Adult
109559111,10955911,5,C,GLARGINE/LANTUS (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20100702.0,20121226.0,20150226,20150226,PER,,TPA2012A09174,TAKEDA,,65.0,YR,,M,N,240.0,LBS,20130829.0,N,OT,US,,2015,Q1,Elderly
109571372,10957137,4,C,LANTUS (INSULING GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,2,F,20090612.0,20121115.0,20150226,20150226,PER,,TPA2012A02972,TAKEDA,,72.0,YR,,M,N,225.0,LBS,20130829.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q1,Elderly
109571372,10957137,4,C,LANTUS (INSULING GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder transitional cell carcinoma,,2015,Q1,2,F,20090612.0,20121115.0,20150226,20150226,PER,,TPA2012A02972,TAKEDA,,72.0,YR,,M,N,225.0,LBS,20130829.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q1,Elderly
109571372,10957137,4,C,LANTUS (INSULING GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder transitional cell carcinoma recurrent,,2015,Q1,2,F,20090612.0,20121115.0,20150226,20150226,PER,,TPA2012A02972,TAKEDA,,72.0,YR,,M,N,225.0,LBS,20130829.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Cardiac disorder,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Cardio-respiratory arrest,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Fatigue,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Pneumonia,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Sensory disturbance,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109577711,10957771,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,9,IU,,,2015,Q1,Sepsis,,2015,Q1,1,I,20141128.0,20150318.0,20150326,20150326,EXP,,CO-BAXTER-2015BAX015069,BAXTER,,81.0,YR,,F,Y,42.0,KG,20150326.0,N,OT,CO,CO,2015,Q1,Elderly
109605771,10960577,11,C,"INSULIN, GLARGINE",,2,,,,,,,,,,,,,,2015,Q1,Embolic stroke,,2015,Q1,1,I,20150123.0,,20150326,20150326,DIR,,,,,65.0,YR,,M,N,106.0,KG,20150325.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q1,Elderly
109605771,10960577,11,C,"INSULIN, GLARGINE",,2,,,,,,,,,,,,,,2015,Q1,Haemorrhagic stroke,,2015,Q1,1,I,20150123.0,,20150326,20150326,DIR,,,,,65.0,YR,,M,N,106.0,KG,20150325.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q1,Elderly
109606761,10960676,7,C,GLARGINE LANTUS (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,201104.0,20120712.0,20150226,20150226,PER,,TPA2012A04227,TAKEDA,,46.0,YR,,M,N,160.0,LBS,20120919.0,N,MD,US,,2015,Q1,Adult
109608041,10960804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG,,,,D,,,,,,,,2015,Q1,Babesiosis,,2015,Q1,1,I,201210.0,20150320.0,20150327,20150327,EXP,,"US-ROXANE LABORATORIES, INC.-2015-RO-00530RO",ROXANE,"MECCHELLA J,RIGBY W,ZBEHLIK A. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE AND RESEARCH 2014 OCT;66:10:1587-1590.",53.0,YR,,M,Y,,,20150327.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
109608041,10960804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG,,,,D,,,,,,,,2015,Q1,Histiocytosis haematophagic,,2015,Q1,1,I,201210.0,20150320.0,20150327,20150327,EXP,,"US-ROXANE LABORATORIES, INC.-2015-RO-00530RO",ROXANE,"MECCHELLA J,RIGBY W,ZBEHLIK A. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE AND RESEARCH 2014 OCT;66:10:1587-1590.",53.0,YR,,M,Y,,,20150327.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
109608041,10960804,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,10 MG,,,,D,,,,,,,,2015,Q1,Pancytopenia,,2015,Q1,1,I,201210.0,20150320.0,20150327,20150327,EXP,,"US-ROXANE LABORATORIES, INC.-2015-RO-00530RO",ROXANE,"MECCHELLA J,RIGBY W,ZBEHLIK A. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE AND RESEARCH 2014 OCT;66:10:1587-1590.",53.0,YR,,M,Y,,,20150327.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
109616411,10961641,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Alanine aminotransferase increased,,2015,Q1,1,I,,20150318.0,20150327,20150327,EXP,,US-GILEAD-2015-0144170,GILEAD,,67.0,YR,E,M,Y,82.0,KG,20150327.0,N,CN,US,US,2015,Q1,Elderly
109616411,10961641,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Aspartate aminotransferase increased,,2015,Q1,1,I,,20150318.0,20150327,20150327,EXP,,US-GILEAD-2015-0144170,GILEAD,,67.0,YR,E,M,Y,82.0,KG,20150327.0,N,CN,US,US,2015,Q1,Elderly
109616411,10961641,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Blood alkaline phosphatase increased,,2015,Q1,1,I,,20150318.0,20150327,20150327,EXP,,US-GILEAD-2015-0144170,GILEAD,,67.0,YR,E,M,Y,82.0,KG,20150327.0,N,CN,US,US,2015,Q1,Elderly
109616411,10961641,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q1,Blood bilirubin increased,,2015,Q1,1,I,,20150318.0,20150327,20150327,EXP,,US-GILEAD-2015-0144170,GILEAD,,67.0,YR,E,M,Y,82.0,KG,20150327.0,N,CN,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Adenocarcinoma pancreas,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Ascites,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Hepatic steatosis,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Large intestine benign neoplasm,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Metastatic lymphoma,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Pancreatitis acute,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109627401,10962740,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,1DF=18UNITS DAILY,,,,D,,,,,,,,2015,Q1,Pancreatitis relapsing,,2015,Q1,1,I,20120207.0,20140402.0,20150327,20150327,EXP,,US-ASTRAZENECA-2014SE25633,ASTRAZENECA,,24131.0,DY,,F,Y,,,20150327.0,N,,US,US,2015,Q1,Elderly
109645201,10964520,3,C,GLARGINE (LANTUS (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,201109.0,20120726.0,20150226,20150226,PER,,TPA2012A01519,TAKEDA,,55.0,YR,,M,N,345.0,LBS,20120918.0,N,CN,US,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Adrenal insufficiency,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Cardio-respiratory arrest,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Cardiogenic shock,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Pancytopenia,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Sepsis,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109697371,10969737,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q1,Urinary tract infection,,2015,Q1,1,I,20131116.0,20150312.0,20150327,20150327,EXP,,HRA-MET20150002,HRA PHARMA,,43.0,YR,,F,N,,,20150324.0,N,,JP,,2015,Q1,Adult
109703921,10970392,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,30,IU,INJECTION,,2015,Q1,Bradycardia,,2015,Q1,1,I,20150221.0,20150323.0,20150331,20150331,EXP,GB-MHRA-ADR 22909055,GB-SA-2015SA037218,AVENTIS,,82.0,YR,E,F,Y,,,20150331.0,N,OT,GB,GB,2015,Q1,Elderly
109703921,10970392,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,30,IU,INJECTION,,2015,Q1,Cold sweat,,2015,Q1,1,I,20150221.0,20150323.0,20150331,20150331,EXP,GB-MHRA-ADR 22909055,GB-SA-2015SA037218,AVENTIS,,82.0,YR,E,F,Y,,,20150331.0,N,OT,GB,GB,2015,Q1,Elderly
109703921,10970392,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,30,IU,INJECTION,,2015,Q1,Hyporesponsive to stimuli,,2015,Q1,1,I,20150221.0,20150323.0,20150331,20150331,EXP,GB-MHRA-ADR 22909055,GB-SA-2015SA037218,AVENTIS,,82.0,YR,E,F,Y,,,20150331.0,N,OT,GB,GB,2015,Q1,Elderly
109703921,10970392,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,30,IU,INJECTION,,2015,Q1,Listless,,2015,Q1,1,I,20150221.0,20150323.0,20150331,20150331,EXP,GB-MHRA-ADR 22909055,GB-SA-2015SA037218,AVENTIS,,82.0,YR,E,F,Y,,,20150331.0,N,OT,GB,GB,2015,Q1,Elderly
109703921,10970392,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D, UNK,,21081.0,30,IU,INJECTION,,2015,Q1,Wrong patient received medication,,2015,Q1,1,I,20150221.0,20150323.0,20150331,20150331,EXP,GB-MHRA-ADR 22909055,GB-SA-2015SA037218,AVENTIS,,82.0,YR,E,F,Y,,,20150331.0,N,OT,GB,GB,2015,Q1,Elderly
109704631,10970463,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Glucose-6-phosphate dehydrogenase deficiency,,2015,Q1,1,I,,20150317.0,20150331,20150331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020155,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20150331.0,N,CN,DE,US,2015,Q1,Adult
109704631,10970463,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Haemolytic anaemia,,2015,Q1,1,I,,20150317.0,20150331,20150331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020155,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,,,20150331.0,N,CN,DE,US,2015,Q1,Adult
109705381,10970538,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,46,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,46,IU,,,2015,Q1,Diarrhoea,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,46,IU,,,2015,Q1,General physical health deterioration,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,46,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,44,IU,,,2015,Q1,Acute myocardial infarction,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,44,IU,,,2015,Q1,Diarrhoea,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,44,IU,,,2015,Q1,General physical health deterioration,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109705381,10970538,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,SUBCUTANEOUS,,,,,D,,,,44,IU,,,2015,Q1,Vomiting,,2015,Q1,1,I,20150315.0,20150324.0,20150331,20150331,EXP,,CO-BAXTER-2015BAX016165,BAXTER,,60.0,YR,,M,Y,87.8,KG,20150331.0,N,OT,CO,CO,2015,Q1,Adult
109721211,10972121,11,C,GLARGINEL/LANTUS (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20110114.0,20120727.0,20150226,20150226,PER,,TPA2012A03601,TAKEDA,,78.0,YR,,M,N,222.0,LBS,20120919.0,N,,US,,2015,Q1,Elderly
109721851,10972185,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,UNKNOWN,UNK,,,,D,,,,,,,,2015,Q1,Cerebrovascular accident,,2015,Q1,1,I,20140620.0,20150317.0,20150331,20150331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-018409,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,85.0,KG,20150331.0,N,CN,US,US,2015,Q1,Adult
109789321,10978932,5,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Condition aggravated,,2015,Q1,1,I,20090829.0,20090914.0,20150226,20150226,PER,,TPA2009A02699,TAKEDA,,51.0,YR,,F,N,190.0,LBS,20091125.0,N,CN,US,,2015,Q1,Adult
109789321,10978932,5,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Gout,,2015,Q1,1,I,20090829.0,20090914.0,20150226,20150226,PER,,TPA2009A02699,TAKEDA,,51.0,YR,,F,N,190.0,LBS,20091125.0,N,CN,US,,2015,Q1,Adult
109789321,10978932,5,C,LANTUS INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Oedema peripheral,,2015,Q1,1,I,20090829.0,20090914.0,20150226,20150226,PER,,TPA2009A02699,TAKEDA,,51.0,YR,,F,N,190.0,LBS,20091125.0,N,CN,US,,2015,Q1,Adult
109902831,10990283,12,C,GLARGINE (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
109902831,10990283,12,C,GLARGINE (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Cystitis,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
109902831,10990283,12,C,GLARGINE (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q1,Urinary tract infection,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,Anaemia,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,Dizziness,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,Fatigue,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,Infection,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,PO2 decreased,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
69657773,6965777,11,C,LANTUS (INSULIN) GLARGINE) FORMULATION UNKNOWN,,2,,,,,,,,,,,,,,2015,Q1,Pyrexia,,2015,Q1,3,F,20090217.0,20150217.0,20090331,20150226,EXP,,2009000822,ASTELLAS,,73.0,YR,,M,N,,,20150224.0,,OT,GR,,2015,Q1,Elderly
87670645,8767064,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,24 UNITS AT BEDTIME,,,,D,,,,24,DF,,,2015,Q1,"Hallucination, visual",,2015,Q1,5,F,,20150227.0,20120831,20150303,EXP,,US-PFIZER INC-2012210115,PFIZER,"EZEJI, G. C.. HALLUCINATIONS ASSOCIATED WITH MIGLITOL USE IN A PATIENT WITH CHRONIC KIDNEY DISEASE AND HYPOTHYROIDISM. BMJ CASE REPORTS. 2015;1-3",71.0,YR,,F,Y,,,20150303.0,N,OT,US,US,2015,Q1,Elderly
88382653,8838265,24,C,GLARGINE,,2,UNKNOWN,20 UNITS,,,,D,,,,,,,,2015,Q1,Accident,,2015,Q1,3,F,20080321.0,20121119.0,20121012,20150205,EXP,,US-ROCHE-1118550,ROCHE,,68.0,YR,,F,Y,,,20150206.0,N,MD,US,US,2015,Q1,Elderly
88382653,8838265,24,C,GLARGINE,,2,UNKNOWN,20 UNITS,,,,D,,,,,,,,2015,Q1,Death,,2015,Q1,3,F,20080321.0,20121119.0,20121012,20150205,EXP,,US-ROCHE-1118550,ROCHE,,68.0,YR,,F,Y,,,20150206.0,N,MD,US,US,2015,Q1,Elderly
88382653,8838265,24,C,GLARGINE,,2,UNKNOWN,20 UNITS,,,,D,,,,,,,,2015,Q1,Joint stiffness,,2015,Q1,3,F,20080321.0,20121119.0,20121012,20150205,EXP,,US-ROCHE-1118550,ROCHE,,68.0,YR,,F,Y,,,20150206.0,N,MD,US,US,2015,Q1,Elderly
98942013,9894201,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,SUBCUTANEOUS,60IU-20JAN14  ALSO 62 IU RESTARTED ON 21 JAN 14.,,,,D,,,,60,IU,,QD,2015,Q1,Non-cardiac chest pain,,2015,Q1,3,F,20140213.0,20150115.0,20140213,20150126,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-20187399,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20150126.0,N,CN,FR,FR,2015,Q1,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Abdominal pain,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Asthenia,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Blood creatinine increased,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,C-reactive protein increased,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Diarrhoea,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Dysuria,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Pleural effusion,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Pyrexia,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
1000332911,10003329,5,C,INSULINA GLARGINE,,2,Subcutaneous,12 U,,,,D,,,,12,IU,,QD,2015,Q2,Weight decreased,,2015,Q2,11,F,20140303.0,20150421.0,20140312,20150430,EXP,,"IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-09771BI",BOEHRINGER INGELHEIM,,79.0,YR,,F,Y,61.0,KG,20150430.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
101473772,10147377,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,QD,2015,Q2,Hypersensitivity,,2015,Q2,2,F,20131228.0,20140512.0,20140501,20150622,PER,,US-SA-2014SA032911,AVENTIS,,41.0,YR,A,M,Y,91.0,KG,20150622.0,N,OT,US,US,2015,Q2,Adult
101473772,10147377,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,QD,2015,Q2,Pruritus generalised,,2015,Q2,2,F,20131228.0,20140512.0,20140501,20150622,PER,,US-SA-2014SA032911,AVENTIS,,41.0,YR,A,M,Y,91.0,KG,20150622.0,N,OT,US,US,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Ascites,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Blood creatinine increased,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Cachexia,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Decreased appetite,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Dehydration,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Dry skin,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Dysgeusia,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Fatigue,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,General physical health deterioration,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Hepatic function abnormal,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Kidney infection,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Malaise,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Mucosal inflammation,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104336288,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,D,,,,10,DF,,QD,2015,Q2,Skin exfoliation,,2015,Q2,8,F,20140716.0,20150601.0,20140905,20150611,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20150611.0,N,OT,GB,GB,2015,Q2,Adult
104755434,10475543,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UT, ONCE DAILY",,,,D,,,,,,FORMULATION UNKNOWN,QD,2015,Q2,Cardio-respiratory arrest,,2015,Q2,4,F,20140904.0,20150527.0,20140925,20150608,EXP,,ES-ASTELLAS-2014EU012721,ASTELLAS,,81.0,YR,,M,Y,,,20150608.0,N,CN,US,ES,2015,Q2,Elderly
104817395,10481739,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,UNKNOWN,,2015,Q2,Clear cell renal cell carcinoma,,2015,Q2,5,F,20140306.0,20150522.0,20140929,20150601,EXP,,US-JNJFOC-20140919032,JANSSEN,,49.0,YR,A,M,Y,,,20150601.0,N,CN,US,US,2015,Q2,Adult
105437123,10543712,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,35,DF,,,2015,Q2,Infected skin ulcer,,2015,Q2,3,F,20141003.0,20150504.0,20141027,20150508,EXP,,CO-ABBVIE-14K-036-1298339-00,ABBVIE,,52.0,YR,,F,Y,55.0,KG,20150508.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q2,Adult
105437123,10543712,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,35,DF,,,2015,Q2,Osteomyelitis,,2015,Q2,3,F,20141003.0,20150504.0,20141027,20150508,EXP,,CO-ABBVIE-14K-036-1298339-00,ABBVIE,,52.0,YR,,F,Y,55.0,KG,20150508.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q2,Adult
105437123,10543712,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,35,DF,,,2015,Q2,Skin ulcer,,2015,Q2,3,F,20141003.0,20150504.0,20141027,20150508,EXP,,CO-ABBVIE-14K-036-1298339-00,ABBVIE,,52.0,YR,,F,Y,55.0,KG,20150508.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Abdominal pain,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Abdominal pain upper,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Adenocarcinoma pancreas,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood albumin decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood calcium increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood glucose increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood magnesium decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood pressure increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Body temperature increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Cholelithiasis,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Decreased appetite,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Dehydration,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Dizziness,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Dyspepsia,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Fatigue,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Febrile neutropenia,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Gallbladder disorder,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Gastrooesophageal reflux disease,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Glycosylated haemoglobin increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Haematocrit decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Haemoglobin decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Hypotension,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Lethargy,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Monocyte percentage increased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Nausea,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Neutrophil count decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Oxygen saturation decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Pancreatic mass,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Platelet count decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Presyncope,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Protein total decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Pulmonary mass,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Radiation sickness syndrome,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Red blood cell count decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Somnolence,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Vomiting,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Weight decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
105973984,10597398,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,White blood cell count decreased,,2015,Q2,4,F,20140828.0,20150403.0,20141121,20150414,EXP,,PHHY2014US148206,SANDOZ,,64.0,YR,,F,Y,65.0,KG,20150414.0,N,CN,US,US,2015,Q2,Adult
106660075,10666007,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, DAILY",,,,D,,,,35,IU,,,2015,Q2,Cerebrovascular accident,,2015,Q2,5,F,201406.0,20150331.0,20141219,20150408,EXP,,US-PFIZER INC-2014348702,PFIZER,,55.0,YR,,M,Y,80.7,KG,20150408.0,N,CN,US,US,2015,Q2,Adult
106660075,10666007,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, DAILY",,,,D,,,,35,IU,,,2015,Q2,Hemiplegia,,2015,Q2,5,F,201406.0,20150331.0,20141219,20150408,EXP,,US-PFIZER INC-2014348702,PFIZER,,55.0,YR,,M,Y,80.7,KG,20150408.0,N,CN,US,US,2015,Q2,Adult
106660075,10666007,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, DAILY",,,,D,,,,35,IU,,,2015,Q2,Intentional product misuse,,2015,Q2,5,F,201406.0,20150331.0,20141219,20150408,EXP,,US-PFIZER INC-2014348702,PFIZER,,55.0,YR,,M,Y,80.7,KG,20150408.0,N,CN,US,US,2015,Q2,Adult
107299742,10729974,11,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,100,IU,UNKNOWN,,2015,Q2,Diabetic neuropathy,,2015,Q2,2,F,201412.0,20150325.0,20150122,20150408,EXP,,US-CELGENE-USA-2015012575,CELGENE,,76.0,YR,,M,Y,,,20150408.0,N,MD,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Abdominal pain,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Abdominal pain upper,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Chest pain,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Cholelithiasis,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Decreased appetite,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Diarrhoea,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Fatigue,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Haematocrit decreased,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Haemoglobin decreased,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Nausea,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Nephrolithiasis,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Prostatic specific antigen increased,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Red blood cell count decreased,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
107708773,10770877,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Ventricular tachycardia,,2015,Q2,3,F,20140924.0,20150414.0,20150206,20150429,EXP,,US-JNJFOC-20150119985,JANSSEN,,70.0,YR,E,M,Y,106.14,KG,20150429.0,N,OT,US,US,2015,Q2,Elderly
108689653,10868965,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 U, QD",,,,D,,,,45,DF,,QD,2015,Q2,Urosepsis,,2015,Q2,3,F,20150214.0,20150417.0,20150225,20150423,EXP,,PHHO2015US002557,NOVARTIS,,72.0,YR,,F,Y,89.43,KG,20150423.0,N,OT,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Asthenia,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Balance disorder,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Body height decreased,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Calcinosis,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Cough,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Depressed mood,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Depression,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Diabetes mellitus,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Discomfort,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Drug dose omission,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Fat tissue increased,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Feeling cold,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Gait disturbance,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Heart rate irregular,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Hypoacusis,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Intentional product misuse,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Kidney infection,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Limb discomfort,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Malaise,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Memory impairment,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Muscle spasms,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Pain in extremity,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Product use issue,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Pyrexia,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Swelling,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Tremor,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108888802,10888880,9,C,GLARGINE,,2,Subcutaneous,60 DAILY,,,,D,,,,,,,,2015,Q2,Weight increased,,2015,Q2,2,F,2011.0,20150603.0,20150305,20150611,EXP,,US-ASTRAZENECA-2012SE88716,ASTRAZENECA,,84.0,YR,,F,Y,92.5,KG,20150611.0,N,,US,US,2015,Q2,Elderly
108921623,10892162,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Discomfort,,2015,Q2,3,F,20150225.0,20150330.0,20150306,20150407,EXP,,MX-BAXTER-2015BAX011260,BAXTER,,73.0,YR,,F,Y,54.0,KG,20150407.0,N,CN,MX,MX,2015,Q2,Elderly
108921623,10892162,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Hyperglycaemia,,2015,Q2,3,F,20150225.0,20150330.0,20150306,20150407,EXP,,MX-BAXTER-2015BAX011260,BAXTER,,73.0,YR,,F,Y,54.0,KG,20150407.0,N,CN,MX,MX,2015,Q2,Elderly
108921623,10892162,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Hypertension,,2015,Q2,3,F,20150225.0,20150330.0,20150306,20150407,EXP,,MX-BAXTER-2015BAX011260,BAXTER,,73.0,YR,,F,Y,54.0,KG,20150407.0,N,CN,MX,MX,2015,Q2,Elderly
108921623,10892162,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Urinary tract infection,,2015,Q2,3,F,20150225.0,20150330.0,20150306,20150407,EXP,,MX-BAXTER-2015BAX011260,BAXTER,,73.0,YR,,F,Y,54.0,KG,20150407.0,N,CN,MX,MX,2015,Q2,Elderly
108921623,10892162,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Vomiting,,2015,Q2,3,F,20150225.0,20150330.0,20150306,20150407,EXP,,MX-BAXTER-2015BAX011260,BAXTER,,73.0,YR,,F,Y,54.0,KG,20150407.0,N,CN,MX,MX,2015,Q2,Elderly
109208044,10920804,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,28,IU,,QD,2015,Q2,Angina unstable,,2015,Q2,4,F,20141116.0,20150616.0,20150317,20150624,EXP,,UA-SA-2015SA030217,AVENTIS,,76.0,YR,E,F,Y,74.0,KG,20150624.0,N,MD,UA,UA,2015,Q2,Elderly
109208044,10920804,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,28,IU,,QD,2015,Q2,Hypoglycaemia,,2015,Q2,4,F,20141116.0,20150616.0,20150317,20150624,EXP,,UA-SA-2015SA030217,AVENTIS,,76.0,YR,E,F,Y,74.0,KG,20150624.0,N,MD,UA,UA,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Asthenia,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Death,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Disease progression,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Fall,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Feeding disorder,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Pancreatic neuroendocrine tumour,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109308262,10930826,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NIGHTLY,,,,D,,,,,,,,2015,Q2,Vomiting,,2015,Q2,2,F,20150315.0,20150415.0,20150319,20150420,EXP,,US-PFIZER INC-2015093446,PFIZER,,77.0,YR,,F,Y,60.0,KG,20150420.0,N,OT,US,US,2015,Q2,Elderly
109324322,10932432,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Angina pectoris,,2015,Q2,2,F,20150124.0,20150429.0,20150318,20150430,EXP,,US-SEPTODONT-201502672,SEPTODONT,,63.0,YR,,M,N,,,20150124.0,N,OT,US,,2015,Q2,Adult
109388952,10938895,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Sublingual,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Product use issue,,2015,Q2,2,F,,20130910.0,20150321,20150525,PER,,US-JNJFOC-20130907143,JANSSEN,"FOWLER JA, SHEN JY, BETTINGER TL. SUCCESSFUL USE OF TOPIRAMATE IN A PATIENT WITH SEVERE POSTHERPETIC NEURALGIA. THE ANNALS OF PHARMACOTHERAPY JAN-2009;43 (1):139-42.",79.0,YR,E,M,Y,,,20150525.0,N,PH,US,US,2015,Q2,Elderly
109407392,10940739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,,,,,D,,,,,,,,2015,Q2,Acute kidney injury,,2015,Q2,2,F,,20140501.0,20150322,20150524,PER,,US-JNJFOC-20140501358,JANSSEN,"JAVAID M, GIORDANO J, TANENBERG RJ, ALHOSAINI H, HOUSTON CM. CANAGLIFLOZIN-ASSOCIATED ACUTE RENAL FAILURE IN A PATIENT WITH STAGE 2 CKD AND COMPENSATED HEART FAILURE. POSTER APR-2014.",38.0,YR,A,F,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109407392,10940739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,,,,,D,,,,,,,,2015,Q2,Hypovolaemia,,2015,Q2,2,F,,20140501.0,20150322,20150524,PER,,US-JNJFOC-20140501358,JANSSEN,"JAVAID M, GIORDANO J, TANENBERG RJ, ALHOSAINI H, HOUSTON CM. CANAGLIFLOZIN-ASSOCIATED ACUTE RENAL FAILURE IN A PATIENT WITH STAGE 2 CKD AND COMPENSATED HEART FAILURE. POSTER APR-2014.",38.0,YR,A,F,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Blood sodium decreased,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Chills,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Febrile neutropenia,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Fluid retention,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Malaise,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Pyrexia,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109482803,10948280,28,C,LISPRO  INSULIN (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Tachycardia,,2015,Q2,3,F,20150228.0,20150416.0,20150320,20150501,EXP,,2015SGN00351,SEATTLE GENETICS,,71.0,YR,,M,N,69.2,KG,20150424.0,N,OT,US,,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Abdominal pain,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Alanine aminotransferase increased,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Aspartate aminotransferase increased,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Blood bilirubin increased,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Nausea,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Proteinuria,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Thrombocytopenia,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109622632,10962263,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Vomiting,,2015,Q2,2,F,20150317.0,20150428.0,20150327,20150430,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-005184,EISAI,,70.0,YR,,M,Y,98.5,KG,20150430.0,N,MD,US,US,2015,Q2,Elderly
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Acute kidney injury,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Diabetic ketoacidosis,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Dyspepsia,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Gastrointestinal infection,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Oral candidiasis,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Product use issue,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109655605,10965560,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,26,IU,UNSPECIFIED,,2015,Q2,Weight decreased,,2015,Q2,5,F,20150315.0,20150612.0,20150330,20150624,EXP,,US-JNJFOC-20150318577,JANSSEN,,34.0,YR,A,M,Y,103.16,KG,20150624.0,N,OT,US,US,2015,Q2,Young Adult
109772431,10977243,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Drug-induced liver injury,,2015,Q2,1,I,,20140428.0,20150402,20150402,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2014R1-80836,RANBAXY,,41.0,YR,,M,Y,,,20150402.0,N,OT,DE,DE,2015,Q2,Adult
109918671,10991867,12,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,5-10UNITS,,,,D,,,,,,INJECTION,QD,2015,Q2,Neutropenia,Neutropenia,2015,Q2,1,I,20140623.0,20141001.0,20150406,20150406,PER,,US-CELGENEUS-USA-2014101466,CELGENE,,68.0,YR,,M,Y,86.6,KG,20150406.0,N,MD,US,US,2015,Q2,Elderly
109945362,10994536,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,14,IU,,QD,2015,Q2,Pancreatic carcinoma,,2015,Q2,2,F,20150327.0,20150416.0,20150407,20150424,EXP,,JP-ASTRAZENECA-2015SE30940,ASTRAZENECA,,30588.0,DY,,M,Y,42.0,KG,20150424.0,N,MD,JP,JP,2015,Q2,Elderly
109996261,10999626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,,QD,2015,Q2,Cardio-respiratory arrest,,2015,Q2,1,I,20150321.0,20150331.0,20150408,20150408,EXP,,CO-BAXTER-2015BAX017766,BAXTER,,74.0,YR,,F,Y,,,20150408.0,N,CN,CO,CO,2015,Q2,Elderly
109996261,10999626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,,QD,2015,Q2,General physical health deterioration,,2015,Q2,1,I,20150321.0,20150331.0,20150408,20150408,EXP,,CO-BAXTER-2015BAX017766,BAXTER,,74.0,YR,,F,Y,,,20150408.0,N,CN,CO,CO,2015,Q2,Elderly
109996261,10999626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,,QD,2015,Q2,Ischaemic stroke,,2015,Q2,1,I,20150321.0,20150331.0,20150408,20150408,EXP,,CO-BAXTER-2015BAX017766,BAXTER,,74.0,YR,,F,Y,,,20150408.0,N,CN,CO,CO,2015,Q2,Elderly
109996261,10999626,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,,QD,2015,Q2,Seizure,,2015,Q2,1,I,20150321.0,20150331.0,20150408,20150408,EXP,,CO-BAXTER-2015BAX017766,BAXTER,,74.0,YR,,F,Y,,,20150408.0,N,CN,CO,CO,2015,Q2,Elderly
110038692,11003869,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 UNK, DAILY",,,,U,,,,20,DF,,QD,2015,Q2,Adenocarcinoma pancreas,,2015,Q2,2,F,20140403.0,20150424.0,20150409,20150429,EXP,,US-009507513-1504USA002641,MERCK,,71.0,YR,,M,Y,,,20150429.0,N,PH,US,US,2015,Q2,Elderly
110038692,11003869,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 UNK, DAILY",,,,U,,,,20,DF,,QD,2015,Q2,Pancreatitis,,2015,Q2,2,F,20140403.0,20150424.0,20150409,20150429,EXP,,US-009507513-1504USA002641,MERCK,,71.0,YR,,M,Y,,,20150429.0,N,PH,US,US,2015,Q2,Elderly
110143922,11014392,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hypotension,,2015,Q2,2,F,,20140528.0,20150412,20150525,PER,,US-JNJFOC-20140407392,JANSSEN,,59.0,YR,A,M,Y,101.6,KG,20150525.0,N,CN,US,US,2015,Q2,Adult
110143922,11014392,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Off label use,,2015,Q2,2,F,,20140528.0,20150412,20150525,PER,,US-JNJFOC-20140407392,JANSSEN,,59.0,YR,A,M,Y,101.6,KG,20150525.0,N,CN,US,US,2015,Q2,Adult
110143922,11014392,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Rash pruritic,,2015,Q2,2,F,,20140528.0,20150412,20150525,PER,,US-JNJFOC-20140407392,JANSSEN,,59.0,YR,A,M,Y,101.6,KG,20150525.0,N,CN,US,US,2015,Q2,Adult
110224921,11022492,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,D,,,,,,FORMULATION UNKNOWN,,2015,Q2,Acute kidney injury,,2015,Q2,1,I,,20140804.0,20150413,20150413,PER,,US-ASTELLAS-2014US009764,ASTELLAS,,53.0,YR,,M,Y,,,20150413.0,N,CN,US,US,2015,Q2,Adult
110224921,11022492,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,D,,,,,,FORMULATION UNKNOWN,,2015,Q2,Toxicity to various agents,,2015,Q2,1,I,,20140804.0,20150413,20150413,PER,,US-ASTELLAS-2014US009764,ASTELLAS,,53.0,YR,,M,Y,,,20150413.0,N,CN,US,US,2015,Q2,Adult
110247131,11024713,19,C,"INSULIN, GLARGINE, HUMAN",,2,,,,,,,,,,,,,,2015,Q2,Dizziness,,2015,Q2,1,I,20150105.0,,20150413,20150413,DIR,,,,,57.0,YR,,M,N,220.0,LBS,20150411.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q2,Adult
110247131,11024713,19,C,"INSULIN, GLARGINE, HUMAN",,2,,,,,,,,,,,,,,2015,Q2,Faeces discoloured,,2015,Q2,1,I,20150105.0,,20150413,20150413,DIR,,,,,57.0,YR,,M,N,220.0,LBS,20150411.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q2,Adult
110247131,11024713,19,C,"INSULIN, GLARGINE, HUMAN",,2,,,,,,,,,,,,,,2015,Q2,Vomiting,,2015,Q2,1,I,20150105.0,,20150413,20150413,DIR,,,,,57.0,YR,,M,N,220.0,LBS,20150411.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q2,Adult
110260291,11026029,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Electrocardiogram QT prolonged,,2015,Q2,1,I,20150330.0,,20150413,20150413,DIR,,,,,39.0,YR,,F,N,129.0,KG,20150410.0,N,,US,,2015,Q2,Adult
110260291,11026029,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Prescribed overdose,,2015,Q2,1,I,20150330.0,,20150413,20150413,DIR,,,,,39.0,YR,,F,N,129.0,KG,20150410.0,N,,US,,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Blood albumin decreased,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Blood creatinine increased,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Blood sodium decreased,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Hyperglycaemia,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Hyperkalaemia,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110308811,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,D,,,,25,DF,,BID,2015,Q2,Renal impairment,,2015,Q2,1,I,20150122.0,20150211.0,20150415,20150415,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20150415.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q2,Adult
110321642,11032164,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, BID",,,,U,,,,10,IU,,Q12H,2015,Q2,Hyperkalaemia,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110321642,11032164,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, BID",,,,U,,,,10,IU,,Q12H,2015,Q2,Infectious colitis,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110321642,11032164,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,U,,,,15,IU,,Q12H,2015,Q2,Hyperkalaemia,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110321642,11032164,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,U,,,,15,IU,,Q12H,2015,Q2,Infectious colitis,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110321642,11032164,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, BID",,,,U,,,,18,IU,,Q12H,2015,Q2,Hyperkalaemia,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110321642,11032164,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, BID",,,,U,,,,18,IU,,Q12H,2015,Q2,Infectious colitis,,2015,Q2,2,F,,20150415.0,20150415,20150428,EXP,,US-APOTEX-2015AP008217,APOTEX,,69.0,YR,,M,Y,68.0,KG,20150428.0,N,OT,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Agoraphobia,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Cardiac arrest,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Diarrhoea,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Faecal incontinence,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Insomnia,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Repetitive speech,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Restlessness,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110376941,11037694,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,4,MG,,,2015,Q2,Urinary incontinence,,2015,Q2,1,I,201503.0,20150309.0,20150416,20150416,EXP,,US-FRI-1000075188,FOREST,,72.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Elderly
110380712,11038071,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D, UNKNOWN,,21081.0,,,,,2015,Q2,Gallbladder empyema,,2015,Q2,2,F,20150320.0,20150414.0,20150416,20150423,EXP,,PL-SA-2015SA046689,AVENTIS,,73.0,YR,E,M,Y,95.0,KG,20150423.0,N,MD,PL,PL,2015,Q2,Elderly
110380712,11038071,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D, UNK,,21081.0,,,,,2015,Q2,Gallbladder empyema,,2015,Q2,2,F,20150320.0,20150414.0,20150416,20150423,EXP,,PL-SA-2015SA046689,AVENTIS,,73.0,YR,E,M,Y,95.0,KG,20150423.0,N,MD,PL,PL,2015,Q2,Elderly
110380962,11038096,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Acute myocardial infarction,,2015,Q2,2,F,20150306.0,20150420.0,20150416,20150428,EXP,,CO-BAXTER-2015BAX019458,BAXTER,,76.0,YR,,M,Y,56.8,KG,20150428.0,N,OT,CO,CO,2015,Q2,Elderly
110380962,11038096,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Cardio-respiratory arrest,,2015,Q2,2,F,20150306.0,20150420.0,20150416,20150428,EXP,,CO-BAXTER-2015BAX019458,BAXTER,,76.0,YR,,M,Y,56.8,KG,20150428.0,N,OT,CO,CO,2015,Q2,Elderly
110380962,11038096,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Diabetic foot,,2015,Q2,2,F,20150306.0,20150420.0,20150416,20150428,EXP,,CO-BAXTER-2015BAX019458,BAXTER,,76.0,YR,,M,Y,56.8,KG,20150428.0,N,OT,CO,CO,2015,Q2,Elderly
110380962,11038096,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Gastrointestinal haemorrhage,,2015,Q2,2,F,20150306.0,20150420.0,20150416,20150428,EXP,,CO-BAXTER-2015BAX019458,BAXTER,,76.0,YR,,M,Y,56.8,KG,20150428.0,N,OT,CO,CO,2015,Q2,Elderly
110471952,11047195,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pancreatitis acute,,2015,Q2,2,F,20150401.0,20150428.0,20150416,20150512,EXP,,2821678,HOSPIRA,,51.0,YR,A,F,Y,68.0,KG,20150512.0,N,MD,JP,JP,2015,Q2,Adult
110475591,11047559,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,8,IU,,BID,2015,Q2,Hospitalisation,,2015,Q2,1,I,20150328.0,20150415.0,20150420,20150420,EXP,,DE-SA-2015SA049333,AVENTIS,,56.0,YR,A,M,Y,70.0,KG,20150420.0,N,MD,DE,DE,2015,Q2,Adult
110482741,11048274,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150313.0,20150413.0,20150420,20150420,EXP,,DE-ABBVIE-15P-062-1376385-00,ABBVIE,,63.0,YR,,F,Y,,,20150420.0,N,CN,COUNTRY NOT SPECIFIED,DE,2015,Q2,Adult
110547861,11054786,14,C,LANTUS/INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Pancytopenia,,2015,Q2,1,I,20150305.0,20150403.0,20150420,20150420,EXP,,20151098,MEDAC,,71.0,YR,,M,N,,,20150413.0,N,OT,FR,,2015,Q2,Elderly
110547861,11054786,14,C,LANTUS/INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Vitamin B12 deficiency,,2015,Q2,1,I,20150305.0,20150403.0,20150420,20150420,EXP,,20151098,MEDAC,,71.0,YR,,M,N,,,20150413.0,N,OT,FR,,2015,Q2,Elderly
110548111,11054811,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"4 IU, QD, BEFORE BEDTIME",,,,D,,,,4,IU,,QD,2015,Q2,Anti-insulin antibody positive,,2015,Q2,1,I,,20150415.0,20150422,20150422,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201504006334,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20150422.0,N,MD,JP,JP,2015,Q2,Elderly
110548111,11054811,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"4 IU, QD, BEFORE BEDTIME",,,,D,,,,4,IU,,QD,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,,20150415.0,20150422,20150422,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201504006334,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20150422.0,N,MD,JP,JP,2015,Q2,Elderly
110548111,11054811,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"4 IU, QD, BEFORE BEDTIME",,,,D,,,,4,IU,,QD,2015,Q2,Hyponatraemia,,2015,Q2,1,I,,20150415.0,20150422,20150422,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201504006334,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20150422.0,N,MD,JP,JP,2015,Q2,Elderly
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Anxiety,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Aphasia,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Blood glucose increased,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Blood sodium decreased,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Chest pain,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Heart rate increased,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Presyncope,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110567742,11056774,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,30,IU,UNSPECIFIED,BID,2015,Q2,Psychomotor hyperactivity,,2015,Q2,2,F,20150202.0,20150403.0,20150422,20150524,PER,,US-JNJFOC-20150404183,JANSSEN,,54.0,YR,A,F,Y,130.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
110627071,11062707,8,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,15,IU,,,2015,Q2,Acute myocardial infarction,,2015,Q2,1,I,20150406.0,20150420.0,20150424,20150424,EXP,,CO-BAXTER-2015BAX021460,BAXTER,,68.0,YR,,F,Y,58.6,KG,20150424.0,N,OT,CO,CO,2015,Q2,Elderly
110644002,11064400,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,20,IU,,,2015,Q2,Hepatic failure,,2015,Q2,2,F,20150330.0,20150506.0,20150424,20150515,EXP,,IT-ABBVIE-15P-083-1373628-00,ABBVIE,,72.0,YR,,F,Y,60.0,KG,20150515.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
110644002,11064400,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,20,IU,,,2015,Q2,Hyperbilirubinaemia,,2015,Q2,2,F,20150330.0,20150506.0,20150424,20150515,EXP,,IT-ABBVIE-15P-083-1373628-00,ABBVIE,,72.0,YR,,F,Y,60.0,KG,20150515.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
110644002,11064400,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,20,IU,,,2015,Q2,Hypoalbuminaemia,,2015,Q2,2,F,20150330.0,20150506.0,20150424,20150515,EXP,,IT-ABBVIE-15P-083-1373628-00,ABBVIE,,72.0,YR,,F,Y,60.0,KG,20150515.0,N,MD,COUNTRY NOT SPECIFIED,IT,2015,Q2,Elderly
110646531,11064653,13,C,INSULINE GLARGINE,,2,Subcutaneous,10 UNITS/M*2,,,,D,,,,,,UNKNOWN,QD,2015,Q2,Rib fracture,,2015,Q2,1,I,20130121.0,20130413.0,20150424,20150424,PER,,US-CELGENEUS-163-21880-13042938,CELGENE,,69.0,YR,,,Y,,,20150424.0,N,OT,US,US,2015,Q2,Elderly
110684152,11068415,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,34,IU,UNKNOWN,QD,2015,Q2,Deep vein thrombosis,,2015,Q2,2,F,201504.0,20150506.0,20150427,20150511,PER,,CO-JNJFOC-20150420372,JANSSEN,,72.0,YR,E,F,Y,,,20150511.0,N,MD,CO,CO,2015,Q2,Elderly
110715854,11071585,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE A DAY BEFORE SLEEP",,,,D,,,,4,IU,,QD,2015,Q2,Anti-insulin antibody increased,,2015,Q2,4,F,,20150522.0,20150428,20150525,EXP,,JP-MERCK-1504JPN021894,MERCK,,74.0,YR,,M,Y,,,20150525.0,N,OT,JP,JP,2015,Q2,Elderly
110715854,11071585,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE A DAY BEFORE SLEEP",,,,D,,,,4,IU,,QD,2015,Q2,Blood glucose increased,,2015,Q2,4,F,,20150522.0,20150428,20150525,EXP,,JP-MERCK-1504JPN021894,MERCK,,74.0,YR,,M,Y,,,20150525.0,N,OT,JP,JP,2015,Q2,Elderly
110715854,11071585,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE A DAY BEFORE SLEEP",,,,D,,,,4,IU,,QD,2015,Q2,Gait disturbance,,2015,Q2,4,F,,20150522.0,20150428,20150525,EXP,,JP-MERCK-1504JPN021894,MERCK,,74.0,YR,,M,Y,,,20150525.0,N,OT,JP,JP,2015,Q2,Elderly
110715854,11071585,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE A DAY BEFORE SLEEP",,,,D,,,,4,IU,,QD,2015,Q2,Hyponatraemia,,2015,Q2,4,F,,20150522.0,20150428,20150525,EXP,,JP-MERCK-1504JPN021894,MERCK,,74.0,YR,,M,Y,,,20150525.0,N,OT,JP,JP,2015,Q2,Elderly
110715854,11071585,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, ONCE A DAY BEFORE SLEEP",,,,D,,,,4,IU,,QD,2015,Q2,Insulin C-peptide increased,,2015,Q2,4,F,,20150522.0,20150428,20150525,EXP,,JP-MERCK-1504JPN021894,MERCK,,74.0,YR,,M,Y,,,20150525.0,N,OT,JP,JP,2015,Q2,Elderly
110722281,11072228,8,C,INSULINE GLARGINE,,2,Unknown,"UNK, DAILY",,,,U,,,,,,,QD,2015,Q2,Blood chromogranin A increased,,2015,Q2,1,I,,20150415.0,20150428,20150428,EXP,,HU-ACTAVIS-2015-08407,ACTAVIS,"PALL A, BECS G, ERDEI A, SIRA L, CZIFRA A, BARNA S, KOVACS P ET AL. PSEUDOPHEOCHROMOCYTOMA INDUCED BY ANXIOLYTIC WITHDRAWAL. EUR J MED RES. 2014",55.0,YR,,F,Y,,,20150428.0,N,OT,HU,HU,2015,Q2,Adult
110722281,11072228,8,C,INSULINE GLARGINE,,2,Unknown,"UNK, DAILY",,,,U,,,,,,,QD,2015,Q2,Drug withdrawal syndrome,,2015,Q2,1,I,,20150415.0,20150428,20150428,EXP,,HU-ACTAVIS-2015-08407,ACTAVIS,"PALL A, BECS G, ERDEI A, SIRA L, CZIFRA A, BARNA S, KOVACS P ET AL. PSEUDOPHEOCHROMOCYTOMA INDUCED BY ANXIOLYTIC WITHDRAWAL. EUR J MED RES. 2014",55.0,YR,,F,Y,,,20150428.0,N,OT,HU,HU,2015,Q2,Adult
110722281,11072228,8,C,INSULINE GLARGINE,,2,Unknown,"UNK, DAILY",,,,U,,,,,,,QD,2015,Q2,Pseudophaeochromocytoma,,2015,Q2,1,I,,20150415.0,20150428,20150428,EXP,,HU-ACTAVIS-2015-08407,ACTAVIS,"PALL A, BECS G, ERDEI A, SIRA L, CZIFRA A, BARNA S, KOVACS P ET AL. PSEUDOPHEOCHROMOCYTOMA INDUCED BY ANXIOLYTIC WITHDRAWAL. EUR J MED RES. 2014",55.0,YR,,F,Y,,,20150428.0,N,OT,HU,HU,2015,Q2,Adult
110725221,11072522,8,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q2,Pyrexia,,2015,Q2,1,I,20150408.0,20150416.0,20150428,20150428,PER,,US-CELGENEUS-USA-2015044042,CELGENE,,71.0,YR,,F,Y,,,20150428.0,N,OT,US,US,2015,Q2,Elderly
110783021,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2015,Q2,Angioedema,,2015,Q2,1,I,201202.0,20150422.0,20150430,20150430,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20150430.0,N,OT,US,US,2015,Q2,Elderly
110783021,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2015,Q2,Hypersensitivity,,2015,Q2,1,I,201202.0,20150422.0,20150430,20150430,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20150430.0,N,OT,US,US,2015,Q2,Elderly
110783021,11078302,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, HS",,,,U,,,,,,,QD,2015,Q2,Swollen tongue,,2015,Q2,1,I,201202.0,20150422.0,20150430,20150430,EXP,,US-009507513-1504USA021756,MERCK,,67.0,YR,,M,Y,,,20150430.0,N,OT,US,US,2015,Q2,Elderly
110797511,11079751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Blood creatinine increased,,2015,Q2,1,I,20140321.0,20150417.0,20150430,20150430,EXP,,PHHO2015US007463,NOVARTIS,,63.0,YR,,F,Y,,,20150430.0,N,OT,US,US,2015,Q2,Adult
110797511,11079751,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Fluid overload,,2015,Q2,1,I,20140321.0,20150417.0,20150430,20150430,EXP,,PHHO2015US007463,NOVARTIS,,63.0,YR,,F,Y,,,20150430.0,N,OT,US,US,2015,Q2,Adult
110810091,11081009,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,,20150413.0,20150429,20150429,EXP,,2015BEX00002,BEXIMCO PHARMACEUTICALS,,69.0,YR,,M,N,68.0,KG,20150423.0,N,PH,US,,2015,Q2,Elderly
110810091,11081009,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Hyperkalaemia,,2015,Q2,1,I,,20150413.0,20150429,20150429,EXP,,2015BEX00002,BEXIMCO PHARMACEUTICALS,,69.0,YR,,M,N,68.0,KG,20150423.0,N,PH,US,,2015,Q2,Elderly
110846242,11084624,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Anaemia,,2015,Q2,2,F,20140415.0,20150327.0,20150503,20150525,PER,,US-JNJFOC-20150322715,JANSSEN,,60.0,YR,A,M,Y,151.0,KG,20150525.0,N,PH,US,US,2015,Q2,Adult
110846242,11084624,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Gastric ulcer haemorrhage,,2015,Q2,2,F,20140415.0,20150327.0,20150503,20150525,PER,,US-JNJFOC-20150322715,JANSSEN,,60.0,YR,A,M,Y,151.0,KG,20150525.0,N,PH,US,US,2015,Q2,Adult
110846242,11084624,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Haemorrhage,,2015,Q2,2,F,20140415.0,20150327.0,20150503,20150525,PER,,US-JNJFOC-20150322715,JANSSEN,,60.0,YR,A,M,Y,151.0,KG,20150525.0,N,PH,US,US,2015,Q2,Adult
110916622,11091662,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:30 UNIT(S),,,,D,,,,,,,QD,2015,Q2,Jugular vein thrombosis,,2015,Q2,2,F,201408.0,20150522.0,20150505,20150529,EXP,,US-SA-2015SA058887,AVENTIS,,59.0,YR,A,F,Y,108.0,KG,20150529.0,N,PH,US,US,2015,Q2,Adult
110916622,11091662,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:30 UNIT(S),,,,D,,,,,,,QD,2015,Q2,Neoplasm malignant,,2015,Q2,2,F,201408.0,20150522.0,20150505,20150529,EXP,,US-SA-2015SA058887,AVENTIS,,59.0,YR,A,F,Y,108.0,KG,20150529.0,N,PH,US,US,2015,Q2,Adult
110916622,11091662,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:30 UNIT(S),,,,D,,,,,,,QD,2015,Q2,Pulmonary embolism,,2015,Q2,2,F,201408.0,20150522.0,20150505,20150529,EXP,,US-SA-2015SA058887,AVENTIS,,59.0,YR,A,F,Y,108.0,KG,20150529.0,N,PH,US,US,2015,Q2,Adult
111022091,11102209,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Eosinophilia,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-ALKEM-000996,ALKEM,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111022091,11102209,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hepatic steatosis,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-ALKEM-000996,ALKEM,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111022091,11102209,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hepatitis,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-ALKEM-000996,ALKEM,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111022091,11102209,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pruritus,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-ALKEM-000996,ALKEM,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111022091,11102209,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Rash,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-ALKEM-000996,ALKEM,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111023191,11102319,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Eosinophilia,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-INDICUS PHARMA-000332,INDICUS,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111023191,11102319,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hepatic steatosis,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-INDICUS PHARMA-000332,INDICUS,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111023191,11102319,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hepatitis,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-INDICUS PHARMA-000332,INDICUS,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111023191,11102319,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pruritus,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-INDICUS PHARMA-000332,INDICUS,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111023191,11102319,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Rash,,2015,Q2,1,I,,20150427.0,20150511,20150511,EXP,,DE-INDICUS PHARMA-000332,INDICUS,"HIERONIMUS A, KLEIN R, HARING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014; 37(3):E57-8.",41.0,YR,,M,Y,,,20150511.0,N,OT,DE,DE,2015,Q2,Adult
111070941,11107094,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Hypersensitivity vasculitis,,2015,Q2,1,I,,20150429.0,20150512,20150512,EXP,,TN-ACTAVIS-2015-09647,ACTAVIS,"RACHED S, SLIM R, FATHALLAH N, GHARIANI N, NOUIRA R, SRIHA B, ET AL. [GABAPENTIN-INDUCED CUTANEOUS LEUKOCYTOCLASTIC VASCULITIS]. THERAPIE. 2014;69(5):469-71. FRENCH",58.0,YR,,F,Y,,,20150512.0,N,OT,TN,TN,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Diabetic foot,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Diabetic neuropathy,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Gangrene,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,General physical health deterioration,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Infectious pleural effusion,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Pneumonia,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111110012,11111001,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Post procedural complication,,2015,Q2,2,F,20141217.0,20150506.0,20150513,20150515,EXP,,CO-BAXTER-2015BAX024860,BAXTER,,61.0,YR,,M,Y,,,20150513.0,N,OT,CO,CO,2015,Q2,Adult
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Asthenia,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Blood pressure decreased,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Dizziness,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Gastric haemorrhage,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Haemoglobin decreased,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111117542,11111754,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,18,IU,,,2015,Q2,Melaena,,2015,Q2,2,F,20140729.0,20150514.0,20150514,20150522,EXP,,IT-ASTRAZENECA-2015SE43121,ASTRAZENECA,,25887.0,DY,,M,Y,,,20150522.0,N,MD,IT,IT,2015,Q2,Elderly
111124101,11112410,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 U, QD",,,,D,,,,30,DF,,QD,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20150502.0,20150504.0,20150514,20150514,EXP,,US-NOVOPROD-448373,NOVO NORDISK,,69.0,YR,E,M,Y,112.93,KG,20150514.0,N,MD,US,US,2015,Q2,Elderly
111124101,11112410,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20150502.0,20150504.0,20150514,20150514,EXP,,US-NOVOPROD-448373,NOVO NORDISK,,69.0,YR,E,M,Y,112.93,KG,20150514.0,N,MD,US,US,2015,Q2,Elderly
111151911,11115191,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,LATENCY: 52 MONTHS,,,,D,,,,,,,,2015,Q2,Pemphigoid,,2015,Q2,1,I,20150126.0,20150507.0,20150515,20150515,EXP,,ES-ASTRAZENECA-2015SE43885,ASTRAZENECA,,80.0,YR,,M,Y,,,20150515.0,N,OT,ES,ES,2015,Q2,Elderly
111204171,11120417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, UNK",,,,D,,,,20,IU,,,2015,Q2,Anaemia,,2015,Q2,1,I,20140526.0,20150508.0,20150518,20150518,EXP,,PHHY2015ES056044,SANDOZ,,70.0,YR,,F,Y,,,20150519.0,N,OT,ES,ES,2015,Q2,Elderly
111204171,11120417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, UNK",,,,D,,,,20,IU,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20140526.0,20150508.0,20150518,20150518,EXP,,PHHY2015ES056044,SANDOZ,,70.0,YR,,F,Y,,,20150519.0,N,OT,ES,ES,2015,Q2,Elderly
111204171,11120417,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, UNK",,,,D,,,,20,IU,,,2015,Q2,Hypocoagulable state,,2015,Q2,1,I,20140526.0,20150508.0,20150518,20150518,EXP,,PHHY2015ES056044,SANDOZ,,70.0,YR,,F,Y,,,20150519.0,N,OT,ES,ES,2015,Q2,Elderly
111243721,11124372,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Citrobacter infection,,2015,Q2,1,I,20150118.0,20150508.0,20150518,20150518,EXP,,1224850-2015-00021,FRESENIUS MEDICAL CARE,,51.0,YR,,F,N,,,20150515.0,N,,US,,2015,Q2,Adult
111243721,11124372,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Opportunistic infection,,2015,Q2,1,I,20150118.0,20150508.0,20150518,20150518,EXP,,1224850-2015-00021,FRESENIUS MEDICAL CARE,,51.0,YR,,F,N,,,20150515.0,N,,US,,2015,Q2,Adult
111243721,11124372,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Peritonitis bacterial,,2015,Q2,1,I,20150118.0,20150508.0,20150518,20150518,EXP,,1224850-2015-00021,FRESENIUS MEDICAL CARE,,51.0,YR,,F,N,,,20150515.0,N,,US,,2015,Q2,Adult
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Bradycardia,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Cardiac arrest,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Chronic obstructive pulmonary disease,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Condition aggravated,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Hypotension,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Lactic acidosis,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Lung infiltration,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Pneumonia,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Pulmonary hypertension,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Respiratory distress,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Respiratory failure,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Right ventricular failure,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Septic shock,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111261912,11126191,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 UNIT/3 ML, 10 UNITS, 1X/DAY",,,,D,,,,,,,QD,2015,Q2,Ventricular tachycardia,,2015,Q2,2,F,201505.0,20150622.0,20150520,20150626,EXP,,US-PFIZER INC-2015105579,PFIZER,,67.0,YR,,F,Y,,,20150626.0,N,OT,US,US,2015,Q2,Elderly
111282621,11128262,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Coagulopathy,,2015,Q2,1,I,20150203.0,,20150520,20150520,DIR,,,,,62.0,YR,,M,N,100.0,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111282621,11128262,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Gastrointestinal haemorrhage,,2015,Q2,1,I,20150203.0,,20150520,20150520,DIR,,,,,62.0,YR,,M,N,100.0,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111282621,11128262,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Haematocrit decreased,,2015,Q2,1,I,20150203.0,,20150520,20150520,DIR,,,,,62.0,YR,,M,N,100.0,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111282621,11128262,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Haemoglobin decreased,,2015,Q2,1,I,20150203.0,,20150520,20150520,DIR,,,,,62.0,YR,,M,N,100.0,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111285251,11128525,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Laboratory test abnormal,,2015,Q2,1,I,20150116.0,,20150520,20150520,DIR,,,,,53.0,YR,,F,N,,,20150519.0,Y,PH,US,,2015,Q2,Adult
111288801,11128880,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Eye pain,,2015,Q2,1,I,20150225.0,20150519.0,20150521,20150521,EXP,,CO-ABBVIE-15P-036-1394976-00,ABBVIE,,59.0,YR,,M,Y,57.0,KG,20150521.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q2,Adult
111288801,11128880,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Macular degeneration,,2015,Q2,1,I,20150225.0,20150519.0,20150521,20150521,EXP,,CO-ABBVIE-15P-036-1394976-00,ABBVIE,,59.0,YR,,M,Y,57.0,KG,20150521.0,N,CN,COUNTRY NOT SPECIFIED,CO,2015,Q2,Adult
111358741,11135874,9,C,GLARGINE,,2,Subcutaneous,10 DAILY,,,,D,,,,,,,,2015,Q2,Acute kidney injury,,2015,Q2,1,I,201412.0,20150408.0,20150526,20150526,EXP,,KR-ASTRAZENECA-2015SE33673,ASTRAZENECA,,77.0,YR,,M,Y,72.5,KG,20150526.0,N,MD,KR,KR,2015,Q2,Elderly
111358741,11135874,9,C,GLARGINE,,2,Subcutaneous,10 DAILY,,,,D,,,,,,,,2015,Q2,Dehydration,,2015,Q2,1,I,201412.0,20150408.0,20150526,20150526,EXP,,KR-ASTRAZENECA-2015SE33673,ASTRAZENECA,,77.0,YR,,M,Y,72.5,KG,20150526.0,N,MD,KR,KR,2015,Q2,Elderly
111358741,11135874,9,C,GLARGINE,,2,Subcutaneous,10 DAILY,,,,D,,,,,,,,2015,Q2,Osteomyelitis,,2015,Q2,1,I,201412.0,20150408.0,20150526,20150526,EXP,,KR-ASTRAZENECA-2015SE33673,ASTRAZENECA,,77.0,YR,,M,Y,72.5,KG,20150526.0,N,MD,KR,KR,2015,Q2,Elderly
111358741,11135874,9,C,GLARGINE,,2,Subcutaneous,10 DAILY,,,,D,,,,,,,,2015,Q2,Weight decreased,,2015,Q2,1,I,201412.0,20150408.0,20150526,20150526,EXP,,KR-ASTRAZENECA-2015SE33673,ASTRAZENECA,,77.0,YR,,M,Y,72.5,KG,20150526.0,N,MD,KR,KR,2015,Q2,Elderly
111387451,11138745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,D,,,,10,DF,,QD,2015,Q2,Cardiovascular disorder,,2015,Q2,1,I,20150514.0,20150515.0,20150527,20150527,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-032784,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20150527.0,N,CN,US,US,2015,Q2,Elderly
111387451,11138745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,D,,,,10,DF,,QD,2015,Q2,Gait disturbance,,2015,Q2,1,I,20150514.0,20150515.0,20150527,20150527,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-032784,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20150527.0,N,CN,US,US,2015,Q2,Elderly
111387451,11138745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,D,,,,10,DF,,QD,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150514.0,20150515.0,20150527,20150527,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-032784,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20150527.0,N,CN,US,US,2015,Q2,Elderly
111387451,11138745,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,D,,,,10,DF,,QD,2015,Q2,Pain in extremity,,2015,Q2,1,I,20150514.0,20150515.0,20150527,20150527,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-032784,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,,,20150527.0,N,CN,US,US,2015,Q2,Elderly
111387581,11138758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Ketoacidosis,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111387581,11138758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Mental status changes,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111387581,11138758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Metabolic acidosis,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111410021,11141002,7,C,LANTUS SOLOSTAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Vaginal haemorrhage,,2015,Q2,1,I,2011.0,,20150526,20150526,DIR,,,,,54.0,YR,,F,N,150.0,LBS,20150522.0,N,,US,,2015,Q2,Adult
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Acidosis,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Alanine aminotransferase increased,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Aspartate aminotransferase increased,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Atelectasis,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Atrial fibrillation,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Bacterial infection,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Blood alkaline phosphatase increased,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Bronchitis,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Candida infection,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Cardiac arrest,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Cerebral disorder,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Chronic kidney disease,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Dermatitis exfoliative,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Electrocardiogram abnormal,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Failure to thrive,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Gastric dilatation,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hyperbilirubinaemia,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hyperglycaemia,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hyperuricaemia,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Medical device complication,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Neuropathy peripheral,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Palmar-plantar erythrodysaesthesia syndrome,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pancreatitis,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pleural effusion,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Pulmonary congestion,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Respiratory failure,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Staphylococcal infection,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Thrombocytopenia,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Urinary tract infection,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111446911,11144691,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Ventricular tachycardia,,2015,Q2,1,I,,20150313.0,20150528,20150528,EXP,,US-ROCHE-1579869,ROCHE,,70.0,YR,,F,Y,,,20150528.0,N,CN,US,US,2015,Q2,Elderly
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Consciousness fluctuating,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Disturbance in attention,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Hypotonia,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Mental status changes,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111449621,11144962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Toxicity to various agents,,2015,Q2,1,I,20150420.0,20150513.0,20150526,20150526,EXP,,ADR-2015-01009,MEDTRONIC,,57.0,YR,A,F,N,,,20150521.0,N,MD,US,,2015,Q2,Adult
111473281,11147328,3,C,INSULINE GLARGINE,,2,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Moyamoya disease,,2015,Q2,1,I,,20150514.0,20150528,20150528,EXP,,"US-IMPAX LABORATORIES, INC-2015-IPXL-00577",IMPAX,"MULYE A,  BRYSON CL, BAHRASSA FF.. A PUFF OF SMOKE IN THE BRAIN: MOYAMOYA DISEASE IN A 25-YEAROLD FEMALE. JOURNAL OF GENERAL INTERNAL MEDICINE. 2015;30 SUPPL. 2:S342",25.0,YR,,F,Y,,,20150528.0,N,OT,US,US,2015,Q2,Young Adult
111473281,11147328,3,C,INSULINE GLARGINE,,2,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Treatment noncompliance,,2015,Q2,1,I,,20150514.0,20150528,20150528,EXP,,"US-IMPAX LABORATORIES, INC-2015-IPXL-00577",IMPAX,"MULYE A,  BRYSON CL, BAHRASSA FF.. A PUFF OF SMOKE IN THE BRAIN: MOYAMOYA DISEASE IN A 25-YEAROLD FEMALE. JOURNAL OF GENERAL INTERNAL MEDICINE. 2015;30 SUPPL. 2:S342",25.0,YR,,F,Y,,,20150528.0,N,OT,US,US,2015,Q2,Young Adult
111498601,11149860,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36 UNITS AT BEDTIME,,,,D,,,,,,,,2015,Q2,Encephalopathy,,2015,Q2,1,I,,20150521.0,20150529,20150529,EXP,,"US-IMPAX LABORATORIES, INC-2015-IPXL-00594",IMPAX,"IJAZ M,TARIQ H, KASHIF M, MARQUEZ J.G. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AMERICAN JOURNAL OF CASE REPORTS. 2015;16:232-5",57.0,YR,,F,Y,110.0,KG,20150529.0,N,OT,US,US,2015,Q2,Adult
111498601,11149860,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36 UNITS AT BEDTIME,,,,D,,,,,,,,2015,Q2,Hypotonia,,2015,Q2,1,I,,20150521.0,20150529,20150529,EXP,,"US-IMPAX LABORATORIES, INC-2015-IPXL-00594",IMPAX,"IJAZ M,TARIQ H, KASHIF M, MARQUEZ J.G. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AMERICAN JOURNAL OF CASE REPORTS. 2015;16:232-5",57.0,YR,,F,Y,110.0,KG,20150529.0,N,OT,US,US,2015,Q2,Adult
111498601,11149860,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,36 UNITS AT BEDTIME,,,,D,,,,,,,,2015,Q2,Toxicity to various agents,,2015,Q2,1,I,,20150521.0,20150529,20150529,EXP,,"US-IMPAX LABORATORIES, INC-2015-IPXL-00594",IMPAX,"IJAZ M,TARIQ H, KASHIF M, MARQUEZ J.G. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AMERICAN JOURNAL OF CASE REPORTS. 2015;16:232-5",57.0,YR,,F,Y,110.0,KG,20150529.0,N,OT,US,US,2015,Q2,Adult
111525081,11152508,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D, UNCONFIRMED,,,,,,,2015,Q2,Drug-induced liver injury,,2015,Q2,1,I,,20150518.0,20150601,20150601,EXP,,DE-ACTAVIS-2015-10545,WATSON,"HIERONIMUS A, KLEIN R, H?RING HU, FRITSCHE A, WAGNER R. JAUNDICE FROM DIABETES THERAPY. DIABETES CARE. 2014;37(3).:E57-8",41.0,YR,,M,Y,,,20150601.0,N,OT,DE,DE,2015,Q2,Adult
111571621,11157162,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,1,I,20150530.0,,20150601,20150601,DIR,,,,,50.0,YR,,M,N,270.0,LBS,20150531.0,N,,US,,2015,Q2,Adult
111580151,11158015,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"2 IU, QD",,,,D,,,,2,IU,,QD,2015,Q2,Anti-insulin antibody positive,,2015,Q2,1,I,201212.0,20150522.0,20150603,20150603,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201505011140,ELI LILLY AND CO,,66.0,YR,,M,Y,74.0,KG,20150603.0,N,MD,JP,JP,2015,Q2,Elderly
111580151,11158015,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"2 IU, QD",,,,D,,,,2,IU,,QD,2015,Q2,Hypoglycaemia,,2015,Q2,1,I,201212.0,20150522.0,20150603,20150603,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201505011140,ELI LILLY AND CO,,66.0,YR,,M,Y,74.0,KG,20150603.0,N,MD,JP,JP,2015,Q2,Elderly
111591901,11159190,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q2,Hypersensitivity vasculitis,,2015,Q2,1,I,,20150526.0,20150603,20150603,EXP,,US-ENDO PHARMACEUTICALS INC-2015-001079,ENDO,"HUSSAIN N, MUSTAFA U, DAVIS J. INDOMETHACIN-RELATED LEUKOCYTOCLASTIC VASCULITIS: A CASE REPORT AND REVIEW OF LITERATURE. CASE REPORTS IN DERMATOLOGY. 2013 FEB 16;5(1):33-37.",50.0,YR,,M,Y,131.66,KG,20150603.0,N,,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
111592421,11159242,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Drug effect decreased,,2015,Q2,1,I,20150530.0,,20150601,20150601,DIR,,,,,58.0,YR,,M,N,280.0,LBS,20150530.0,N,,US,,2015,Q2,Adult
111592421,11159242,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Product substitution issue,,2015,Q2,1,I,20150530.0,,20150601,20150601,DIR,,,,,58.0,YR,,M,N,280.0,LBS,20150530.0,N,,US,,2015,Q2,Adult
111606711,11160671,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,44 U AM/52 U PM,,,,D, UNK,,21081.0,,,,BID,2015,Q2,Blood glucose increased,,2015,Q2,1,I,,20140515.0,20150604,20150604,PER,,US-SA-2014SA066452,AVENTIS,,70.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS AM AND 8 UNITS PM,,,,D, UNKNOWN,,21081.0,,,,BID,2015,Q2,Gait disturbance,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS AM AND 8 UNITS PM,,,,D, UNKNOWN,,21081.0,,,,BID,2015,Q2,Off label use,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS AM AND 8 UNITS PM,,,,D, UNKNOWN,,21081.0,,,,BID,2015,Q2,Pain in extremity,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS IN AM AND 8 UNITS IN PM,,,,D, 4F689A,,21081.0,,,,BID,2015,Q2,Gait disturbance,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS IN AM AND 8 UNITS IN PM,,,,D, 4F689A,,21081.0,,,,BID,2015,Q2,Off label use,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111609331,11160933,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS IN AM AND 8 UNITS IN PM,,,,D, 4F689A,,21081.0,,,,BID,2015,Q2,Pain in extremity,,2015,Q2,1,I,2013.0,20140527.0,20150604,20150604,PER,,US-SA-2014SA071610,AVENTIS,,77.0,YR,E,F,Y,,,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Abdominal discomfort,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Chest pain,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Drug ineffective,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Ear infection,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Eustachian tube disorder,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Fibromyalgia,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Gastrooesophageal reflux disease,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Hypertension,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Intentional product misuse,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Magnesium deficiency,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Osteopenia,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Product use issue,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Rib fracture,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Ulcer,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111639621,11163962,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS, EVERY MORNING",,,,D,,,,,,,,2015,Q2,Vitamin B complex deficiency,,2015,Q2,1,I,2000.0,20150528.0,20150604,20150604,EXP,,US-AUROBINDO-AUR-APL-2015-04798,AUROBINDO,,65.0,YR,,F,Y,124.3,KG,20150604.0,N,CN,US,US,2015,Q2,Elderly
111738351,11173835,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Pancreatitis,,2015,Q2,1,I,20150207.0,,20150608,20150608,DIR,,,,,54.0,YR,,M,N,211.0,LBS,20150605.0,N,OT,US,,2015,Q2,Adult
111773141,11177314,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Erythema,,2015,Q2,1,I,20150606.0,20150608.0,20150610,20150610,PER,,US-BAYER-2015-322252,BAYER,,58.0,YR,A,F,Y,77.98,KG,20150610.0,N,CN,US,US,2015,Q2,Adult
111773141,11177314,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Lower extremity mass,,2015,Q2,1,I,20150606.0,20150608.0,20150610,20150610,PER,,US-BAYER-2015-322252,BAYER,,58.0,YR,A,F,Y,77.98,KG,20150610.0,N,CN,US,US,2015,Q2,Adult
111773141,11177314,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Pruritus,,2015,Q2,1,I,20150606.0,20150608.0,20150610,20150610,PER,,US-BAYER-2015-322252,BAYER,,58.0,YR,A,F,Y,77.98,KG,20150610.0,N,CN,US,US,2015,Q2,Adult
111774461,11177446,19,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q2,Atrial tachycardia,,2015,Q2,1,I,201408.0,20150602.0,20150610,20150610,EXP,,SK-ASTRAZENECA-2015SE54479,ASTRAZENECA,PALKO M. NEW TRENDS AND NEW EFFECTIVE OPPORTUNITIES IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS- INHIBITION OF SGLT2 BY DAPAGLIFLOZIN. A CASE REPORT FROM AMBULATORY CARE OF PRACTICAL IN TERNIST DIABETOLOGIST..,74.0,YR,,M,Y,,,20150610.0,N,OT,SK,SK,2015,Q2,Elderly
111774461,11177446,19,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,1,I,201408.0,20150602.0,20150610,20150610,EXP,,SK-ASTRAZENECA-2015SE54479,ASTRAZENECA,PALKO M. NEW TRENDS AND NEW EFFECTIVE OPPORTUNITIES IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS- INHIBITION OF SGLT2 BY DAPAGLIFLOZIN. A CASE REPORT FROM AMBULATORY CARE OF PRACTICAL IN TERNIST DIABETOLOGIST..,74.0,YR,,M,Y,,,20150610.0,N,OT,SK,SK,2015,Q2,Elderly
111774461,11177446,19,C,GLARGINE,,2,,,,,,D,,,,,,,,2015,Q2,Vomiting,,2015,Q2,1,I,201408.0,20150602.0,20150610,20150610,EXP,,SK-ASTRAZENECA-2015SE54479,ASTRAZENECA,PALKO M. NEW TRENDS AND NEW EFFECTIVE OPPORTUNITIES IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS- INHIBITION OF SGLT2 BY DAPAGLIFLOZIN. A CASE REPORT FROM AMBULATORY CARE OF PRACTICAL IN TERNIST DIABETOLOGIST..,74.0,YR,,M,Y,,,20150610.0,N,OT,SK,SK,2015,Q2,Elderly
111810011,11181001,9,C,SOLOSTAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Metrorrhagia,,2015,Q2,1,I,2011.0,,20150610,20150610,DIR,,,,,54.0,YR,,F,N,150.0,LBS,20150522.0,N,,US,,2015,Q2,Adult
111891281,11189128,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Supraventricular tachycardia,,2015,Q2,1,I,20140804.0,,20150612,20150612,DIR,,,,,59.0,YR,A,M,N,271.0,LBS,20150611.0,N,CN,US,,2015,Q2,Adult
111891391,11189139,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Abdominal pain,,2015,Q2,1,I,20140728.0,,20150612,20150612,DIR,,,,,59.0,YR,,M,N,271.0,LBS,20150611.0,N,,US,,2015,Q2,Adult
111891391,11189139,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,White blood cell count increased,,2015,Q2,1,I,20140728.0,,20150612,20150612,DIR,,,,,59.0,YR,,M,N,271.0,LBS,20150611.0,N,,US,,2015,Q2,Adult
111949771,11194977,11,C,INSULIN GLARGINE (INSULIN GLARGINE),INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Hypersensitivity vasculitis,,2015,Q2,1,I,,20150604.0,20150615,20150615,EXP,,FK201502676,FRESENIUS KABI,,50.0,YR,,M,N,290.0,LBS,20150609.0,N,OT,US,,2015,Q2,Adult
111972451,11197245,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,,20150217.0,20150617,20150617,PER,,US-SA-2015SA022722,AVENTIS,,55.0,YR,A,M,Y,80.92,KG,20150617.0,N,CN,US,US,2015,Q2,Adult
111972451,11197245,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Headache,,2015,Q2,1,I,,20150217.0,20150617,20150617,PER,,US-SA-2015SA022722,AVENTIS,,55.0,YR,A,M,Y,80.92,KG,20150617.0,N,CN,US,US,2015,Q2,Adult
111972451,11197245,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hypertension,,2015,Q2,1,I,,20150217.0,20150617,20150617,PER,,US-SA-2015SA022722,AVENTIS,,55.0,YR,A,M,Y,80.92,KG,20150617.0,N,CN,US,US,2015,Q2,Adult
111980261,11198026,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,8,IU,,,2015,Q2,Cardio-respiratory arrest,,2015,Q2,1,I,20150608.0,20150611.0,20150617,20150617,EXP,,CO-BAXTER-2015BAX032291,BAXTER,,57.0,YR,,F,Y,56.0,KG,20150617.0,N,OT,CO,CO,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Acne,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Gynaecomastia,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Lymphadenopathy,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Lymphadenopathy mediastinal,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Metastases to liver,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Neurotoxicity,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Pulmonary granuloma,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111987381,11198738,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q2,Pulmonary mass,,2015,Q2,1,I,201408.0,20150612.0,20150618,20150618,EXP,,MX-AMGEN-MEXSP2015059133,AMGEN,,61.0,YR,A,M,Y,96.0,KG,20150618.0,N,MD,MX,MX,2015,Q2,Adult
111990241,11199024,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,60U,,,,D,,,,,,,,2015,Q2,Thrombocytopenia,,2015,Q2,1,I,,20150323.0,20150618,20150618,PER,,US-LUPIN PHARMACEUTICALS INC.-2015-01007,LUPIN,"STARR J, RAGUCCI K. THROMBOCYTOPENIA ASSOCIATED WITH INTRAVENOUS CIPROFLOXACIN. PHARMACOTHERAPY. 2005;25(7):1030-1034.",72.0,YR,,F,Y,,,20150618.0,N,PH,US,US,2015,Q2,Elderly
112016831,11201683,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,D,,,,36,IU,,QD,2015,Q2,Encephalopathy,,2015,Q2,1,I,,20150615.0,20150619,20150619,EXP,,US-TEVA-571673USA,TEVA,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150619.0,N,MD,US,US,2015,Q2,Adult
112016831,11201683,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,D,,,,36,IU,,QD,2015,Q2,Hypotonia,,2015,Q2,1,I,,20150615.0,20150619,20150619,EXP,,US-TEVA-571673USA,TEVA,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150619.0,N,MD,US,US,2015,Q2,Adult
112016831,11201683,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,D,,,,36,IU,,QD,2015,Q2,Toxicity to various agents,,2015,Q2,1,I,,20150615.0,20150619,20150619,EXP,,US-TEVA-571673USA,TEVA,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150619.0,N,MD,US,US,2015,Q2,Adult
112020411,11202041,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,INJECTION,,2015,Q2,Dysarthria,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,INJECTION,,2015,Q2,Fall,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,INJECTION,,2015,Q2,Gait disturbance,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,INJECTION,,2015,Q2,Head injury,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,INJECTION,,2015,Q2,Hypoglycaemia,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,D,,,,8,IU,INJECTION,QD,2015,Q2,Dysarthria,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,D,,,,8,IU,INJECTION,QD,2015,Q2,Fall,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,D,,,,8,IU,INJECTION,QD,2015,Q2,Gait disturbance,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,D,,,,8,IU,INJECTION,QD,2015,Q2,Head injury,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112020411,11202041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU, QD",,,,D,,,,8,IU,INJECTION,QD,2015,Q2,Hypoglycaemia,,2015,Q2,1,I,20150312.0,20150609.0,20150619,20150619,EXP,IT-AIFA-312150/312149,IT-ELI_LILLY_AND_COMPANY-IT201506003452,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20150618.0,N,CN,IT,IT,2015,Q2,Adult
112031031,11203103,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Abdominal pain,,2015,Q2,1,I,,20150611.0,20150619,20150619,EXP,,US-JNJFOC-20150609570,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20150619.0,N,CN,US,US,2015,Q2,Adult
112031031,11203103,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Supraventricular tachycardia,,2015,Q2,1,I,,20150611.0,20150619,20150619,EXP,,US-JNJFOC-20150609570,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20150619.0,N,CN,US,US,2015,Q2,Adult
112031042,11203104,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Abdominal pain,,2015,Q2,2,F,20140728.0,20150622.0,20150619,20150629,PER,,US-JNJFOC-20150609606,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20150629.0,N,CN,US,US,2015,Q2,Adult
112031042,11203104,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Leukocytosis,,2015,Q2,2,F,20140728.0,20150622.0,20150619,20150629,PER,,US-JNJFOC-20150609606,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20150629.0,N,CN,US,US,2015,Q2,Adult
112031042,11203104,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Supraventricular tachycardia,,2015,Q2,2,F,20140728.0,20150622.0,20150619,20150629,PER,,US-JNJFOC-20150609606,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20150629.0,N,CN,US,US,2015,Q2,Adult
112059031,11205903,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 ML, UNK",,,,U,,,,100,ML,,,2015,Q2,Clostridium difficile infection,,2015,Q2,1,I,20100610.0,20100629.0,20150622,20150622,PER,,US-MPIJNJ-2010-03268,TAKEDA,,56.0,YR,,M,Y,83.9,KG,20150622.0,N,OT,US,US,2015,Q2,Adult
112059031,11205903,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 ML, UNK",,,,U,,,,100,ML,,,2015,Q2,Febrile neutropenia,,2015,Q2,1,I,20100610.0,20100629.0,20150622,20150622,PER,,US-MPIJNJ-2010-03268,TAKEDA,,56.0,YR,,M,Y,83.9,KG,20150622.0,N,OT,US,US,2015,Q2,Adult
112059031,11205903,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 ML, UNK",,,,U,,,,100,ML,,,2015,Q2,Urinary tract infection,,2015,Q2,1,I,20100610.0,20100629.0,20150622,20150622,PER,,US-MPIJNJ-2010-03268,TAKEDA,,56.0,YR,,M,Y,83.9,KG,20150622.0,N,OT,US,US,2015,Q2,Adult
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Drug interaction,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Dysphagia,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Extrapyramidal disorder,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Lethargy,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Salivary hypersecretion,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112116421,11211642,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q2,Sedation,,2015,Q2,1,I,,20150609.0,20150623,20150623,EXP,,ES-ACTAVIS-2015-12101,ACTAVIS,"LERTXUNDI U, HERNANDEZ R, ALBENIZ JM, ECHABURU SD, RUIZ B, GARC?A MG, ET AL. POSSIBLE INTERACTION BETWEEN LETROZOLE AND LONG-ACTING INJECTABLE ZUCLOPENTHIXOL. NORD J PSYCHIATRY. 2015;69(1):79-80",68.0,YR,,F,Y,,,20150623.0,N,PH,ES,ES,2015,Q2,Elderly
112161001,11216100,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Abdominal pain,,2015,Q2,1,I,20140728.0,,20150623,20150623,DIR,,,,,59.0,YR,,M,N,271.0,LBS,20150611.0,N,CN,US,,2015,Q2,Adult
112161001,11216100,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Localised intraabdominal fluid collection,,2015,Q2,1,I,20140728.0,,20150623,20150623,DIR,,,,,59.0,YR,,M,N,271.0,LBS,20150611.0,N,CN,US,,2015,Q2,Adult
112161001,11216100,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,White blood cell count increased,,2015,Q2,1,I,20140728.0,,20150623,20150623,DIR,,,,,59.0,YR,,M,N,271.0,LBS,20150611.0,N,CN,US,,2015,Q2,Adult
112174231,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Dyspnoea,,2015,Q2,1,I,,20150617.0,20150625,20150625,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20150625.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
112174231,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Hypertension,,2015,Q2,1,I,,20150617.0,20150625,20150625,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20150625.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
112174231,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Neutropenia,,2015,Q2,1,I,,20150617.0,20150625,20150625,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20150625.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
112174231,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Oedema peripheral,,2015,Q2,1,I,,20150617.0,20150625,20150625,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20150625.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
112174231,11217423,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,White blood cell count increased,,2015,Q2,1,I,,20150617.0,20150625,20150625,EXP,,US-DRREDDYS-USA/USA/15/0048894,DR REDDYS,"ISKANDAR J, VANCE J, KABLINGER A, KAVURU B. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. J CLIN PSYCHOPHARMACOL. 2015;35(3):347-8.",45.0,YR,,M,Y,,,20150625.0,N,OT,COUNTRY NOT SPECIFIED,US,2015,Q2,Adult
112191141,11219114,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Cough,,2015,Q2,1,I,20150313.0,20150618.0,20150625,20150625,EXP,ES-AGEMED-642521440,ES-GILEAD-2015-0159545,GILEAD,,59.0,YR,A,M,Y,,,20150625.0,N,PH,ES,ES,2015,Q2,Adult
112191141,11219114,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q2,Haemoptysis,,2015,Q2,1,I,20150313.0,20150618.0,20150625,20150625,EXP,ES-AGEMED-642521440,ES-GILEAD-2015-0159545,GILEAD,,59.0,YR,A,M,Y,,,20150625.0,N,PH,ES,ES,2015,Q2,Adult
112196641,11219664,7,C,LANTUS SOLOSTAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Neoplasm malignant,,2015,Q2,1,I,2011.0,,20150624,20150624,DIR,,,,,54.0,YR,,F,N,150.0,LBS,20150522.0,N,,US,,2015,Q2,Adult
112196641,11219664,7,C,LANTUS SOLOSTAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Unevaluable event,,2015,Q2,1,I,2011.0,,20150624,20150624,DIR,,,,,54.0,YR,,F,N,150.0,LBS,20150522.0,N,,US,,2015,Q2,Adult
112196641,11219664,7,C,LANTUS SOLOSTAR INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Vaginal haemorrhage,,2015,Q2,1,I,2011.0,,20150624,20150624,DIR,,,,,54.0,YR,,F,N,150.0,LBS,20150522.0,N,,US,,2015,Q2,Adult
112203321,11220332,6,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20150526.0,,20150625,20150625,DIR,,,,,72.0,YR,,F,N,36.0,KG,20150624.0,N,PH,US,,2015,Q2,Elderly
112203321,11220332,6,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Fluid intake reduced,,2015,Q2,1,I,20150526.0,,20150625,20150625,DIR,,,,,72.0,YR,,F,N,36.0,KG,20150624.0,N,PH,US,,2015,Q2,Elderly
112203321,11220332,6,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q2,Lactic acidosis,,2015,Q2,1,I,20150526.0,,20150625,20150625,DIR,,,,,72.0,YR,,F,N,36.0,KG,20150624.0,N,PH,US,,2015,Q2,Elderly
112218591,11221859,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, QD, 10 UNITS",,,,D,,,,,,,QD,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,,20150619.0,20150626,20150626,EXP,,JP-GLAXOSMITHKLINE-JP2015GSK089640,GLAXOSMITHKLINE,"TAMAKI M, ET AL.. A CASE OF FALSE HYPOGLYCEMIA BY SMBG DUE TO IMPROPER STORAGE OF GLUCOMETER TEST STRIPS. DIABETOLOGY INTERNATIONAL.. 2014;5;3:199-201",72.0,YR,,M,Y,,,20150626.0,N,OT,JP,JP,2015,Q2,Elderly
112218591,11221859,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, QD, 10 UNITS",,,,D,,,,,,,QD,2015,Q2,Glycosylated haemoglobin increased,,2015,Q2,1,I,,20150619.0,20150626,20150626,EXP,,JP-GLAXOSMITHKLINE-JP2015GSK089640,GLAXOSMITHKLINE,"TAMAKI M, ET AL.. A CASE OF FALSE HYPOGLYCEMIA BY SMBG DUE TO IMPROPER STORAGE OF GLUCOMETER TEST STRIPS. DIABETOLOGY INTERNATIONAL.. 2014;5;3:199-201",72.0,YR,,M,Y,,,20150626.0,N,OT,JP,JP,2015,Q2,Elderly
112218591,11221859,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, QD, 10 UNITS",,,,D,,,,,,,QD,2015,Q2,Hypoglycaemia,,2015,Q2,1,I,,20150619.0,20150626,20150626,EXP,,JP-GLAXOSMITHKLINE-JP2015GSK089640,GLAXOSMITHKLINE,"TAMAKI M, ET AL.. A CASE OF FALSE HYPOGLYCEMIA BY SMBG DUE TO IMPROPER STORAGE OF GLUCOMETER TEST STRIPS. DIABETOLOGY INTERNATIONAL.. 2014;5;3:199-201",72.0,YR,,M,Y,,,20150626.0,N,OT,JP,JP,2015,Q2,Elderly
112218591,11221859,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, QD, 10 UNITS",,,,D,,,,,,,QD,2015,Q2,Incorrect product storage,,2015,Q2,1,I,,20150619.0,20150626,20150626,EXP,,JP-GLAXOSMITHKLINE-JP2015GSK089640,GLAXOSMITHKLINE,"TAMAKI M, ET AL.. A CASE OF FALSE HYPOGLYCEMIA BY SMBG DUE TO IMPROPER STORAGE OF GLUCOMETER TEST STRIPS. DIABETOLOGY INTERNATIONAL.. 2014;5;3:199-201",72.0,YR,,M,Y,,,20150626.0,N,OT,JP,JP,2015,Q2,Elderly
112218591,11221859,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, QD, 10 UNITS",,,,D,,,,,,,QD,2015,Q2,Medication error,,2015,Q2,1,I,,20150619.0,20150626,20150626,EXP,,JP-GLAXOSMITHKLINE-JP2015GSK089640,GLAXOSMITHKLINE,"TAMAKI M, ET AL.. A CASE OF FALSE HYPOGLYCEMIA BY SMBG DUE TO IMPROPER STORAGE OF GLUCOMETER TEST STRIPS. DIABETOLOGY INTERNATIONAL.. 2014;5;3:199-201",72.0,YR,,M,Y,,,20150626.0,N,OT,JP,JP,2015,Q2,Elderly
112234611,11223461,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,AS DIRECTED,,,,D,,,,,,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150609.0,20150622.0,20150628,20150628,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,GB-TEVA-572871ACC,TEVA,,46.0,YR,,M,Y,84.0,KG,20150628.0,N,MD,GB,GB,2015,Q2,Adult
112234611,11223461,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,AS DIRECTED,,,,D,,,,,,,,2015,Q2,Palpitations,,2015,Q2,1,I,20150609.0,20150622.0,20150628,20150628,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,GB-TEVA-572871ACC,TEVA,,46.0,YR,,M,Y,84.0,KG,20150628.0,N,MD,GB,GB,2015,Q2,Adult
112234611,11223461,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,AS DIRECTED,,,,D,,,,,,,,2015,Q2,Peripheral swelling,,2015,Q2,1,I,20150609.0,20150622.0,20150628,20150628,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,GB-TEVA-572871ACC,TEVA,,46.0,YR,,M,Y,84.0,KG,20150628.0,N,MD,GB,GB,2015,Q2,Adult
112243351,11224335,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Palpitations,,2015,Q2,1,I,20150520.0,,20150626,20150626,DIR,,,,,59.0,YR,,F,N,75.75,KG,20150624.0,N,CN,US,,2015,Q2,Adult
112243351,11224335,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Troponin increased,,2015,Q2,1,I,20150520.0,,20150626,20150626,DIR,,,,,59.0,YR,,F,N,75.75,KG,20150624.0,N,CN,US,,2015,Q2,Adult
112245821,11224582,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150609.0,20150622.0,20150625,20150625,EXP,,NL01PV15_39213,SYNTHON,,46.0,YR,,M,N,84.0,KG,20150624.0,N,OT,GB,,2015,Q2,Adult
112245821,11224582,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Palpitations,,2015,Q2,1,I,20150609.0,20150622.0,20150625,20150625,EXP,,NL01PV15_39213,SYNTHON,,46.0,YR,,M,N,84.0,KG,20150624.0,N,OT,GB,,2015,Q2,Adult
112245821,11224582,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q2,Peripheral swelling,,2015,Q2,1,I,20150609.0,20150622.0,20150625,20150625,EXP,,NL01PV15_39213,SYNTHON,,46.0,YR,,M,N,84.0,KG,20150624.0,N,OT,GB,,2015,Q2,Adult
112270161,11227016,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,AS DIRECTED,,,,U,,,,,,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150609.0,20150622.0,20150630,20150630,EXP,,GB-AUROBINDO-AUR-APL-2015-05430,AUROBINDO,,46.0,YR,,M,Y,84.0,KG,20150630.0,N,MD,GB,GB,2015,Q2,Adult
112270161,11227016,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,AS DIRECTED,,,,U,,,,,,,,2015,Q2,Palpitations,,2015,Q2,1,I,20150609.0,20150622.0,20150630,20150630,EXP,,GB-AUROBINDO-AUR-APL-2015-05430,AUROBINDO,,46.0,YR,,M,Y,84.0,KG,20150630.0,N,MD,GB,GB,2015,Q2,Adult
112270161,11227016,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,AS DIRECTED,,,,U,,,,,,,,2015,Q2,Peripheral swelling,,2015,Q2,1,I,20150609.0,20150622.0,20150630,20150630,EXP,,GB-AUROBINDO-AUR-APL-2015-05430,AUROBINDO,,46.0,YR,,M,Y,84.0,KG,20150630.0,N,MD,GB,GB,2015,Q2,Adult
112311911,11231191,3,C,LANTUS SOLO STAR (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Joint swelling,,2015,Q2,1,I,,20150303.0,20150612,20150612,PER,,2015TUS003004,TAKEDA,,65.0,YR,,M,N,,,20150422.0,N,CN,US,,2015,Q2,Elderly
112311911,11231191,3,C,LANTUS SOLO STAR (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q2,Myalgia,,2015,Q2,1,I,,20150303.0,20150612,20150612,PER,,2015TUS003004,TAKEDA,,65.0,YR,,M,N,,,20150422.0,N,CN,US,,2015,Q2,Elderly
89923704,8992370,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,INJECTION,QD,2015,Q2,International normalised ratio increased,,2015,Q2,4,F,20121212.0,20130204.0,20121231,20150525,PER,,US-JNJFOC-20121210173,JANSSEN,,77.0,YR,E,F,Y,113.0,KG,20150525.0,N,CN,US,US,2015,Q2,Elderly
89923704,8992370,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10,IU,INJECTION,QD,2015,Q2,Medication error,,2015,Q2,4,F,20121212.0,20130204.0,20121231,20150525,PER,,US-JNJFOC-20121210173,JANSSEN,,77.0,YR,E,F,Y,113.0,KG,20150525.0,N,CN,US,US,2015,Q2,Elderly
92632332,9263233,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Dyspnoea exertional,,2015,Q2,2,F,20120801.0,20150524.0,20130430,20150529,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2013-BI-11024BP",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,122.0,KG,20150529.0,N,MD,US,US,2015,Q2,Adult
92632332,9263233,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q2,Fatigue,,2015,Q2,2,F,20120801.0,20150524.0,20130430,20150529,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2013-BI-11024BP",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,122.0,KG,20150529.0,N,MD,US,US,2015,Q2,Adult
93929804,9392980,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, ONCE DAILY",,,,U,,,,,,FORMULATION UNKNOWN,QD,2015,Q2,Respiratory failure,,2015,Q2,4,F,20130329.0,20150529.0,20130710,20150612,EXP,,US-ASTELLAS-2013EU003313,ASTELLAS,,59.0,YR,,F,Y,,,20150612.0,N,CN,US,US,2015,Q2,Adult
94198029,9419802,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,FORMULATION: INJECTION,,,,D,,,,,,,,2015,Q2,Haemorrhage intracranial,,2015,Q2,9,F,20130712.0,20150529.0,20130725,20150625,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2013-BI-21858YA",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,84.0,KG,20150625.0,N,MD,US,US,2015,Q2,Elderly
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Deep vein thrombosis,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Fatigue,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Haematoma,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Polyneuropathy,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Pyrexia,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98023983,9802398,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Rash,,2015,Q2,3,F,20101130.0,20150609.0,20140107,20150622,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-15423833,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20150622.0,N,CN,US,US,2015,Q2,Adult
98278163,9827816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Colitis,,2015,Q2,3,F,20140106.0,20150611.0,20140117,20150619,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19981208,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,,,20150619.0,N,CN,US,US,2015,Q2,Adult
98278163,9827816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q2,Malignant neoplasm progression,,2015,Q2,3,F,20140106.0,20150611.0,20140117,20150619,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19981208,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,,,20150619.0,N,CN,US,US,2015,Q2,Adult
98468403,9846840,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Erythroleukaemia,,2015,Q2,3,F,20140113.0,20150521.0,20140127,20150526,PER,,US-JNJFOC-20140115024,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20150526.0,N,MD,US,US,2015,Q2,Elderly
98468403,9846840,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q2,Syncope,,2015,Q2,3,F,20140113.0,20150521.0,20140127,20150526,PER,,US-JNJFOC-20140115024,PHARMACYCLICS,,68.0,YR,E,M,Y,,,20150526.0,N,MD,US,US,2015,Q2,Elderly
99937364,9993736,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,8-12 UNITS/DAY,,,,D,,,,,,,QD,2015,Q2,Pneumonitis,,2015,Q2,4,F,20130626.0,20150428.0,20140310,20150504,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-10504GD",BOEHRINGER INGELHEIM,"YAJIMA T,JINGU D,SHOJI M,IGARASHI T,WATANABE H,TAKAHASHI H. A CASE OF DRUG-INDUCED PNEUMONITIS CAUSED BY VILDAGLIPTIN. ANN JPN RESPIR SOC 2015;4:2:176-180.",85.0,YR,,M,Y,49.5,KG,20150504.0,N,OT,COUNTRY NOT SPECIFIED,JP,2015,Q2,Elderly
103443113,10344311,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100UNIT/ML,,,,D,,,,,,,,2015,Q3,Deep vein thrombosis,,2015,Q3,3,F,20140711.0,20150901.0,20140728,20150908,EXP,,US-ROCHE-1434652,ROCHE,,55.0,YR,,M,Y,,,20150908.0,N,MD,US,US,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Colorectal cancer,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Diaphragmalgia,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Gastrointestinal cancer metastatic,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Hepatic cancer,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Lung adenocarcinoma metastatic,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Metastases to bone,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Metastases to liver,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Myalgia,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Neoplasm malignant,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104378522,10437852,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Tumour necrosis,,2015,Q3,2,F,2014.0,20150826.0,20140908,20150831,EXP,,DK-ABBVIE-14K-044-1279107-00,ABBVIE,,53.0,YR,,M,Y,99.0,KG,20150831.0,N,PH,DK,DK,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Activities of daily living impaired,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Acute kidney injury,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Anaemia,Anaemia,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Chest pain,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Chronic kidney disease,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Cough,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
104508616,10450861,16,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE:18U/S,,,,D,,,,,,,QD,2015,Q3,Gastroenteritis,,2015,Q3,6,F,20140707.0,20150727.0,20140912,20150804,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-32991BI",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,,,20150804.0,N,MD,COUNTRY NOT SPECIFIED,AU,2015,Q3,Adult
107875843,10787584,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,.02,ML,,QD,2015,Q3,Hyperkalaemia,,2015,Q3,3,F,20150102.0,20150901.0,20150212,20150908,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150908.0,N,MD,GB,GB,2015,Q3,Elderly
107875843,10787584,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,.02,ML,,QD,2015,Q3,Presyncope,,2015,Q3,3,F,20150102.0,20150901.0,20150212,20150908,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150908.0,N,MD,GB,GB,2015,Q3,Elderly
107875843,10787584,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,.02,ML,,QD,2015,Q3,Pseudomonas infection,,2015,Q3,3,F,20150102.0,20150901.0,20150212,20150908,EXP,,GB-ROCHE-1530843,ROCHE,,79.0,YR,,M,Y,,,20150908.0,N,MD,GB,GB,2015,Q3,Elderly
108719712,10871971,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,16,IU,UNKNOWN,QD,2015,Q3,Eyelid oedema,,2015,Q3,2,F,201501.0,20150630.0,20150226,20150715,PER,,US-CELGENEUS-USA-2015024179,CELGENE,,73.0,YR,,M,Y,69.6,KG,20150715.0,N,MD,US,US,2015,Q3,Elderly
108719712,10871971,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,16,IU,UNKNOWN,QD,2015,Q3,Rash pruritic,,2015,Q3,2,F,201501.0,20150630.0,20150226,20150715,PER,,US-CELGENEUS-USA-2015024179,CELGENE,,73.0,YR,,M,Y,69.6,KG,20150715.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Hypotension,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Leukopenia,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Malaise,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Pain,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Pancytopenia,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Platelet count decreased,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,Pyrexia,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110509502,11050950,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS AT BEDTIME,,,,D,,,,,,INJECTION,,2015,Q3,White blood cell count decreased,,2015,Q3,2,F,20141014.0,20150707.0,20150421,20150716,EXP,,US-SA-2015SA050430,AVENTIS,,81.0,YR,E,M,Y,86.18,KG,20150716.0,N,MD,US,US,2015,Q3,Elderly
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Dehydration,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Fatigue,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Oedema peripheral,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110768042,11076804,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Pyrexia,,2015,Q3,2,F,20140818.0,20150714.0,20150429,20150721,EXP,,PHHO2015US007366,NOVARTIS,,63.0,YR,,F,Y,,,20150721.0,N,OT,US,US,2015,Q3,Adult
110955362,11095536,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Oesophageal perforation,,2015,Q3,2,F,,20150624.0,20150506,20150702,EXP,,US-GILEAD-2015-0151780,GILEAD,,61.0,YR,A,F,Y,,,20150702.0,N,OT,US,US,2015,Q3,Adult
111559123,11155912,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Acute coronary syndrome,,2015,Q3,3,F,20150508.0,20150707.0,20150602,20150716,EXP,,CO-BAXTER-2015BAX028096,BAXTER,,75.0,YR,,F,Y,67.0,KG,20150716.0,N,OT,CO,CO,2015,Q3,Elderly
111559123,11155912,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Acute myocardial infarction,,2015,Q3,3,F,20150508.0,20150707.0,20150602,20150716,EXP,,CO-BAXTER-2015BAX028096,BAXTER,,75.0,YR,,F,Y,67.0,KG,20150716.0,N,OT,CO,CO,2015,Q3,Elderly
111559123,11155912,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Endocarditis,,2015,Q3,3,F,20150508.0,20150707.0,20150602,20150716,EXP,,CO-BAXTER-2015BAX028096,BAXTER,,75.0,YR,,F,Y,67.0,KG,20150716.0,N,OT,CO,CO,2015,Q3,Elderly
111559123,11155912,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Femoral artery occlusion,,2015,Q3,3,F,20150508.0,20150707.0,20150602,20150716,EXP,,CO-BAXTER-2015BAX028096,BAXTER,,75.0,YR,,F,Y,67.0,KG,20150716.0,N,OT,CO,CO,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Areflexia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Ataxia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Cerebellar ataxia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Diplopia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Dizziness,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Dyslalia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Eye movement disorder,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Gait disturbance,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Hyporeflexia,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Nausea,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Nuclear magnetic resonance imaging abnormal,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Nystagmus,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Vitamin B1 decreased,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Vomiting,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111587033,11158703,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE:8 UNIT(S),,,,D, UNK,,21081.0,,,,QD,2015,Q3,Wernicke's encephalopathy,,2015,Q3,3,F,201211.0,20150706.0,20150603,20150713,EXP,,JP-SA-2015SA074390,AVENTIS,"KANEKO Y, TSURUTANI Y, SAGAWA N, KONDO M, SATA A, MIYAO M, ET AL. A CASE OF AN ELDERLY DIABETIC PATIENT DEVELOPING WERNICKE^S ENCEPHALOPATHY WITHOUT ALCOHOL ABUSE OR AN UNBALANCED DIET. JAPANESE JOURNAL OF GERIATRICS 2015 APR;52(2):177-83.",70.0,YR,E,M,Y,47.4,KG,20150713.0,N,MD,JP,JP,2015,Q3,Elderly
111667572,11166757,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Fatigue,,2015,Q3,2,F,20150512.0,20150717.0,20150605,20150807,PER,,US-JNJFOC-20150513569,JANSSEN,,46.0,YR,,F,Y,,,20150807.0,N,MD,US,US,2015,Q3,Adult
111667572,11166757,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Medication error,,2015,Q3,2,F,20150512.0,20150717.0,20150605,20150807,PER,,US-JNJFOC-20150513569,JANSSEN,,46.0,YR,,F,Y,,,20150807.0,N,MD,US,US,2015,Q3,Adult
111832764,11183276,9,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,D,,,,18.0,IU,UNKNOWN,QD,2015,Q3,Invasive ductal breast carcinoma,,2015,Q3,4,F,20150519.0,20150915.0,20150611,20150922,PER,,US-CELGENEUS-USA-2015060571,CELGENE,,55.0,YR,,F,Y,85.81,KG,20150922.0,N,MD,US,US,2015,Q3,Adult
111832764,11183276,9,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,D,,,,18.0,IU,UNKNOWN,QD,2015,Q3,Peripheral swelling,,2015,Q3,4,F,20150519.0,20150915.0,20150611,20150922,PER,,US-CELGENEUS-USA-2015060571,CELGENE,,55.0,YR,,F,Y,85.81,KG,20150922.0,N,MD,US,US,2015,Q3,Adult
111840304,11184030,9,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,D,,,,18.0,IU,UNKNOWN,QD,2015,Q3,Invasive ductal breast carcinoma,,2015,Q3,4,F,20150519.0,20150915.0,20150612,20150923,EXP,,US-CELGENE-USA-2015060571,CELGENE,,55.0,YR,,F,Y,85.81,KG,20150923.0,N,MD,US,US,2015,Q3,Adult
111840304,11184030,9,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,18 IU (INTERNATIONAL UNIT),,,,D,,,,18.0,IU,UNKNOWN,QD,2015,Q3,Peripheral swelling,,2015,Q3,4,F,20150519.0,20150915.0,20150612,20150923,EXP,,US-CELGENE-USA-2015060571,CELGENE,,55.0,YR,,F,Y,85.81,KG,20150923.0,N,MD,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Dizziness,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Dry skin,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Dysphagia,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Emotional disorder,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Fatigue,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Injection site dryness,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Seizure,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111895152,11189515,18,C,Insulin glargine biomep,,2,Subcutaneous,"10 IU, UNK",,,,U,,,,10.0,IU,,QD,2015,Q3,Tremor,,2015,Q3,2,F,20150312.0,20150814.0,20150615,20150827,EXP,,US-ACORDA-ACO_110417_2015,ACORDA,,47.0,YR,,F,Y,105.21,KG,20150827.0,N,CN,US,US,2015,Q3,Adult
111921925,11192192,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE UNIT:100,,,,D,,,,,,,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,5,F,20150511.0,20150914.0,20150616,20150923,EXP,,US-BIOGENIDEC-2015BI075967,BIOGEN,,39.0,YR,A,F,Y,68.0,KG,20150923.0,N,MD,US,US,2015,Q3,Adult
111921925,11192192,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,20.0,IU,,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,5,F,20150511.0,20150914.0,20150616,20150923,EXP,,US-BIOGENIDEC-2015BI075967,BIOGEN,,39.0,YR,A,F,Y,68.0,KG,20150923.0,N,MD,US,US,2015,Q3,Adult
111921925,11192192,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,20.0,IU,,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,5,F,20150511.0,20150914.0,20150616,20150923,EXP,,US-BIOGENIDEC-2015BI075967,BIOGEN,,39.0,YR,A,F,Y,68.0,KG,20150923.0,N,MD,US,US,2015,Q3,Adult
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Blood potassium decreased,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Diarrhoea,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Hyperhidrosis,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Incorrect dose administered,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Prostatitis,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Urinary retention,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Urinary tract infection,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111954112,11195411,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,UNSPECIFIED,,2015,Q3,Wrong technique in product usage process,,2015,Q3,2,F,20150525.0,20150729.0,20150617,20150810,EXP,,CO-JNJFOC-20150404887,JANSSEN,,86.0,YR,E,M,Y,40.0,KG,20150810.0,N,OT,CO,CO,2015,Q3,Elderly
111995292,11199529,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,U,,,,36.0,IU,,QD,2015,Q3,Encephalopathy,,2015,Q3,2,F,,20150811.0,20150618,20150811,EXP,,US-MYLANLABS-2015M1019783,MYLAN,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150811.0,N,MD,US,US,2015,Q3,Adult
111995292,11199529,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,U,,,,36.0,IU,,QD,2015,Q3,Hypotonia,,2015,Q3,2,F,,20150811.0,20150618,20150811,EXP,,US-MYLANLABS-2015M1019783,MYLAN,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150811.0,N,MD,US,US,2015,Q3,Adult
111995292,11199529,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,PRN DOSING,,,,U,,,,36.0,IU,,QD,2015,Q3,Toxicity to various agents,,2015,Q3,2,F,,20150811.0,20150618,20150811,EXP,,US-MYLANLABS-2015M1019783,MYLAN,"IJAZ M, TARIQ H, KASHIF M, MARQUEZ JG. ENCEPHALOPATHY AND HYPOTONIA DUE TO BACLOFEN TOXICITY IN A PATIENT WITH END-STAGE RENAL DISEASE. AM-J-CASE-REP 2015; 16:232-235.",57.0,YR,,F,Y,110.0,KG,20150811.0,N,MD,US,US,2015,Q3,Adult
112241043,11224104,2,C,GLARGINE,,2,Unknown,48/52 UNITS,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,3,F,20141112.0,20150804.0,20150629,20150817,EXP,,CA-JNJFOC-20150613469,JANSSEN,,66.0,YR,E,F,Y,75.7,KG,20150817.0,N,MD,CA,CA,2015,Q3,Elderly
112351211,11235121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Muscle spasms,,2015,Q3,1,I,20150609.0,20150622.0,20150702,20150702,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,PHHY2015GB075857,SANDOZ,,46.0,YR,,M,Y,84.0,KG,20150702.0,N,OT,GB,GB,2015,Q3,Adult
112351211,11235121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Palpitations,,2015,Q3,1,I,20150609.0,20150622.0,20150702,20150702,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,PHHY2015GB075857,SANDOZ,,46.0,YR,,M,Y,84.0,KG,20150702.0,N,OT,GB,GB,2015,Q3,Adult
112351211,11235121,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Peripheral swelling,,2015,Q3,1,I,20150609.0,20150622.0,20150702,20150702,EXP,GB-MHRA-TPP23248390C1376849YC1433854809374,PHHY2015GB075857,SANDOZ,,46.0,YR,,M,Y,84.0,KG,20150702.0,N,OT,GB,GB,2015,Q3,Adult
112360323,11236032,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Arterial occlusive disease,,2015,Q3,3,F,20150530.0,20150803.0,20150702,20150807,EXP,,IT-SA-2015SA095691,AVENTIS,,79.0,YR,E,M,Y,77.0,KG,20150807.0,N,OT,IT,IT,2015,Q3,Elderly
112364484,11236448,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Foot operation,,2015,Q3,4,F,20150714.0,20150826.0,20150702,20150909,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-042265,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,,,20150909.0,N,OT,GB,GB,2015,Q3,Elderly
112364484,11236448,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Postoperative wound infection,,2015,Q3,4,F,20150714.0,20150826.0,20150702,20150909,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-042265,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,,,20150909.0,N,OT,GB,GB,2015,Q3,Elderly
112377331,11237733,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D, UNKNOWN,,,,,,,2015,Q3,Rash macular,,2015,Q3,1,I,,20140529.0,20150703,20150703,PER,,GB-LUPIN PHARMACEUTICALS INC.-2014-01124,LUPIN,"STEPHENS J, MALLIPEDHI A, MACIVER C, UDIAWAR M, PRICE D. CUTANEOUS ALLERGY TO INSULIN: COULD STATINS AND ACE INHIBITORS PLAY A ROLE? A CASE REPORT. DIABETES RESEARCH AND CLINICAL PRACTICE. 2014;104:E20-E22.",48.0,YR,,M,Y,,,20150703.0,N,OT,GB,GB,2015,Q3,Adult
112377331,11237733,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D, UNKNOWN,,,,,,,2015,Q3,Urticaria,,2015,Q3,1,I,,20140529.0,20150703,20150703,PER,,GB-LUPIN PHARMACEUTICALS INC.-2014-01124,LUPIN,"STEPHENS J, MALLIPEDHI A, MACIVER C, UDIAWAR M, PRICE D. CUTANEOUS ALLERGY TO INSULIN: COULD STATINS AND ACE INHIBITORS PLAY A ROLE? A CASE REPORT. DIABETES RESEARCH AND CLINICAL PRACTICE. 2014;104:E20-E22.",48.0,YR,,M,Y,,,20150703.0,N,OT,GB,GB,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Blood creatine phosphokinase increased,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Constipation,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Cough,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Decreased appetite,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Fatigue,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Foot fracture,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Haemoglobin decreased,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Night sweats,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Oedema peripheral,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Off label use,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Pyrexia,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Upper-airway cough syndrome,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394641,11239464,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 UNK, UNK",,,,U,,,,,,,,2015,Q3,Weight increased,,2015,Q3,1,I,20141012.0,20141210.0,20150706,20150706,EXP,,US-009507513-1506USA005487,MERCK,,60.0,YR,,M,Y,97.0,KG,20150706.0,N,MD,US,US,2015,Q3,Adult
112394651,11239465,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q3,Drug hypersensitivity,,2015,Q3,1,I,201001.0,20100513.0,20150706,20150706,EXP,,US-MERCK-1506USA006282,MERCK,,66.0,YR,,M,Y,147.5,KG,20150706.0,N,PH,US,US,2015,Q3,Elderly
112394651,11239465,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q3,Eosinophilic pneumonia,,2015,Q3,1,I,201001.0,20100513.0,20150706,20150706,EXP,,US-MERCK-1506USA006282,MERCK,,66.0,YR,,M,Y,147.5,KG,20150706.0,N,PH,US,US,2015,Q3,Elderly
112394651,11239465,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q3,Haemoptysis,,2015,Q3,1,I,201001.0,20100513.0,20150706,20150706,EXP,,US-MERCK-1506USA006282,MERCK,,66.0,YR,,M,Y,147.5,KG,20150706.0,N,PH,US,US,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Dyspepsia,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Gingival atrophy,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Gingival bleeding,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Gingival disorder,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Gingival pain,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Gingival swelling,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112395221,11239522,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Oesophageal discomfort,,2015,Q3,1,I,20150426.0,,20150701,20150701,DIR,,,,,70.0,YR,,M,N,200.0,LBS,20150630.0,N,,US,,2015,Q3,Elderly
112480991,11248099,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Haemolytic anaemia,,2015,Q3,1,I,20150627.0,,20150707,20150707,DIR,,,,,52.0,YR,,M,N,61.9,KG,20150706.0,N,PH,US,,2015,Q3,Adult
112480991,11248099,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Refusal of treatment by patient,,2015,Q3,1,I,20150627.0,,20150707,20150707,DIR,,,,,52.0,YR,,M,N,61.9,KG,20150706.0,N,PH,US,,2015,Q3,Adult
112505601,11250560,6,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Acute myocardial infarction,,2015,Q3,1,I,20150629.0,20150701.0,20150708,20150708,EXP,,CO-BAXTER-2015BAX036492,BAXTER,,78.0,YR,,M,Y,42.0,KG,20150708.0,N,OT,CO,CO,2015,Q3,Elderly
112532331,11253233,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Drug ineffective,,2015,Q3,1,I,201405.0,20140610.0,20150709,20150709,PER,,US-TEVA-488011USA,TEVA,,44.0,YR,,F,Y,95.34,KG,20150709.0,N,CN,US,US,2015,Q3,Adult
112532331,11253233,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Dysgeusia,,2015,Q3,1,I,201405.0,20140610.0,20150709,20150709,PER,,US-TEVA-488011USA,TEVA,,44.0,YR,,F,Y,95.34,KG,20150709.0,N,CN,US,US,2015,Q3,Adult
112532331,11253233,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,201405.0,20140610.0,20150709,20150709,PER,,US-TEVA-488011USA,TEVA,,44.0,YR,,F,Y,95.34,KG,20150709.0,N,CN,US,US,2015,Q3,Adult
112625871,11262587,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Colitis,,2015,Q3,1,I,20130615.0,20150508.0,20150710,20150710,EXP,,US-BAYER-2015-228664,BAYER,,68.0,YR,E,M,Y,,,20150710.0,N,OT,US,US,2015,Q3,Elderly
112625871,11262587,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Diverticulum,,2015,Q3,1,I,20130615.0,20150508.0,20150710,20150710,EXP,,US-BAYER-2015-228664,BAYER,,68.0,YR,E,M,Y,,,20150710.0,N,OT,US,US,2015,Q3,Elderly
112625871,11262587,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Duodenitis,,2015,Q3,1,I,20130615.0,20150508.0,20150710,20150710,EXP,,US-BAYER-2015-228664,BAYER,,68.0,YR,E,M,Y,,,20150710.0,N,OT,US,US,2015,Q3,Elderly
112625871,11262587,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Gastritis,,2015,Q3,1,I,20130615.0,20150508.0,20150710,20150710,EXP,,US-BAYER-2015-228664,BAYER,,68.0,YR,E,M,Y,,,20150710.0,N,OT,US,US,2015,Q3,Elderly
112625871,11262587,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Rectal haemorrhage,,2015,Q3,1,I,20130615.0,20150508.0,20150710,20150710,EXP,,US-BAYER-2015-228664,BAYER,,68.0,YR,E,M,Y,,,20150710.0,N,OT,US,US,2015,Q3,Elderly
112636421,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2015,Q3,Dizziness,,2015,Q3,1,I,20150605.0,20150630.0,20150713,20150713,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20150713.0,N,OT,DK,DK,2015,Q3,Elderly
112636421,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2015,Q3,Malaise,,2015,Q3,1,I,20150605.0,20150630.0,20150713,20150713,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20150713.0,N,OT,DK,DK,2015,Q3,Elderly
112636421,11263642,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE A DAY",,,,U,,,,,,,QD,2015,Q3,Sinus bradycardia,,2015,Q3,1,I,20150605.0,20150630.0,20150713,20150713,EXP,,DK-AUROBINDO-AUR-APL-2015-05658,AUROBINDO,,66.0,YR,,M,Y,,,20150713.0,N,OT,DK,DK,2015,Q3,Elderly
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Cataract cortical,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Diabetic retinopathy,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Hypoglycaemia,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Macular oedema,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Vision blurred,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Visual acuity reduced,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112702212,11270221,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,,2015,Q3,Vitreous haemorrhage,,2015,Q3,2,F,,20150908.0,20150714,20150915,EXP,,IE-SA-2015SA099523,AVENTIS,,28.0,YR,A,M,Y,,,20150915.0,N,MD,IE,IE,2015,Q3,Young Adult
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Blindness,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Blood cholesterol increased,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Dizziness,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Fall,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Haematuria,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Humerus fracture,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Hypotension,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Inguinal hernia,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Oedema,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Syncope,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Urinary retention,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112719662,11271966,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,D,,,,,,,,2015,Q3,Weight decreased,,2015,Q3,2,F,201505.0,20150805.0,20150715,20150813,EXP,,US-ASTRAZENECA-2015SE66907,ASTRAZENECA,,766.0,MON,,M,Y,99.8,KG,20150813.0,N,MD,US,US,2015,Q3,Elderly
112734311,11273431,2,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150713.0,,20150714,20150714,DIR,,,,,33.0,YR,,F,N,157.0,LBS,20150713.0,N,MD,US,,2015,Q3,Young Adult
112755721,11275572,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Ketoacidosis,,2015,Q3,1,I,20150522.0,20150713.0,20150716,20150716,EXP,,US-JNJFOC-20150709613,JANSSEN,,47.0,YR,A,F,Y,77.0,KG,20150716.0,N,MD,US,US,2015,Q3,Adult
112755721,11275572,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Mental status changes,,2015,Q3,1,I,20150522.0,20150713.0,20150716,20150716,EXP,,US-JNJFOC-20150709613,JANSSEN,,47.0,YR,A,F,Y,77.0,KG,20150716.0,N,MD,US,US,2015,Q3,Adult
112765201,11276520,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004411,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Youth
112765201,11276520,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Exposure during breast feeding,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004411,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Youth
112765201,11276520,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Maternal exposure during pregnancy,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004411,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Youth
112765261,11276526,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Apgar score low,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004448,ELI LILLY AND CO,,0.0,DY,,,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Child
112765261,11276526,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Exposure during breast feeding,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004448,ELI LILLY AND CO,,0.0,DY,,,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Child
112765261,11276526,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Foetal exposure during pregnancy,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004448,ELI LILLY AND CO,,0.0,DY,,,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Child
112765261,11276526,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"28 IU, QD",,,,D,,,,28,IU,,QD,2015,Q3,Polydactyly,,2015,Q3,1,I,20131226.0,20150707.0,20150716,20150716,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201507004448,ELI LILLY AND CO,,0.0,DY,,,Y,,,20150716.0,N,CN,JP,JP,2015,Q3,Child
112779431,11277943,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Abdominal pain,,2015,Q3,1,I,20140728.0,20150611.0,20150716,20150716,EXP,,US-GILEAD-2015-0158473,GILEAD,,59.0,YR,A,M,Y,122.9,KG,20150716.0,N,MD,US,US,2015,Q3,Adult
112779431,11277943,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Leukocytosis,,2015,Q3,1,I,20140728.0,20150611.0,20150716,20150716,EXP,,US-GILEAD-2015-0158473,GILEAD,,59.0,YR,A,M,Y,122.9,KG,20150716.0,N,MD,US,US,2015,Q3,Adult
112779431,11277943,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Supraventricular tachycardia,,2015,Q3,1,I,20140728.0,20150611.0,20150716,20150716,EXP,,US-GILEAD-2015-0158473,GILEAD,,59.0,YR,A,M,Y,122.9,KG,20150716.0,N,MD,US,US,2015,Q3,Adult
112789392,11278939,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q3,Arterial occlusive disease,,2015,Q3,2,F,20150530.0,20150804.0,20150717,20150811,EXP,,IT-ACTAVIS-2015-14964,ACTAVIS,,79.0,YR,,M,Y,,,20150811.0,N,CN,IT,IT,2015,Q3,Elderly
112794621,11279462,3,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,D,,,,25,IU,,,2015,Q3,Cardio-respiratory arrest,,2015,Q3,1,I,20150613.0,20150709.0,20150717,20150717,EXP,,CO-BAXTER-2015BAX038181,BAXTER,,28.0,YR,,M,Y,60.0,KG,20150717.0,N,OT,CO,CO,2015,Q3,Young Adult
112794621,11279462,3,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,D,,,,25,IU,,,2015,Q3,Peritoneal dialysis complication,,2015,Q3,1,I,20150613.0,20150709.0,20150717,20150717,EXP,,CO-BAXTER-2015BAX038181,BAXTER,,28.0,YR,,M,Y,60.0,KG,20150717.0,N,OT,CO,CO,2015,Q3,Young Adult
112794621,11279462,3,C,GLARGINE INSULINE,,2,Subcutaneous,,,,,D,,,,25,IU,,,2015,Q3,Peritonitis bacterial,,2015,Q3,1,I,20150613.0,20150709.0,20150717,20150717,EXP,,CO-BAXTER-2015BAX038181,BAXTER,,28.0,YR,,M,Y,60.0,KG,20150717.0,N,OT,CO,CO,2015,Q3,Young Adult
112809632,11280963,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Gastrointestinal haemorrhage,,2015,Q3,2,F,20120822.0,20150902.0,20150717,20150911,EXP,,US-JNJFOC-20150708053,JANSSEN,,70.0,YR,E,M,Y,,,20150911.0,N,CN,US,US,2015,Q3,Elderly
112831683,11283168,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Arterial occlusive disease,,2015,Q3,3,F,20150530.0,20150804.0,20150720,20150812,EXP,IT-MINISAL02-317135,IT-TEVA-577990ACC,TEVA,,79.0,YR,,M,Y,,,20150812.0,N,MD,IT,IT,2015,Q3,Elderly
112831683,11283168,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Pain in extremity,,2015,Q3,3,F,20150530.0,20150804.0,20150720,20150812,EXP,IT-MINISAL02-317135,IT-TEVA-577990ACC,TEVA,,79.0,YR,,M,Y,,,20150812.0,N,MD,IT,IT,2015,Q3,Elderly
112868422,11286842,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Arterial occlusive disease,,2015,Q3,2,F,20150530.0,20150804.0,20150721,20150818,EXP,IT-ACCORD-032230,IT-ACCORD-032230,ACCORD,,79.0,YR,,M,Y,,,20150818.0,N,MD,IT,IT,2015,Q3,Elderly
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Acute myocardial infarction,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Atrial fibrillation,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Cerebrovascular accident,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Drug administration error,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Hyperosmolar hyperglycaemic state,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Oedema peripheral,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112885212,11288521,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,UNITS,,,,D,,,,,,,,2015,Q3,Renal failure,,2015,Q3,2,F,201506.0,20150814.0,20150721,20150826,EXP,,GB-BAXTER-2015BAX038348,BAXTER,,49.0,YR,,M,Y,,,20150826.0,N,OT,GB,PT,2015,Q3,Adult
112894121,11289412,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,E,,,,D,,,,,,UNKNOWN,QD,2015,Q3,Diabetic hyperglycaemic coma,,2015,Q3,1,I,20121201.0,20131016.0,20150721,20150721,EXP,,DE-CELGENE-062-50794-13103348,CELGENE,,75.0,YR,,F,Y,65.0,KG,20150721.0,N,MD,DE,DE,2015,Q3,Elderly
112894121,11289412,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Diabetic hyperglycaemic coma,,2015,Q3,1,I,20121201.0,20131016.0,20150721,20150721,EXP,,DE-CELGENE-062-50794-13103348,CELGENE,,75.0,YR,,F,Y,65.0,KG,20150721.0,N,MD,DE,DE,2015,Q3,Elderly
112899721,11289972,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Urinary retention,,2015,Q3,1,I,20150507.0,20150618.0,20150721,20150721,PER,,PHHY2015US076973,SANDOZ,,84.0,YR,,,Y,,,20150721.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Chest discomfort,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Chest pain,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Disease progression,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Fatigue,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Infusion site erythema,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Infusion site nodule,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Infusion site pain,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Oedema peripheral,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112909051,11290905,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Oxygen consumption increased,,2015,Q3,1,I,20150505.0,20150506.0,20150722,20150722,PER,,US-UNITED THERAPEUTICS-UNT-2015-005374,UNITED THERAPEUTICS,,66.0,YR,,F,Y,90.7,KG,20150722.0,N,CN,US,US,2015,Q3,Elderly
112918241,11291824,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,,D,,,,,,,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20130111.0,20150714.0,20150722,20150722,EXP,,IT-WATSON-2015-14758,WATSON,,74.0,YR,,M,Y,,,20150722.0,N,CN,IT,IT,2015,Q3,Elderly
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Balanoposthitis,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Dysuria,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Erythema,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Fatigue,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Hypoaesthesia,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Intentional product misuse,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Vision blurred,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112922521,11292252,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,D,,,,,,,,2015,Q3,Weight decreased,,2015,Q3,1,I,2015.0,20150715.0,20150722,20150722,EXP,,BR-ASTRAZENECA-2015SE70011,ASTRAZENECA,,56.0,YR,,M,Y,,,20150722.0,N,,BR,BR,2015,Q3,Adult
112945401,11294540,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Altered state of consciousness,,2015,Q3,1,I,,20150713.0,20150721,20150721,EXP,,NSR_02157_2015,NORTHSTAR,,57.0,YR,,F,N,110.0,KG,20150720.0,N,MD,US,,2015,Q3,Adult
112945401,11294540,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Disturbance in attention,,2015,Q3,1,I,,20150713.0,20150721,20150721,EXP,,NSR_02157_2015,NORTHSTAR,,57.0,YR,,F,N,110.0,KG,20150720.0,N,MD,US,,2015,Q3,Adult
112945401,11294540,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Hypotonia,,2015,Q3,1,I,,20150713.0,20150721,20150721,EXP,,NSR_02157_2015,NORTHSTAR,,57.0,YR,,F,N,110.0,KG,20150720.0,N,MD,US,,2015,Q3,Adult
112945401,11294540,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Muscle spasms,,2015,Q3,1,I,,20150713.0,20150721,20150721,EXP,,NSR_02157_2015,NORTHSTAR,,57.0,YR,,F,N,110.0,KG,20150720.0,N,MD,US,,2015,Q3,Adult
112945401,11294540,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Toxicity to various agents,,2015,Q3,1,I,,20150713.0,20150721,20150721,EXP,,NSR_02157_2015,NORTHSTAR,,57.0,YR,,F,N,110.0,KG,20150720.0,N,MD,US,,2015,Q3,Adult
112957381,11295738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Duodenal ulcer,,2015,Q3,1,I,20140815.0,,20150722,20150722,DIR,,,,,77.0,YR,,F,N,59.4,KG,20150721.0,N,PH,US,,2015,Q3,Elderly
112957381,11295738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Melaena,,2015,Q3,1,I,20140815.0,,20150722,20150722,DIR,,,,,77.0,YR,,F,N,59.4,KG,20150721.0,N,PH,US,,2015,Q3,Elderly
112957381,11295738,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Upper gastrointestinal haemorrhage,,2015,Q3,1,I,20140815.0,,20150722,20150722,DIR,,,,,77.0,YR,,F,N,59.4,KG,20150721.0,N,PH,US,,2015,Q3,Elderly
113020721,11302072,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,1,I,20150422.0,,20150723,20150723,DIR,,,,,68.0,YR,,M,N,156.0,LBS,20150721.0,Y,CN,US,,2015,Q3,Elderly
113020721,11302072,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Femoral neck fracture,,2015,Q3,1,I,20150422.0,,20150723,20150723,DIR,,,,,68.0,YR,,M,N,156.0,LBS,20150721.0,Y,CN,US,,2015,Q3,Elderly
113074221,11307422,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,12.0,IU,,BID,2015,Q3,Pancreatitis,,2015,Q3,1,I,20150528.0,20150716.0,20150723,20150723,EXP,,IT-ASTRAZENECA-2015SE70131,ASTRAZENECA,,25372.0,DY,,F,Y,,,20150724.0,N,MD,IT,IT,2015,Q3,Elderly
113098582,11309858,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,21081.0,,,SOLUTION FOR INJECTION,,2015,Q3,Loss of consciousness,,2015,Q3,2,F,20150611.0,20150720.0,20150724,20150904,PER,,CA-SA-2015SA107505,AVENTIS,,64.0,YR,A,M,Y,127.2,KG,20150904.0,N,MD,CA,CA,2015,Q3,Adult
113116401,11311640,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Device lead issue,,2015,Q3,1,I,20150330.0,,20150724,20150724,DIR,,,,,76.0,YR,,F,N,,,20150406.0,N,PH,US,,2015,Q3,Elderly
113116401,11311640,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,International normalised ratio increased,,2015,Q3,1,I,20150330.0,,20150724,20150724,DIR,,,,,76.0,YR,,F,N,,,20150406.0,N,PH,US,,2015,Q3,Elderly
113116401,11311640,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Venous occlusion,,2015,Q3,1,I,20150330.0,,20150724,20150724,DIR,,,,,76.0,YR,,F,N,,,20150406.0,N,PH,US,,2015,Q3,Elderly
113116581,11311658,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 UNITS,,,,,,,,42.0,IU,,HS,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150401.0,,20150724,20150724,DIR,,,,,56.0,YR,,M,N,,,20150406.0,N,PH,US,,2015,Q3,Adult
113116581,11311658,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 UNITS,,,,,,,,42.0,IU,,HS,2015,Q3,Vomiting,,2015,Q3,1,I,20150401.0,,20150724,20150724,DIR,,,,,56.0,YR,,M,N,,,20150406.0,N,PH,US,,2015,Q3,Adult
113119951,11311995,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML,,,,D,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,1,I,20150121.0,20150720.0,20150727,20150727,EXP,,NL-AMGEN-NLDSL2015073293,AMGEN,,66.0,YR,E,F,Y,,,20150727.0,N,OT,NL,NL,2015,Q3,Elderly
113119951,11311995,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML,,,,D,,,,,,,,2015,Q3,Bursa removal,,2015,Q3,1,I,20150121.0,20150720.0,20150727,20150727,EXP,,NL-AMGEN-NLDSL2015073293,AMGEN,,66.0,YR,E,F,Y,,,20150727.0,N,OT,NL,NL,2015,Q3,Elderly
113119951,11311995,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100E/ML,,,,D,,,,,,,,2015,Q3,Musculoskeletal pain,,2015,Q3,1,I,20150121.0,20150720.0,20150727,20150727,EXP,,NL-AMGEN-NLDSL2015073293,AMGEN,,66.0,YR,E,F,Y,,,20150727.0,N,OT,NL,NL,2015,Q3,Elderly
113120771,11312077,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Drug dose omission,,2015,Q3,1,I,20150723.0,20150723.0,20150727,20150727,PER,,US-ELI_LILLY_AND_COMPANY-US201507008759,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20150727.0,N,CN,US,US,2015,Q3,Adult
113120771,11312077,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Underdose,,2015,Q3,1,I,20150723.0,20150723.0,20150727,20150727,PER,,US-ELI_LILLY_AND_COMPANY-US201507008759,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20150727.0,N,CN,US,US,2015,Q3,Adult
113121231,11312123,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D, UNKNOWN,,21081.0,,,,,2015,Q3,Chest pain,,2015,Q3,1,I,20150708.0,20150714.0,20150727,20150727,EXP,,US-SA-2015SA110055,AVENTIS,,66.0,YR,E,M,Y,,,20150727.0,N,MD,US,US,2015,Q3,Elderly
113123954,11312395,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,28.0,IU,,,2015,Q3,Diabetic foot,,2015,Q3,4,F,20150715.0,20150920.0,20150727,20150928,EXP,,CO-BAXTER-2015BAX039584,BAXTER,,69.0,YR,,F,Y,67.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Elderly
113123954,11312395,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,28.0,IU,,,2015,Q3,Extremity necrosis,,2015,Q3,4,F,20150715.0,20150920.0,20150727,20150928,EXP,,CO-BAXTER-2015BAX039584,BAXTER,,69.0,YR,,F,Y,67.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Elderly
113123954,11312395,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,28.0,IU,,,2015,Q3,Sepsis,,2015,Q3,4,F,20150715.0,20150920.0,20150727,20150928,EXP,,CO-BAXTER-2015BAX039584,BAXTER,,69.0,YR,,F,Y,67.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Elderly
113124401,11312440,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150314.0,,20150724,20150724,DIR,,,,,44.0,YR,,M,N,,,20150408.0,N,PH,US,,2015,Q3,Adult
113124401,11312440,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150314.0,,20150724,20150724,DIR,,,,,44.0,YR,,M,N,,,20150408.0,N,PH,US,,2015,Q3,Adult
113173061,11317306,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150606.0,,20150727,20150727,DIR,,,,,58.0,YR,,M,N,,,20150609.0,N,PH,US,,2015,Q3,Adult
113173061,11317306,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150606.0,,20150727,20150727,DIR,,,,,58.0,YR,,M,N,,,20150609.0,N,PH,US,,2015,Q3,Adult
113173061,11317306,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Cough,,2015,Q3,1,I,20150606.0,,20150727,20150727,DIR,,,,,58.0,YR,,M,N,,,20150609.0,N,PH,US,,2015,Q3,Adult
113173061,11317306,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Dyspnoea,,2015,Q3,1,I,20150606.0,,20150727,20150727,DIR,,,,,58.0,YR,,M,N,,,20150609.0,N,PH,US,,2015,Q3,Adult
113178211,11317821,12,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10-30,,,,D,,,,,,UNKNOWN,,2015,Q3,Acute myocardial infarction,,2015,Q3,1,I,20150515.0,20150717.0,20150728,20150728,EXP,,CA-CELGENE-CAN-2015074344,CELGENE,,79.0,YR,,M,Y,81.6,KG,20150728.0,N,PH,CA,CA,2015,Q3,Elderly
113178211,11317821,12,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10-30,,,,D,,,,,,UNKNOWN,,2015,Q3,Coronary artery disease,,2015,Q3,1,I,20150515.0,20150717.0,20150728,20150728,EXP,,CA-CELGENE-CAN-2015074344,CELGENE,,79.0,YR,,M,Y,81.6,KG,20150728.0,N,PH,CA,CA,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Beta haemolytic streptococcal infection,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Blood sodium decreased,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Blood urea increased,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Dehydration,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Depression,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Hyponatraemia,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Insomnia,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113185351,11318535,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, AT BED TIME",,,,U,,,,,,,,2015,Q3,Transient ischaemic attack,,2015,Q3,1,I,,20150715.0,20150729,20150729,EXP,,US-AUROBINDO-AUR-APL-2015-06287,AUROBINDO,,82.0,YR,,F,Y,46.6,KG,20150729.0,N,OT,US,US,2015,Q3,Elderly
113196571,11319657,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Blood creatinine increased,,2015,Q3,1,I,20150505.0,,20150728,20150728,DIR,,,,,62.0,YR,,F,N,,,20150514.0,N,PH,US,,2015,Q3,Adult
113196571,11319657,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Cardioactive drug level increased,,2015,Q3,1,I,20150505.0,,20150728,20150728,DIR,,,,,62.0,YR,,F,N,,,20150514.0,N,PH,US,,2015,Q3,Adult
113196571,11319657,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Ventricular extrasystoles,,2015,Q3,1,I,20150505.0,,20150728,20150728,DIR,,,,,62.0,YR,,F,N,,,20150514.0,N,PH,US,,2015,Q3,Adult
113196961,11319696,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20150113.0,,20150728,20150728,DIR,,,,,58.0,YR,,M,N,,,20150518.0,N,PH,US,,2015,Q3,Adult
113196961,11319696,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Haemorrhage,,2015,Q3,1,I,20150113.0,,20150728,20150728,DIR,,,,,58.0,YR,,M,N,,,20150518.0,N,PH,US,,2015,Q3,Adult
113196961,11319696,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,International normalised ratio fluctuation,,2015,Q3,1,I,20150113.0,,20150728,20150728,DIR,,,,,58.0,YR,,M,N,,,20150518.0,N,PH,US,,2015,Q3,Adult
113198291,11319829,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,International normalised ratio fluctuation,,2015,Q3,1,I,20150227.0,,20150728,20150728,DIR,,,,,24.0,YR,A,F,N,,,20150518.0,N,PH,US,,2015,Q3,Young Adult
113198291,11319829,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Migraine with aura,,2015,Q3,1,I,20150227.0,,20150728,20150728,DIR,,,,,24.0,YR,A,F,N,,,20150518.0,N,PH,US,,2015,Q3,Young Adult
113198291,11319829,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Staphylococcal bacteraemia,,2015,Q3,1,I,20150227.0,,20150728,20150728,DIR,,,,,24.0,YR,A,F,N,,,20150518.0,N,PH,US,,2015,Q3,Young Adult
113198781,11319878,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150504.0,,20150728,20150728,DIR,,,,,62.0,YR,A,F,N,,,20150508.0,N,PH,US,,2015,Q3,Adult
113198781,11319878,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150504.0,,20150728,20150728,DIR,,,,,62.0,YR,A,F,N,,,20150508.0,N,PH,US,,2015,Q3,Adult
113198871,11319887,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,12.0,IU,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150502.0,,20150728,20150728,DIR,,,,,70.0,YR,,M,N,,,20150508.0,N,PH,US,,2015,Q3,Elderly
113203361,11320336,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,QD,2015,Q3,Death,,2015,Q3,1,I,20150625.0,20150722.0,20150729,20150729,EXP,,CO-BAXTER-2015BAX040541,BAXTER,,70.0,YR,,F,Y,83.0,KG,20150729.0,N,OT,CO,CO,2015,Q3,Elderly
113203361,11320336,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,QD,2015,Q3,Pneumonia,,2015,Q3,1,I,20150625.0,20150722.0,20150729,20150729,EXP,,CO-BAXTER-2015BAX040541,BAXTER,,70.0,YR,,F,Y,83.0,KG,20150729.0,N,OT,CO,CO,2015,Q3,Elderly
113203361,11320336,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,QD,2015,Q3,Urinary tract infection,,2015,Q3,1,I,20150625.0,20150722.0,20150729,20150729,EXP,,CO-BAXTER-2015BAX040541,BAXTER,,70.0,YR,,F,Y,83.0,KG,20150729.0,N,OT,CO,CO,2015,Q3,Elderly
113203482,11320348,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,30.0,IU,,,2015,Q3,Diabetic foot,,2015,Q3,2,F,20150714.0,20150810.0,20150729,20150817,EXP,,CO-BAXTER-2015BAX040335,BAXTER,,59.0,YR,,M,Y,104.0,KG,20150817.0,N,OT,CO,CO,2015,Q3,Adult
113203482,11320348,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,30.0,IU,,,2015,Q3,Extremity necrosis,,2015,Q3,2,F,20150714.0,20150810.0,20150729,20150817,EXP,,CO-BAXTER-2015BAX040335,BAXTER,,59.0,YR,,M,Y,104.0,KG,20150817.0,N,OT,CO,CO,2015,Q3,Adult
113203482,11320348,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,30.0,IU,,,2015,Q3,Postoperative wound infection,,2015,Q3,2,F,20150714.0,20150810.0,20150729,20150817,EXP,,CO-BAXTER-2015BAX040335,BAXTER,,59.0,YR,,M,Y,104.0,KG,20150817.0,N,OT,CO,CO,2015,Q3,Adult
113265041,11326504,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150714.0,20150728.0,20150731,20150731,EXP,,CH-JNJFOC-20150720471,JANSSEN,,47.0,YR,A,F,Y,,,20150731.0,N,MD,CH,CH,2015,Q3,Adult
113267871,11326787,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Leukopenia,,2015,Q3,1,I,20150228.0,,20150729,20150729,DIR,,,,,57.0,YR,,M,N,,,20150306.0,N,PH,US,,2015,Q3,Adult
113276641,11327664,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 UNITS  AT BEDTIME  SC,,,,,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150204.0,,20150730,20150730,DIR,,,,,26.0,YR,,M,N,,,20150213.0,N,PH,US,,2015,Q3,Young Adult
113282431,11328243,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Depression,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US089782,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,,,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282431,11328243,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Hyponatraemia,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US089782,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,,,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282431,11328243,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Insomnia,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US089782,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,,,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282431,11328243,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US089782,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,,,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282431,11328243,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Transient ischaemic attack,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US089782,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,,,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282451,11328245,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Depression,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US092358,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,46.6,KG,20150731.0,N,OT,US,US,2015,Q3,Elderly
113282451,11328245,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Sedation,,2015,Q3,1,I,,20150721.0,20150731,20150731,EXP,,PHHY2015US092358,SANDOZ,"HUNTSBERRY AM, LINNEBUR SA, VEJAR M.. HYPONATREMIA AFTER INITIATION AND RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN AN OLDER ADULT. CLIN-INTERV-AGING. 2015;101091-96",82.0,YR,,F,Y,46.6,KG,20150731.0,N,OT,US,US,2015,Q3,Elderly
113295951,11329595,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150223.0,,20150730,20150730,DIR,,,,,79.0,YR,,M,N,,,20150224.0,N,PH,US,,2015,Q3,Elderly
113296861,11329686,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150202.0,,20150730,20150730,DIR,,,,,48.0,YR,,F,N,,,20150209.0,N,PH,US,,2015,Q3,Adult
113296861,11329686,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,HS,2015,Q3,Hyperhidrosis,,2015,Q3,1,I,20150202.0,,20150730,20150730,DIR,,,,,48.0,YR,,F,N,,,20150209.0,N,PH,US,,2015,Q3,Adult
113297191,11329719,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU/KG,,HS,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150205.0,,20150730,20150730,DIR,,,,,53.0,YR,,M,N,,,20150213.0,N,PH,US,,2015,Q3,Adult
113297961,11329796,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20150217.0,,20150730,20150730,DIR,,,,,53.0,YR,,M,N,,,20150220.0,N,PH,US,,2015,Q3,Adult
113298021,11329802,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Blood potassium increased,,2015,Q3,1,I,20150202.0,,20150730,20150730,DIR,,,,,48.0,YR,,F,N,,,20150209.0,N,PH,US,,2015,Q3,Adult
113346611,11334661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Delirium,,2015,Q3,1,I,20141016.0,,20150731,20150731,DIR,,,,,62.0,YR,,M,N,,,20141128.0,N,PH,US,,2015,Q3,Adult
113346611,11334661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Mental status changes,,2015,Q3,1,I,20141016.0,,20150731,20150731,DIR,,,,,62.0,YR,,M,N,,,20141128.0,N,PH,US,,2015,Q3,Adult
113355731,11335573,5,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20150728.0,,20150731,20150731,DIR,,,,,62.0,YR,,F,N,100.0,KG,20150730.0,N,MD,US,,2015,Q3,Adult
113355731,11335573,5,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Vomiting,,2015,Q3,1,I,20150728.0,,20150731,20150731,DIR,,,,,62.0,YR,,F,N,100.0,KG,20150730.0,N,MD,US,,2015,Q3,Adult
113407021,11340702,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS,,,Y,D,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20140912.0,,20150803,20150803,DIR,,,,,74.0,YR,,F,N,,,20140918.0,N,PH,US,,2015,Q3,Elderly
113407021,11340702,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS,,,Y,D,,,,,,,HS,2015,Q3,Drug prescribing error,,2015,Q3,1,I,20140912.0,,20150803,20150803,DIR,,,,,74.0,YR,,F,N,,,20140918.0,N,PH,US,,2015,Q3,Elderly
113407021,11340702,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS,,,Y,D,,,,,,,HS,2015,Q3,Hyperhidrosis,,2015,Q3,1,I,20140912.0,,20150803,20150803,DIR,,,,,74.0,YR,,F,N,,,20140918.0,N,PH,US,,2015,Q3,Elderly
113407021,11340702,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS,,,Y,D,,,,,,,HS,2015,Q3,Tachypnoea,,2015,Q3,1,I,20140912.0,,20150803,20150803,DIR,,,,,74.0,YR,,F,N,,,20140918.0,N,PH,US,,2015,Q3,Elderly
113412161,11341216,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Drug-induced liver injury,,2015,Q3,1,I,,20150721.0,20150805,20150805,PER,,US-JNJFOC-20150719850,JANSSEN,"ANASTASIA EJ, ROSENSTEIN RS, BERGSMAN JA, PARRA D. USE OF APIXABAN AFTER DEVELOPEMENT OF SUSPECTED RIVAROXABAN-INDUCED HEPATIC STEATOSIS; A CASE REPORT. BLOOD COAGULATION AND FIBRINOLYSIS 2014.",67.0,YR,E,M,Y,,,20150805.0,N,OT,US,US,2015,Q3,Elderly
113449121,11344912,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,25.0,IU,,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150406.0,20150730.0,20150806,20150806,EXP,,IT-ASTRAZENECA-2015SE74536,ASTRAZENECA,,24353.0,DY,,M,Y,,,20150806.0,N,MD,IT,IT,2015,Q3,Elderly
113452121,11345212,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3 UNITS AT BEDTIME SC,,,,,,,,,,,HS,2015,Q3,Cardiac arrest,,2015,Q3,1,I,20141218.0,,20150805,20150805,DIR,,,,,33.0,YR,,F,N,,,20141218.0,N,PH,US,,2015,Q3,Young Adult
113452121,11345212,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3 UNITS AT BEDTIME SC,,,,,,,,,,,HS,2015,Q3,Hyperglycaemia,,2015,Q3,1,I,20141218.0,,20150805,20150805,DIR,,,,,33.0,YR,,F,N,,,20141218.0,N,PH,US,,2015,Q3,Young Adult
113453371,11345337,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,26.0,IU,,QD,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141220.0,,20150805,20150805,DIR,,,,,68.0,YR,,F,N,,,20141220.0,N,PH,US,,2015,Q3,Elderly
113467931,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Anti-insulin antibody increased,,2015,Q3,1,I,,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20150806.0,N,CN,JP,JP,2015,Q3,Elderly
113467931,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20150806.0,N,CN,JP,JP,2015,Q3,Elderly
113467931,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Vomiting,,2015,Q3,1,I,,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20150806.0,N,CN,JP,JP,2015,Q3,Elderly
113467931,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,,,20150806.0,N,CN,JP,JP,2015,Q3,Elderly
113471221,11347122,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Feeding disorder,,2015,Q3,1,I,201507.0,20150724.0,20150806,20150806,EXP,,US-CELGENE-USA-2015076303,CELGENE,,74.0,YR,,M,Y,71.28,KG,20150806.0,N,PH,US,US,2015,Q3,Elderly
113494901,11349490,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 UNITS  AT BEDTIME  SC,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141130.0,,20150805,20150805,DIR,,,,,61.0,YR,,F,N,,,20141203.0,N,PH,US,,2015,Q3,Adult
113495161,11349516,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Coma scale abnormal,,2015,Q3,1,I,,20150729.0,20150807,20150807,EXP,GB-MHRA-EYC 00126010,GB-TEVA-582822ACC,TEVA,,85.0,YR,,M,Y,,,20150807.0,N,PH,GB,GB,2015,Q3,Elderly
113495181,11349518,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 UNITS AT BEDTIME SC,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141202.0,,20150805,20150805,DIR,,,,,56.0,YR,,M,N,,,20141205.0,N,PH,US,,2015,Q3,Adult
113497991,11349799,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141220.0,,20150805,20150805,DIR,,,,,82.0,YR,,F,N,,,20141223.0,N,PH,US,,2015,Q3,Elderly
113498471,11349847,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNITS  AT BEDTIME  SC,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141216.0,,20150805,20150805,DIR,,,,,33.0,YR,,M,N,,,20141223.0,N,PH,US,,2015,Q3,Young Adult
113503471,11350347,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Coma scale abnormal,,2015,Q3,1,I,,20150729.0,20150807,20150807,EXP,GB-MHRA-EYC 00126010,GB-PFIZER INC-2015254751,PFIZER,,85.0,YR,,M,Y,,,20150807.0,N,PH,GB,GB,2015,Q3,Elderly
113503471,11350347,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Product use issue,,2015,Q3,1,I,,20150729.0,20150807,20150807,EXP,GB-MHRA-EYC 00126010,GB-PFIZER INC-2015254751,PFIZER,,85.0,YR,,M,Y,,,20150807.0,N,PH,GB,GB,2015,Q3,Elderly
113504621,11350462,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 UNITS,,,,,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141130.0,,20150805,20150805,DIR,,,,,77.0,YR,,M,N,,,20141205.0,N,PH,US,,2015,Q3,Elderly
113504791,11350479,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 UNITS,,,Y,Y,,,,,,,HS,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,20141201.0,,20150805,20150805,DIR,,,,,73.0,YR,,M,N,,,20141205.0,N,PH,US,,2015,Q3,Elderly
113563343,11356334,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"45 IU/ML, UNK",,,,D,,,,45.0,DF,,,2015,Q3,Neutropenia,,2015,Q3,3,F,20150730.0,20150902.0,20150807,20150910,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051413,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,75.0,KG,20150910.0,N,OT,KR,KR,2015,Q3,Elderly
113563343,11356334,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"45 IU/ML, UNK",,,,D,,,,45.0,DF,,,2015,Q3,Pneumonia,,2015,Q3,3,F,20150730.0,20150902.0,20150807,20150910,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051413,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,75.0,KG,20150910.0,N,OT,KR,KR,2015,Q3,Elderly
113587991,11358799,5,C,INSULINE GLARGINE (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,1,I,,20150224.0,20150716,20150716,PER,,2015AP007417,APOTEX,,53.0,YR,,M,N,,,20150519.0,N,OT,US,,2015,Q3,Adult
113587991,11358799,5,C,INSULINE GLARGINE (INSULIN GLARGINE),,2,,,,,,,,,,,,,,2015,Q3,Leukopenia,,2015,Q3,1,I,,20150224.0,20150716,20150716,PER,,2015AP007417,APOTEX,,53.0,YR,,M,N,,,20150519.0,N,OT,US,,2015,Q3,Adult
113621341,11362134,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Coma scale abnormal,,2015,Q3,1,I,,20150729.0,20150810,20150810,EXP,GB-MHRA-EYC 00126010,PHHY2015GB091312,SANDOZ,,85.0,YR,,M,Y,,,20150810.0,N,OT,GB,GB,2015,Q3,Elderly
113625491,11362549,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Dry mouth,,2015,Q3,1,I,,20150727.0,20150810,20150810,PER,,US-PFIZER INC-2015252310,PFIZER,,64.0,YR,,F,Y,78.0,KG,20150810.0,N,CN,US,US,2015,Q3,Adult
113625491,11362549,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Oral pain,,2015,Q3,1,I,,20150727.0,20150810,20150810,PER,,US-PFIZER INC-2015252310,PFIZER,,64.0,YR,,F,Y,78.0,KG,20150810.0,N,CN,US,US,2015,Q3,Adult
113625491,11362549,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Rash erythematous,,2015,Q3,1,I,,20150727.0,20150810,20150810,PER,,US-PFIZER INC-2015252310,PFIZER,,64.0,YR,,F,Y,78.0,KG,20150810.0,N,CN,US,US,2015,Q3,Adult
113625491,11362549,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Stomatitis,,2015,Q3,1,I,,20150727.0,20150810,20150810,PER,,US-PFIZER INC-2015252310,PFIZER,,64.0,YR,,F,Y,78.0,KG,20150810.0,N,CN,US,US,2015,Q3,Adult
113626875,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Hypoxia,,2015,Q3,5,F,20150727.0,20150915.0,20150810,20150921,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20150921.0,N,OT,US,US,2015,Q3,Elderly
113626875,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Myocardial infarction,,2015,Q3,5,F,20150727.0,20150915.0,20150810,20150921,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20150921.0,N,OT,US,US,2015,Q3,Elderly
113626875,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Pneumonia,,2015,Q3,5,F,20150727.0,20150915.0,20150810,20150921,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20150921.0,N,OT,US,US,2015,Q3,Elderly
113637071,11363707,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Coma scale abnormal,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,,GB-AUROBINDO-AUR-APL-2015-06997,AUROBINDO,,85.0,YR,,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Elderly
113688381,11368838,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 U, QD",,,,D,,,,12.0,DF,,QD,2015,Q3,Hepatic enzyme increased,,2015,Q3,1,I,20140914.0,20150522.0,20150812,20150812,PER,,PHHY2015US066158,NOVARTIS,,17.0,YR,,M,Y,52.5,KG,20150812.0,N,OT,US,US,2015,Q3,Youth
113688381,11368838,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 U, QD",,,,D,,,,12.0,DF,,QD,2015,Q3,Pulmonary function test decreased,,2015,Q3,1,I,20140914.0,20150522.0,20150812,20150812,PER,,PHHY2015US066158,NOVARTIS,,17.0,YR,,M,Y,52.5,KG,20150812.0,N,OT,US,US,2015,Q3,Youth
113688381,11368838,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 U, QD",,,,D,,,,12.0,DF,,QD,2015,Q3,Pyrexia,,2015,Q3,1,I,20140914.0,20150522.0,20150812,20150812,PER,,PHHY2015US066158,NOVARTIS,,17.0,YR,,M,Y,52.5,KG,20150812.0,N,OT,US,US,2015,Q3,Youth
113688381,11368838,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 U, QD",,,,D,,,,12.0,DF,,QD,2015,Q3,Respiratory distress,,2015,Q3,1,I,20140914.0,20150522.0,20150812,20150812,PER,,PHHY2015US066158,NOVARTIS,,17.0,YR,,M,Y,52.5,KG,20150812.0,N,OT,US,US,2015,Q3,Youth
113742441,11374244,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"73 IU, DAILY",,,,D,,,,73.0,IU,,,2015,Q3,Pneumonitis,,2015,Q3,1,I,,20150802.0,20150812,20150812,EXP,,IL-AMGEN-ISRSP2015080934,AMGEN,"WATAD, ABDULLA. ETANERCEPT-INDUCED PNEUMONITIS: SEVERE COMPLICATION OF TUMOR NECROSIS FACTOR-ALPHA BLOCKER TREATMENT. THE ISRAEL MEDICAL ASSOCIATION JOURNAL. 2015;17(2):130-2",63.0,YR,A,F,Y,,,20150812.0,N,MD,IL,IL,2015,Q3,Adult
113788271,11378827,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,200708.0,20090727.0,20150811,20150811,PER,,US-ELI_LILLY_AND_COMPANY-US200907006194,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
113788271,11378827,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Nodule,,2015,Q3,1,I,200708.0,20090727.0,20150811,20150811,PER,,US-ELI_LILLY_AND_COMPANY-US200907006194,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
113788271,11378827,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Skin mass,,2015,Q3,1,I,200708.0,20090727.0,20150811,20150811,PER,,US-ELI_LILLY_AND_COMPANY-US200907006194,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
113809691,11380969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, UNKNOWN",,,,D,,,,30.0,IU,,,2015,Q3,Pyelonephritis,,2015,Q3,1,I,20080518.0,20150803.0,20150814,20150814,EXP,,US-ELI_LILLY_AND_COMPANY-US201508000742,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20150813.0,N,CN,US,US,2015,Q3,Youth
113861431,11386143,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,D,,,,,,,,2015,Q3,Mastication disorder,,2015,Q3,1,I,200804.0,20150804.0,20150817,20150817,EXP,,US-SHIRE-US201509910,SHIRE,,54.0,YR,,M,Y,,,20150817.0,N,MD,US,US,2015,Q3,Adult
113861431,11386143,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,D,,,,,,,,2015,Q3,Pneumonia,,2015,Q3,1,I,200804.0,20150804.0,20150817,20150817,EXP,,US-SHIRE-US201509910,SHIRE,,54.0,YR,,M,Y,,,20150817.0,N,MD,US,US,2015,Q3,Adult
113861431,11386143,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,D,,,,,,,,2015,Q3,Wrong technique in product usage process,,2015,Q3,1,I,200804.0,20150804.0,20150817,20150817,EXP,,US-SHIRE-US201509910,SHIRE,,54.0,YR,,M,Y,,,20150817.0,N,MD,US,US,2015,Q3,Adult
113876262,11387626,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,D, UNKNOWN,,,10.0,IU,,QD,2015,Q3,Dyslalia,,2015,Q3,2,F,20100630.0,20150824.0,20150817,20150901,EXP,,JP-NOVOPROD-459303,NOVO NORDISK,,56.0,YR,A,F,Y,,,20150901.0,N,MD,JP,JP,2015,Q3,Adult
113876262,11387626,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,D, UNKNOWN,,,10.0,IU,,QD,2015,Q3,Multiple sclerosis,,2015,Q3,2,F,20100630.0,20150824.0,20150817,20150901,EXP,,JP-NOVOPROD-459303,NOVO NORDISK,,56.0,YR,A,F,Y,,,20150901.0,N,MD,JP,JP,2015,Q3,Adult
113876262,11387626,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,D, UNKNOWN,,,10.0,IU,,QD,2015,Q3,Myelitis,,2015,Q3,2,F,20100630.0,20150824.0,20150817,20150901,EXP,,JP-NOVOPROD-459303,NOVO NORDISK,,56.0,YR,A,F,Y,,,20150901.0,N,MD,JP,JP,2015,Q3,Adult
113879301,11387930,8,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Cellulitis,,2015,Q3,1,I,20150702.0,20150803.0,20150817,20150817,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-052755,BRISTOL MYERS SQUIBB,,47.0,YR,,M,Y,,,20150817.0,N,CN,US,US,2015,Q3,Adult
113879301,11387930,8,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Headache,,2015,Q3,1,I,20150702.0,20150803.0,20150817,20150817,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-052755,BRISTOL MYERS SQUIBB,,47.0,YR,,M,Y,,,20150817.0,N,CN,US,US,2015,Q3,Adult
113900133,11390013,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Hernia repair,,2015,Q3,3,F,20141118.0,20150831.0,20150818,20150914,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-052651,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,102.0,KG,20150914.0,N,OT,US,US,2015,Q3,Adult
113900133,11390013,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Incisional hernia,,2015,Q3,3,F,20141118.0,20150831.0,20150818,20150914,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-052651,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,102.0,KG,20150914.0,N,OT,US,US,2015,Q3,Adult
113923581,11392358,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,TABLET,,2015,Q3,Cerebrovascular accident,,2015,Q3,1,I,20150613.0,20150811.0,20150818,20150818,EXP,,CO-BAXTER-2015BAX044383,BAXTER,,73.0,YR,,F,Y,44.0,KG,20150818.0,N,OT,CO,CO,2015,Q3,Elderly
113923581,11392358,10,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,TABLET,,2015,Q3,Cerebrovascular disorder,,2015,Q3,1,I,20150613.0,20150811.0,20150818,20150818,EXP,,CO-BAXTER-2015BAX044383,BAXTER,,73.0,YR,,F,Y,44.0,KG,20150818.0,N,OT,CO,CO,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Angioedema,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Asthenia,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Cyanosis,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Drug hypersensitivity,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Eyelid oedema,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Pallor,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Peripheral swelling,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Respiratory distress,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Respiratory failure,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Road traffic accident,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Swelling,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Swelling face,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Swollen tongue,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113932881,11393288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Thinking abnormal,,2015,Q3,1,I,20150605.0,20150615.0,20150818,20150818,EXP,,PHEH2015US011625,NOVARTIS,,68.0,YR,,F,Y,,,20150818.0,N,PH,US,US,2015,Q3,Elderly
113940091,11394009,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,1,I,20150422.0,,20150817,20150817,DIR,,,,,68.0,YR,,M,N,156.0,LBS,20150721.0,N,CN,US,,2015,Q3,Elderly
113940091,11394009,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Femoral neck fracture,,2015,Q3,1,I,20150422.0,,20150817,20150817,DIR,,,,,68.0,YR,,M,N,156.0,LBS,20150721.0,N,CN,US,,2015,Q3,Elderly
113953501,11395350,18,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20150727.0,,20150817,20150817,DIR,,,,,49.0,YR,,F,N,148.0,LBS,20150814.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
113953501,11395350,18,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Pulmonary embolism,,2015,Q3,1,I,20150727.0,,20150817,20150817,DIR,,,,,49.0,YR,,F,N,148.0,LBS,20150814.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
113953501,11395350,18,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Seizure,,2015,Q3,1,I,20150727.0,,20150817,20150817,DIR,,,,,49.0,YR,,F,N,148.0,LBS,20150814.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
113953501,11395350,18,C,GLARGINE,,2,,,,,,,,,,,,,,2015,Q3,Treatment failure,,2015,Q3,1,I,20150727.0,,20150817,20150817,DIR,,,,,49.0,YR,,F,N,148.0,LBS,20150814.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
113957581,11395758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,201506.0,,20150818,20150818,DIR,,,,,49.0,YR,,F,N,186.0,LBS,20150811.0,N,,US,,2015,Q3,Adult
113957581,11395758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Musculoskeletal stiffness,,2015,Q3,1,I,201506.0,,20150818,20150818,DIR,,,,,49.0,YR,,F,N,186.0,LBS,20150811.0,N,,US,,2015,Q3,Adult
113957581,11395758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Therapy cessation,,2015,Q3,1,I,201506.0,,20150818,20150818,DIR,,,,,49.0,YR,,F,N,186.0,LBS,20150811.0,N,,US,,2015,Q3,Adult
113957581,11395758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Visual impairment,,2015,Q3,1,I,201506.0,,20150818,20150818,DIR,,,,,49.0,YR,,F,N,186.0,LBS,20150811.0,N,,US,,2015,Q3,Adult
113957581,11395758,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Weight increased,,2015,Q3,1,I,201506.0,,20150818,20150818,DIR,,,,,49.0,YR,,F,N,186.0,LBS,20150811.0,N,,US,,2015,Q3,Adult
113997962,11399796,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,D,,,,16.0,IU,,QD,2015,Q3,Fatigue,,2015,Q3,2,F,201505.0,20150818.0,20150820,20150826,EXP,,PT-NOVOPROD-460307,NOVO NORDISK,,58.0,YR,A,F,Y,,,20150826.0,N,CN,PT,PT,2015,Q3,Adult
113997962,11399796,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,D,,,,16.0,IU,,QD,2015,Q3,Pruritus generalised,,2015,Q3,2,F,201505.0,20150818.0,20150820,20150826,EXP,,PT-NOVOPROD-460307,NOVO NORDISK,,58.0,YR,A,F,Y,,,20150826.0,N,CN,PT,PT,2015,Q3,Adult
113997962,11399796,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,D,,,,16.0,IU,,QD,2015,Q3,Rash,,2015,Q3,2,F,201505.0,20150818.0,20150820,20150826,EXP,,PT-NOVOPROD-460307,NOVO NORDISK,,58.0,YR,A,F,Y,,,20150826.0,N,CN,PT,PT,2015,Q3,Adult
113997962,11399796,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,D,,,,16.0,IU,,QD,2015,Q3,Renal pain,,2015,Q3,2,F,201505.0,20150818.0,20150820,20150826,EXP,,PT-NOVOPROD-460307,NOVO NORDISK,,58.0,YR,A,F,Y,,,20150826.0,N,CN,PT,PT,2015,Q3,Adult
113997962,11399796,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,,D,,,,16.0,IU,,QD,2015,Q3,Toothache,,2015,Q3,2,F,201505.0,20150818.0,20150820,20150826,EXP,,PT-NOVOPROD-460307,NOVO NORDISK,,58.0,YR,A,F,Y,,,20150826.0,N,CN,PT,PT,2015,Q3,Adult
113999581,11399958,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Haemolytic anaemia,,2015,Q3,1,I,20140909.0,20140923.0,20150805,20150805,PER,,GTI002571,GRIFOLS,,46.0,YR,,M,N,140.0,KG,20150701.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Blood pressure decreased,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,C-reactive protein increased,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Heart rate increased,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Pneumonia klebsiella,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Pyelonephritis,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Pyrexia,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Septic shock,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114062622,11406262,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,White blood cell count decreased,,2015,Q3,2,F,,20150824.0,20150821,20150908,EXP,,PHJP2015JP014113,NOVARTIS,,54.0,YR,,F,Y,96.0,KG,20150908.0,N,,JP,JP,2015,Q3,Adult
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Back pain,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Drug withdrawal syndrome,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Movement disorder,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Pain,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Pneumonia,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Urinary tract infection,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Viral infection,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114103181,11410318,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Vomiting,,2015,Q3,1,I,20150818.0,,20150820,20150820,DIR,,,,,75.0,YR,,F,N,113.0,LBS,20150819.0,N,PH,US,,2015,Q3,Elderly
114146851,11414685,5,C,LANTUS (INSULIN GLARGINE RECOMBINANT),,2,,,,,,,,,,,,,,2015,Q3,Application site discolouration,,2015,Q3,1,I,20150720.0,20150810.0,20150821,20150821,EXP,,2015SMT00229,SMITH AND NEPHEW,,74.0,YR,,M,N,90.7,KG,20150819.0,N,CN,US,,2015,Q3,Elderly
114146851,11414685,5,C,LANTUS (INSULIN GLARGINE RECOMBINANT),,2,,,,,,,,,,,,,,2015,Q3,Application site infection,,2015,Q3,1,I,20150720.0,20150810.0,20150821,20150821,EXP,,2015SMT00229,SMITH AND NEPHEW,,74.0,YR,,M,N,90.7,KG,20150819.0,N,CN,US,,2015,Q3,Elderly
114146851,11414685,5,C,LANTUS (INSULIN GLARGINE RECOMBINANT),,2,,,,,,,,,,,,,,2015,Q3,Gangrene,,2015,Q3,1,I,20150720.0,20150810.0,20150821,20150821,EXP,,2015SMT00229,SMITH AND NEPHEW,,74.0,YR,,M,N,90.7,KG,20150819.0,N,CN,US,,2015,Q3,Elderly
114146851,11414685,5,C,LANTUS (INSULIN GLARGINE RECOMBINANT),,2,,,,,,,,,,,,,,2015,Q3,Toe amputation,,2015,Q3,1,I,20150720.0,20150810.0,20150821,20150821,EXP,,2015SMT00229,SMITH AND NEPHEW,,74.0,YR,,M,N,90.7,KG,20150819.0,N,CN,US,,2015,Q3,Elderly
114147841,11414784,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150704.0,,20150824,20150824,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q3,Young Adult
114147841,11414784,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q3,Hypotension,,2015,Q3,1,I,20150704.0,,20150824,20150824,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q3,Young Adult
114147841,11414784,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q3,Sepsis,,2015,Q3,1,I,20150704.0,,20150824,20150824,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q3,Young Adult
114147841,11414784,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q3,Syncope,,2015,Q3,1,I,20150704.0,,20150824,20150824,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q3,Young Adult
114174521,11417452,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150824.0,20150825.0,20150825,20150825,PER,,US-ELI_LILLY_AND_COMPANY-US201508007439,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20150825.0,N,PH,US,US,2015,Q3,Adult
114176201,11417620,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20150814.0,20150825,20150825,EXP,,PHHY2015US100798,SANDOZ,"VASUDVAN S, HIRSCH IB. INTERFERENCE OF INTRAVENOUS VITAMIN C WITH BLOOD GLUCOSE TESTING. DIABETES CARE. 2014;37:E93-E94",56.0,YR,,F,Y,,,20150825.0,N,OT,US,US,2015,Q3,Adult
114176201,11417620,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Laboratory test interference,,2015,Q3,1,I,,20150814.0,20150825,20150825,EXP,,PHHY2015US100798,SANDOZ,"VASUDVAN S, HIRSCH IB. INTERFERENCE OF INTRAVENOUS VITAMIN C WITH BLOOD GLUCOSE TESTING. DIABETES CARE. 2014;37:E93-E94",56.0,YR,,F,Y,,,20150825.0,N,OT,US,US,2015,Q3,Adult
114190311,11419031,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,45 UNITS AT BEDTIME,,,,D,,,,,,,,2015,Q3,Myositis,,2015,Q3,1,I,,20150817.0,20150826,20150826,EXP,,US-ACCORD-033312,ACCORD,"PEREL-WINKLER A, BELOKOVSKAYA R, AMIGUES I, LARUSSO M, HUSSAIN N. A CASE OF DOCETAXEL INDUCED MYOSITIS AND REVIEW OF THE LITERATURE. CASE REP RHEUMATOL. 2015;2015:795242.",65.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Elderly
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Finger amputation,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Heparin-induced thrombocytopenia,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Pneumonia aspiration,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Postoperative wound infection,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Sepsis,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114211141,11421114,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Skin necrosis,,2015,Q3,1,I,,20150818.0,20150826,20150826,EXP,,US-FRESENIUS KABI-FK201504022,FRESENIUS KABI,"MCALISTER R,ITO S. MINIMAL PROLONGATION OF PROTHROMBIN TIME WITH EXTENDED EXPOSURE TO ARGATROBAN.. PHARMACOTHERAPY 2015;NUMBER 7:E122-E126.",56.0,YR,,F,Y,,,20150826.0,N,OT,US,US,2015,Q3,Adult
114243421,11424342,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,6.0,IU,,,2015,Q3,Death,,2015,Q3,1,I,20150815.0,20150821.0,20150827,20150827,EXP,,CO-BAXTER-2015BAX046673,BAXTER,,77.0,YR,,F,Y,69.0,KG,20150827.0,N,CN,CO,CO,2015,Q3,Elderly
114243421,11424342,15,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,6.0,IU,,,2015,Q3,Noninfectious peritonitis,,2015,Q3,1,I,20150815.0,20150821.0,20150827,20150827,EXP,,CO-BAXTER-2015BAX046673,BAXTER,,77.0,YR,,F,Y,69.0,KG,20150827.0,N,CN,CO,CO,2015,Q3,Elderly
114336171,11433617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Anxiety,,2015,Q3,1,I,20150727.0,20150826.0,20150831,20150831,EXP,GB-MHRA-EYC 00126998,GB-DRREDDYS-GER/UKI/15/0050339,DR REDDYS,,65.0,YR,,M,Y,53.97,KG,20150831.0,N,CN,GB,GB,2015,Q3,Elderly
114336171,11433617,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Suicidal ideation,,2015,Q3,1,I,20150727.0,20150826.0,20150831,20150831,EXP,GB-MHRA-EYC 00126998,GB-DRREDDYS-GER/UKI/15/0050339,DR REDDYS,,65.0,YR,,M,Y,53.97,KG,20150831.0,N,CN,GB,GB,2015,Q3,Elderly
114365421,11436542,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, EACH EVENING",,,,D,,,,,,,QD,2015,Q3,Blood glucose increased,,2015,Q3,1,I,201402.0,20140326.0,20150821,20150821,PER,,US-ELI_LILLY_AND_COMPANY-US201403009857,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
114365421,11436542,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, EACH EVENING",,,,D,,,,,,,QD,2015,Q3,Drug dose omission,,2015,Q3,1,I,201402.0,20140326.0,20150821,20150821,PER,,US-ELI_LILLY_AND_COMPANY-US201403009857,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
114365421,11436542,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, EACH EVENING",,,,D,,,,,,,QD,2015,Q3,Inappropriate schedule of drug administration,,2015,Q3,1,I,201402.0,20140326.0,20150821,20150821,PER,,US-ELI_LILLY_AND_COMPANY-US201403009857,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20150804.0,N,CN,US,US,2015,Q3,Adult
114448891,11444889,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Bone cancer,,2015,Q3,1,I,20141120.0,,20150831,20150831,DIR,,,,,55.0,YR,,M,N,149.0,LBS,20150828.0,N,,US,,2015,Q3,Adult
114457391,11445739,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 2X/DAY (100 UNIT/ML)",,,,D,,,,15.0,IU,,BID,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,1,I,20150819.0,20150825.0,20150902,20150902,EXP,,US-PFIZER INC-2015285493,PFIZER,,38.0,YR,,M,Y,84.0,KG,20150902.0,N,MD,US,US,2015,Q3,Adult
114457391,11445739,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 2X/DAY (100 UNIT/ML)",,,,D,,,,15.0,IU,,BID,2015,Q3,Erectile dysfunction,,2015,Q3,1,I,20150819.0,20150825.0,20150902,20150902,EXP,,US-PFIZER INC-2015285493,PFIZER,,38.0,YR,,M,Y,84.0,KG,20150902.0,N,MD,US,US,2015,Q3,Adult
114457391,11445739,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 2X/DAY (100 UNIT/ML)",,,,D,,,,15.0,IU,,BID,2015,Q3,Essential hypertension,,2015,Q3,1,I,20150819.0,20150825.0,20150902,20150902,EXP,,US-PFIZER INC-2015285493,PFIZER,,38.0,YR,,M,Y,84.0,KG,20150902.0,N,MD,US,US,2015,Q3,Adult
114457391,11445739,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 2X/DAY (100 UNIT/ML)",,,,D,,,,15.0,IU,,BID,2015,Q3,Hypothyroidism,,2015,Q3,1,I,20150819.0,20150825.0,20150902,20150902,EXP,,US-PFIZER INC-2015285493,PFIZER,,38.0,YR,,M,Y,84.0,KG,20150902.0,N,MD,US,US,2015,Q3,Adult
114457391,11445739,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, 2X/DAY (100 UNIT/ML)",,,,D,,,,15.0,IU,,BID,2015,Q3,Libido decreased,,2015,Q3,1,I,20150819.0,20150825.0,20150902,20150902,EXP,,US-PFIZER INC-2015285493,PFIZER,,38.0,YR,,M,Y,84.0,KG,20150902.0,N,MD,US,US,2015,Q3,Adult
114518661,11451866,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Anxiety,,2015,Q3,1,I,20150727.0,20150826.0,20150903,20150903,EXP,GB-MHRA-EYC 00126998,GB-WATSON-2015-18532,WATSON,,65.0,YR,,M,Y,53.97,KG,20150903.0,N,CN,GB,GB,2015,Q3,Elderly
114518661,11451866,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Suicidal ideation,,2015,Q3,1,I,20150727.0,20150826.0,20150903,20150903,EXP,GB-MHRA-EYC 00126998,GB-WATSON-2015-18532,WATSON,,65.0,YR,,M,Y,53.97,KG,20150903.0,N,CN,GB,GB,2015,Q3,Elderly
114529101,11452910,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 U, UNK",,,,D,,,,100.0,IU,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20091022.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200910006724,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20150814.0,N,CN,US,US,2015,Q3,Elderly
114529101,11452910,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 U, UNK",,,,D,,,,100.0,IU,,,2015,Q3,Blood triglycerides increased,,2015,Q3,1,I,,20091022.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200910006724,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20150814.0,N,CN,US,US,2015,Q3,Elderly
114529101,11452910,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 U, UNK",,,,D,,,,100.0,IU,,,2015,Q3,Essential hypertension,,2015,Q3,1,I,,20091022.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200910006724,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20150814.0,N,CN,US,US,2015,Q3,Elderly
114529101,11452910,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 U, UNK",,,,D,,,,100.0,IU,,,2015,Q3,Headache,,2015,Q3,1,I,,20091022.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200910006724,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20150814.0,N,CN,US,US,2015,Q3,Elderly
114529101,11452910,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 U, UNK",,,,D,,,,100.0,IU,,,2015,Q3,Hypotension,,2015,Q3,1,I,,20091022.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200910006724,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20150814.0,N,CN,US,US,2015,Q3,Elderly
114580491,11458049,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,38.0,IU,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20150713.0,20150901.0,20150904,20150904,EXP,ES-AGEMED-443114540,ES-SA-2015SA133407,AVENTIS,,58.0,YR,A,M,Y,83.0,KG,20150904.0,N,MD,ES,ES,2015,Q3,Adult
114580491,11458049,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,38.0,IU,,,2015,Q3,Haemoptysis,,2015,Q3,1,I,20150713.0,20150901.0,20150904,20150904,EXP,ES-AGEMED-443114540,ES-SA-2015SA133407,AVENTIS,,58.0,YR,A,M,Y,83.0,KG,20150904.0,N,MD,ES,ES,2015,Q3,Adult
114678101,11467810,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Haemoptysis,,2015,Q3,1,I,20150713.0,20150901.0,20150908,20150908,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201509002146,ELI LILLY AND CO,,58.0,YR,,M,Y,83.0,KG,20150907.0,N,CN,ES,ES,2015,Q3,Adult
114678101,11467810,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Hypoxic-ischaemic encephalopathy,,2015,Q3,1,I,20150713.0,20150901.0,20150908,20150908,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201509002146,ELI LILLY AND CO,,58.0,YR,,M,Y,83.0,KG,20150907.0,N,CN,ES,ES,2015,Q3,Adult
114678101,11467810,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Myocardial ischaemia,,2015,Q3,1,I,20150713.0,20150901.0,20150908,20150908,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201509002146,ELI LILLY AND CO,,58.0,YR,,M,Y,83.0,KG,20150907.0,N,CN,ES,ES,2015,Q3,Adult
114678101,11467810,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Tracheal haemorrhage,,2015,Q3,1,I,20150713.0,20150901.0,20150908,20150908,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201509002146,ELI LILLY AND CO,,58.0,YR,,M,Y,83.0,KG,20150907.0,N,CN,ES,ES,2015,Q3,Adult
114692171,11469217,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Diarrhoea,,2015,Q3,1,I,20150818.0,20150824.0,20150908,20150908,PER,,US-BAYER-2015-409373,BAYER,,64.0,YR,A,M,Y,,,20150908.0,N,PH,US,US,2015,Q3,Adult
114692171,11469217,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Dry mouth,,2015,Q3,1,I,20150818.0,20150824.0,20150908,20150908,PER,,US-BAYER-2015-409373,BAYER,,64.0,YR,A,M,Y,,,20150908.0,N,PH,US,US,2015,Q3,Adult
114692171,11469217,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Thirst,,2015,Q3,1,I,20150818.0,20150824.0,20150908,20150908,PER,,US-BAYER-2015-409373,BAYER,,64.0,YR,A,M,Y,,,20150908.0,N,PH,US,US,2015,Q3,Adult
114710271,11471027,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Condition aggravated,,2015,Q3,1,I,20150814.0,20150828.0,20150908,20150908,EXP,,CO-BAXTER-2015BAX048090,BAXTER,,71.0,YR,,M,Y,74.0,KG,20150908.0,N,OT,CO,CO,2015,Q3,Elderly
114710271,11471027,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Intestinal obstruction,,2015,Q3,1,I,20150814.0,20150828.0,20150908,20150908,EXP,,CO-BAXTER-2015BAX048090,BAXTER,,71.0,YR,,M,Y,74.0,KG,20150908.0,N,OT,CO,CO,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Application site erosion,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Application site reaction,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Application site ulcer,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Drug ineffective,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Drug intolerance,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114816921,11481692,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"14000 UNK, DAILY",,,,U,,,,,,,,2015,Q3,Pruritus,,2015,Q3,1,I,20150716.0,20150728.0,20150909,20150909,EXP,,DE-MUNDIPHARMA DS AND PHARMACOVIGILANCE-DEU-2015-0017059,PURDUE,,88.0,YR,,F,Y,,,20150909.0,N,MD,DE,DE,2015,Q3,Elderly
114916581,11491658,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Epistaxis,,2015,Q3,1,I,201303.0,20150406.0,20150910,20150910,EXP,,US-BAYER-2015-131332,BAYER,,64.0,YR,A,M,Y,,,20150910.0,N,CN,US,US,2015,Q3,Adult
114916581,11491658,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,D,,,,,,,,2015,Q3,Haemorrhagic disorder,,2015,Q3,1,I,201303.0,20150406.0,20150910,20150910,EXP,,US-BAYER-2015-131332,BAYER,,64.0,YR,A,M,Y,,,20150910.0,N,CN,US,US,2015,Q3,Adult
114953151,11495315,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,1,I,,20150901.0,20150911,20150911,EXP,,US-NOVOPROD-463078,NOVO NORDISK,,55.0,YR,A,F,Y,,,20150911.0,N,CN,US,US,2015,Q3,Adult
114953151,11495315,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2015,Q3,Surgery,,2015,Q3,1,I,,20150901.0,20150911,20150911,EXP,,US-NOVOPROD-463078,NOVO NORDISK,,55.0,YR,A,F,Y,,,20150911.0,N,CN,US,US,2015,Q3,Adult
115012621,11501262,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Asthenia,,2015,Q3,1,I,20150824.0,20150901.0,20150914,20150914,PER,,US-CELGENEUS-USA-2015091184,CELGENE,,65.0,YR,,F,Y,81.5,KG,20150914.0,N,MD,US,US,2015,Q3,Elderly
115012621,11501262,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,UNKNOWN,,2015,Q3,Fatigue,,2015,Q3,1,I,20150824.0,20150901.0,20150914,20150914,PER,,US-CELGENEUS-USA-2015091184,CELGENE,,65.0,YR,,F,Y,81.5,KG,20150914.0,N,MD,US,US,2015,Q3,Elderly
115035781,11503578,25,C,Solosolostar insulin glargine,,2,Unknown,"8 UNITS, AT BEDTIME",,,,U,,,,,,FORMULATION UNKNOWN,QD,2015,Q3,Malignant neoplasm progression,,2015,Q3,1,I,20150709.0,20150722.0,20150914,20150914,PER,,US-ASTELLAS-2015US026473,ASTELLAS,,83.0,YR,,M,Y,,,20150914.0,N,MD,US,US,2015,Q3,Elderly
115052541,11505254,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Condition aggravated,,2015,Q3,1,I,201503.0,,20150914,20150914,DIR,,,,,56.0,YR,,F,N,295.0,LBS,20150911.0,N,CN,US,,2015,Q3,Adult
115052541,11505254,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Hepatic encephalopathy,,2015,Q3,1,I,201503.0,,20150914,20150914,DIR,,,,,56.0,YR,,F,N,295.0,LBS,20150911.0,N,CN,US,,2015,Q3,Adult
115054911,11505491,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Death,,2015,Q3,1,I,,,20150914,20150914,DIR,,,,,56.0,YR,,F,N,295.0,LBS,20150911.0,N,CN,US,,2015,Q3,Adult
115110731,11511073,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34IU (INTERNATIONAL UNIT)1X A DAY,,,,D,,,,34.0,IU,,QD,2015,Q3,Diabetic gastroparesis,,2015,Q3,1,I,20141119.0,20141210.0,20150915,20150915,EXP,,US-BAXALTA-2014BAX073664,BAXALTA,,52.0,YR,,M,Y,64.5,KG,20150915.0,N,MD,US,US,2015,Q3,Adult
115139711,11513971,9,C,INSULINE GLARGINE,,2,Subcutaneous,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20140916.0,20150907.0,20150916,20150916,EXP,,PHHY2015ES108207,SANDOZ,,59.0,YR,,M,Y,,,20150916.0,N,OT,ES,ES,2015,Q3,Adult
115139711,11513971,9,C,INSULINE GLARGINE,,2,Subcutaneous,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Hypocoagulable state,,2015,Q3,1,I,20140916.0,20150907.0,20150916,20150916,EXP,,PHHY2015ES108207,SANDOZ,,59.0,YR,,M,Y,,,20150916.0,N,OT,ES,ES,2015,Q3,Adult
115139711,11513971,9,C,INSULINE GLARGINE,,2,Subcutaneous,"38 IU, UNK",,,,D,,,,38.0,IU,,,2015,Q3,Pericardial haemorrhage,,2015,Q3,1,I,20140916.0,20150907.0,20150916,20150916,EXP,,PHHY2015ES108207,SANDOZ,,59.0,YR,,M,Y,,,20150916.0,N,OT,ES,ES,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Cough,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Dyspnoea exertional,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Fatigue,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Headache,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Hyperhidrosis,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Infection,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Leukopenia,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115171281,11517128,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Pancytopenia,,2015,Q3,1,I,,20141125.0,20150917,20150917,EXP,,LB-GLAXOSMITHKLINE-LB2014GSK028512,GLAXOSMITHKLINE,"MECCHELLA JN, RIGBY WF, ZBEHLIK AJ. PANCYTOPENIA AND COUGH IN A MAN WITH AMYOPATHIC DERMATOMYOSITIS. ARTHRITIS CARE + RESEARCH. 2014;66(10):1587-1590",53.0,YR,,M,Y,,,20150917.0,N,MD,LB,LB,2015,Q3,Adult
115271141,11527114,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, EACH MORNING",,,,D,,,,30.0,IU,,QD,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,,20090727.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200907006259,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20150824.0,N,CN,US,US,2015,Q3,Elderly
115271141,11527114,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, EACH EVENING",,,,D,,,,50.0,IU,,QD,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,,20090727.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200907006259,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20150824.0,N,CN,US,US,2015,Q3,Elderly
115318051,11531805,5,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,D,,,,,,SOLUTION,QD,2015,Q3,Systemic inflammatory response syndrome,,2015,Q3,1,I,20150906.0,20150908.0,20150921,20150921,EXP,,US-CELGENE-USA-2015092027,CELGENE,,54.0,YR,,M,Y,91.9,KG,20150921.0,N,MD,US,US,2015,Q3,Adult
115327311,11532731,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20120314.0,20120315.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201203005684,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115327311,11532731,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Epidural analgesia,,2015,Q3,1,I,20120314.0,20120315.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201203005684,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115328801,11532880,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Drug dose omission,,2015,Q3,1,I,20120323.0,20120323.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201203009046,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115328801,11532880,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Injection site erythema,,2015,Q3,1,I,20120323.0,20120323.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201203009046,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115328981,11532898,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Incorrect dose administered,,2015,Q3,1,I,20120326.0,20120326.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201203009290,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115375411,11537541,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,30.0,IU,,QD,2015,Q3,Diabetes mellitus,,2015,Q3,1,I,20150619.0,20150916.0,20150922,20150922,EXP,,EG-SA-2015SA143964,AVENTIS,,63.0,YR,A,F,Y,,,20150922.0,N,CN,EG,EG,2015,Q3,Adult
115375411,11537541,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,30.0,IU,,QD,2015,Q3,Myocardial infarction,,2015,Q3,1,I,20150619.0,20150916.0,20150922,20150922,EXP,,EG-SA-2015SA143964,AVENTIS,,63.0,YR,A,F,Y,,,20150922.0,N,CN,EG,EG,2015,Q3,Adult
115375411,11537541,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,30.0,IU,,QD,2015,Q3,Pneumonitis,,2015,Q3,1,I,20150619.0,20150916.0,20150922,20150922,EXP,,EG-SA-2015SA143964,AVENTIS,,63.0,YR,A,F,Y,,,20150922.0,N,CN,EG,EG,2015,Q3,Adult
115375411,11537541,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNKNOWN,,21081.0,30.0,IU,,QD,2015,Q3,Renal failure,,2015,Q3,1,I,20150619.0,20150916.0,20150922,20150922,EXP,,EG-SA-2015SA143964,AVENTIS,,63.0,YR,A,F,Y,,,20150922.0,N,CN,EG,EG,2015,Q3,Adult
115410991,11541099,6,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,10.0,IU,,,2015,Q3,Acute myocardial infarction,,2015,Q3,1,I,20150911.0,20150917.0,20150923,20150923,EXP,,CO-BAXTER-2015BAX051683,BAXTER,,54.0,YR,,M,Y,72.0,KG,20150923.0,N,OT,CO,CO,2015,Q3,Adult
115425041,11542504,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20120424.0,20120424.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201204009002,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115428311,11542831,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20120406.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201204003336,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115428841,11542884,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Arteriosclerosis,,2015,Q3,1,I,,20120509.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205004173,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115428841,11542884,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Cardiac disorder,,2015,Q3,1,I,,20120509.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205004173,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115429771,11542977,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Blood glucose fluctuation,,2015,Q3,1,I,201205.0,20120514.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205006438,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115429811,11542981,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Anxiety,,2015,Q3,1,I,20120507.0,20120514.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205006454,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115429811,11542981,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20120507.0,20120514.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205006454,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115429811,11542981,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Injection site extravasation,,2015,Q3,1,I,20120507.0,20120514.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205006454,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115429811,11542981,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Underdose,,2015,Q3,1,I,20120507.0,20120514.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205006454,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Adult
115431451,11543145,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 U, QD",,,,D,,,,40.0,IU,,QD,2015,Q3,Stress,,2015,Q3,1,I,20120523.0,20120523.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205008882,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115431451,11543145,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 U, QD",,,,D,,,,40.0,IU,,QD,2015,Q3,Underdose,,2015,Q3,1,I,20120523.0,20120523.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201205008882,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115463511,11546351,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20110919.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201109005533,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115467301,11546730,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, UNKNOWN",,,,D,,,,26.0,IU,,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20110406.0,20120113.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201201004445,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115467301,11546730,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, UNKNOWN",,,,D,,,,26.0,IU,,,2015,Q3,Weight decreased,,2015,Q3,1,I,20110406.0,20120113.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201201004445,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20150826.0,N,CN,US,US,2015,Q3,Elderly
115535641,11553564,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNKNOWN",,,,D,,,,70.0,IU,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20100701.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201007000609,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20150827.0,N,CN,US,US,2015,Q3,Adult
115535641,11553564,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNKNOWN",,,,D,,,,70.0,IU,,,2015,Q3,Drug dose omission,,2015,Q3,1,I,,20100701.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201007000609,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20150827.0,N,CN,US,US,2015,Q3,Adult
115535641,11553564,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNKNOWN",,,,D,,,,70.0,IU,,,2015,Q3,Renal impairment,,2015,Q3,1,I,,20100701.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201007000609,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20150827.0,N,CN,US,US,2015,Q3,Adult
115535641,11553564,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNKNOWN",,,,D,,,,70.0,IU,,,2015,Q3,Visual acuity reduced,,2015,Q3,1,I,,20100701.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201007000609,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20150827.0,N,CN,US,US,2015,Q3,Adult
115562021,11556202,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,QD,2015,Q3,Agitation,,2015,Q3,1,I,20150812.0,20150918.0,20150925,20150925,EXP,,IT-SA-2015SA144534,AVENTIS,,46.0,YR,A,F,Y,,,20150925.0,N,MD,IT,IT,2015,Q3,Adult
115562021,11556202,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D, UNK,,21081.0,,,,QD,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150812.0,20150918.0,20150925,20150925,EXP,,IT-SA-2015SA144534,AVENTIS,,46.0,YR,A,F,Y,,,20150925.0,N,MD,IT,IT,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Death,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Decreased appetite,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Depression,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Hip fracture,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Mobility decreased,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115612121,11561212,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,50.0,IU,,,2015,Q3,Thrombophlebitis,,2015,Q3,1,I,201503.0,20150921.0,20150928,20150928,EXP,,CO-BAXTER-2015BAX052334,BAXTER,,64.0,YR,,M,Y,70.0,KG,20150928.0,N,OT,CO,CO,2015,Q3,Adult
115614191,11561419,2,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Erectile dysfunction,,2015,Q3,1,I,,20150921.0,20150928,20150928,EXP,,US-TEVA-596287USA,TEVA,"PANGANIBAN B, KINDER B, LITNER J. A PAINFUL UROLOGIC EMERGENCY. . JAAPA 2014; 27(5):54-55.",52.0,YR,,M,Y,,,20150928.0,N,OT,US,US,2015,Q3,Adult
115614191,11561419,2,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Priapism,,2015,Q3,1,I,,20150921.0,20150928,20150928,EXP,,US-TEVA-596287USA,TEVA,"PANGANIBAN B, KINDER B, LITNER J. A PAINFUL UROLOGIC EMERGENCY. . JAAPA 2014; 27(5):54-55.",52.0,YR,,M,Y,,,20150928.0,N,OT,US,US,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Agitation,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Amnesia,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Fall,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Nausea,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115645451,11564545,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,QD,2015,Q3,Panic reaction,,2015,Q3,1,I,20150812.0,20150918.0,20150928,20150928,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201509006408,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20150928.0,N,CN,IT,IT,2015,Q3,Adult
115682941,11568294,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Erectile dysfunction,,2015,Q3,1,I,,20150919.0,20150925,20150925,EXP,,US-ZYDUS-009095,ZYDUS PHARM,,52.0,YR,,M,N,,,20150923.0,N,OT,US,,2015,Q3,Adult
115682941,11568294,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Priapism,,2015,Q3,1,I,,20150919.0,20150925,20150925,EXP,,US-ZYDUS-009095,ZYDUS PHARM,,52.0,YR,,M,N,,,20150923.0,N,OT,US,,2015,Q3,Adult
115708531,11570853,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,12.0,IU,,QD,2015,Q3,Acute myocardial infarction,,2015,Q3,1,I,20150823.0,20150924.0,20150929,20150929,EXP,,CO-BAXTER-2015BAX052822,BAXTER,,52.0,YR,,F,Y,61.4,KG,20150929.0,N,OT,CO,CO,2015,Q3,Adult
115752451,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2015,Q3,Cytomegalovirus test positive,,2015,Q3,1,I,20060814.0,20070508.0,20150930,20150930,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20150930.0,N,,COUNTRY NOT SPECIFIED,JP,2015,Q3,Young Adult
115752451,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2015,Q3,Pancreatic leak,,2015,Q3,1,I,20060814.0,20070508.0,20150930,20150930,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20150930.0,N,,COUNTRY NOT SPECIFIED,JP,2015,Q3,Young Adult
115752451,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2015,Q3,Pancytopenia,,2015,Q3,1,I,20060814.0,20070508.0,20150930,20150930,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20150930.0,N,,COUNTRY NOT SPECIFIED,JP,2015,Q3,Young Adult
115752451,11575245,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,10.0,IU,INJECTION,QD,2015,Q3,Renal impairment,,2015,Q3,1,I,20060814.0,20070508.0,20150930,20150930,EXP,,JP-ASTELLAS-2007JP001997,ASTELLAS,"KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250",32.0,YR,,F,Y,47.0,KG,20150930.0,N,,COUNTRY NOT SPECIFIED,JP,2015,Q3,Young Adult
115754281,11575428,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Bradycardia,,2015,Q3,1,I,20150813.0,,20150929,20150929,DIR,,,,,64.0,YR,,F,N,,,20150928.0,N,PH,US,,2015,Q3,Adult
115754281,11575428,43,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Conduction disorder,,2015,Q3,1,I,20150813.0,,20150929,20150929,DIR,,,,,64.0,YR,,F,N,,,20150928.0,N,PH,US,,2015,Q3,Adult
115754551,11575455,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD IN AM",,,,D, UNKNOWN,,,,,,QD,2015,Q3,Eye haemorrhage,,2015,Q3,1,I,201412.0,20150818.0,20150930,20150930,EXP,,US-NOVOPROD-461157,NOVO NORDISK,,59.0,YR,A,F,Y,68.93,KG,20150930.0,N,CN,US,US,2015,Q3,Adult
115754551,11575455,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD IN AM",,,,D, UNKNOWN,,,,,,QD,2015,Q3,Stress,,2015,Q3,1,I,201412.0,20150818.0,20150930,20150930,EXP,,US-NOVOPROD-461157,NOVO NORDISK,,59.0,YR,A,F,Y,68.93,KG,20150930.0,N,CN,US,US,2015,Q3,Adult
115767071,11576707,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,12.0,IU,,QD,2015,Q3,Cardiac failure,,2015,Q3,1,I,20150916.0,20150925.0,20150930,20150930,EXP,,CO-BAXTER-2015BAX053129,BAXTER,,55.0,YR,,F,Y,62.0,KG,20150930.0,N,OT,CO,CO,2015,Q3,Adult
115767961,11576796,5,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Cardio-respiratory arrest,,2015,Q3,1,I,20150909.0,20150924.0,20150930,20150930,EXP,,CO-BAXTER-2015BAX052837,BAXTER,,64.0,YR,,F,Y,73.0,KG,20150930.0,N,OT,CO,CO,2015,Q3,Adult
115767961,11576796,5,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Respiratory failure,,2015,Q3,1,I,20150909.0,20150924.0,20150930,20150930,EXP,,CO-BAXTER-2015BAX052837,BAXTER,,64.0,YR,,F,Y,73.0,KG,20150930.0,N,OT,CO,CO,2015,Q3,Adult
115778021,11577802,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS EVERY NIGHT,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Akathisia,,2015,Q3,1,I,20150811.0,20150917.0,20150930,20150930,EXP,,AU-JNJFOC-20150915768,JANSSEN,,55.0,YR,A,F,Y,62.2,KG,20150930.0,N,OT,AU,AU,2015,Q3,Adult
115778021,11577802,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS EVERY NIGHT,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Drug level increased,,2015,Q3,1,I,20150811.0,20150917.0,20150930,20150930,EXP,,AU-JNJFOC-20150915768,JANSSEN,,55.0,YR,A,F,Y,62.2,KG,20150930.0,N,OT,AU,AU,2015,Q3,Adult
115778021,11577802,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS EVERY NIGHT,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Parkinsonism,,2015,Q3,1,I,20150811.0,20150917.0,20150930,20150930,EXP,,AU-JNJFOC-20150915768,JANSSEN,,55.0,YR,A,F,Y,62.2,KG,20150930.0,N,OT,AU,AU,2015,Q3,Adult
115835481,11583548,46,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q3,Haemolytic anaemia,,2015,Q3,1,I,20150901.0,,20150930,20150930,DIR,,,,,67.0,YR,,F,N,67.3,KG,20150929.0,N,PH,US,,2015,Q3,Elderly
116005741,11600574,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Incorrect dose administered,,2015,Q3,1,I,201404.0,20140606.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201406002699,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20150903.0,N,CN,US,US,2015,Q3,Elderly
116005741,11600574,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Vision blurred,,2015,Q3,1,I,201404.0,20140606.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201406002699,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20150903.0,N,CN,US,US,2015,Q3,Elderly
116053741,11605374,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20140221.0,20140331.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201404000345,ELI LILLY AND CO,,69.0,YR,,F,Y,80.27,KG,20150903.0,N,OT,US,US,2015,Q3,Elderly
116053741,11605374,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Ear pain,,2015,Q3,1,I,20140221.0,20140331.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201404000345,ELI LILLY AND CO,,69.0,YR,,F,Y,80.27,KG,20150903.0,N,OT,US,US,2015,Q3,Elderly
116053741,11605374,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Headache,,2015,Q3,1,I,20140221.0,20140331.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201404000345,ELI LILLY AND CO,,69.0,YR,,F,Y,80.27,KG,20150903.0,N,OT,US,US,2015,Q3,Elderly
116053741,11605374,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,D,,,,,,,,2015,Q3,Underdose,,2015,Q3,1,I,20140221.0,20140331.0,20150916,20150916,PER,,US-ELI_LILLY_AND_COMPANY-US201404000345,ELI LILLY AND CO,,69.0,YR,,F,Y,80.27,KG,20150903.0,N,OT,US,US,2015,Q3,Elderly
79894617,7989461,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, QD",560.0,IU,,D,,,,14,IU,,QD,2015,Q3,Colitis,,2015,Q3,7,F,20110601.0,20150720.0,20110614,20150731,EXP,,ES-NOVOPROD-329358,NOVO NORDISK,,67.0,YR,E,M,Y,68.5,KG,20150731.0,N,MD,ES,ES,2015,Q3,Elderly
97028864,9702886,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2015,Q3,Seizure,,2015,Q3,4,F,20130924.0,20140207.0,20131121,20150722,PER,,US-GILEAD-2013-0088300,GILEAD,,63.0,YR,A,M,Y,73.47,KG,20150722.0,N,MD,US,US,2015,Q3,Adult
98077106,9807710,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS SUBQ Q WEEKLY,,,,D,,,,25.0,IU,UNSPECIFIED,/wk,2015,Q3,Asthma,,2015,Q3,6,F,20131224.0,20150630.0,20140110,20150703,PER,,US-JNJFOC-20131217321,JANSSEN,,59.0,YR,A,F,Y,98.7,KG,20150703.0,N,MD,US,US,2015,Q3,Adult
98077106,9807710,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS SUBQ Q WEEKLY,,,,D,,,,25.0,IU,UNSPECIFIED,/wk,2015,Q3,Haemorrhagic anaemia,,2015,Q3,6,F,20131224.0,20150630.0,20140110,20150703,PER,,US-JNJFOC-20131217321,JANSSEN,,59.0,YR,A,F,Y,98.7,KG,20150703.0,N,MD,US,US,2015,Q3,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Cataract,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Fall,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Gait disturbance,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Headache,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Intervertebral disc degeneration,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Neoplasm,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Pain in extremity,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Peroneal nerve palsy,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Sciatica,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
102845345,10284534,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSE:45 UNIT(S),,,,,,,,,,,,2015,Q4,Stress,,2015,Q4,5,F,20140528.0,20151006.0,20140708,20151015,EXP,,US-SA-2014SA063241,AVENTIS,,58.0,YR,A,F,Y,61.69,KG,20151013.0,,CN,US,US,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Ascites,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Blood creatinine increased,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Cachexia,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Decreased appetite,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Dehydration,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Dry skin,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Dysgeusia,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Fatigue,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,General physical health deterioration,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Hepatic function abnormal,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Kidney infection,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Malaise,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Mucosal inflammation,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
104336289,10433628,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,DF,,QD,2015,Q4,Skin exfoliation,,2015,Q4,9,F,20140716.0,20151105.0,20140905,20151119,EXP,,PHFR2014GB005933,NOVARTIS,,55.0,YR,,M,Y,64.2,KG,20151119.0,,OT,GB,GB,2015,Q4,Adult
106135526,10613552,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2015,Q4,Anaemia,,2015,Q4,6,F,20140910.0,20150701.0,20141128,20151001,EXP,,ES-CELGENE-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20151001.0,,OT,ES,ES,2015,Q4,Elderly
106135526,10613552,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,26.0,IU,UNKNOWN,,2015,Q4,Lung adenocarcinoma,,2015,Q4,6,F,20140910.0,20150701.0,20141128,20151001,EXP,,ES-CELGENE-ESP-2014113013,CELGENE,,67.0,YR,,M,Y,71.0,KG,20151001.0,,OT,ES,ES,2015,Q4,Elderly
107049863,10704986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Acute hepatic failure,,2015,Q4,3,F,,20151103.0,20150112,20151112,EXP,,US-GILEAD-2015-0131119,GILEAD,,52.0,YR,A,F,Y,,,20151112.0,,MD,US,US,2015,Q4,Adult
107049863,10704986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hepatic cirrhosis,,2015,Q4,3,F,,20151103.0,20150112,20151112,EXP,,US-GILEAD-2015-0131119,GILEAD,,52.0,YR,A,F,Y,,,20151112.0,,MD,US,US,2015,Q4,Adult
107049863,10704986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Jaundice,,2015,Q4,3,F,,20151103.0,20150112,20151112,EXP,,US-GILEAD-2015-0131119,GILEAD,,52.0,YR,A,F,Y,,,20151112.0,,MD,US,US,2015,Q4,Adult
107049863,10704986,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Liver disorder,,2015,Q4,3,F,,20151103.0,20150112,20151112,EXP,,US-GILEAD-2015-0131119,GILEAD,,52.0,YR,A,F,Y,,,20151112.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Abdominal pain,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Gastritis erosive,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Impaired gastric emptying,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Nausea,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Oesophagitis,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Toxicity to various agents,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
107435794,10743579,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 U, QD",,,,,,,,15.0,DF,,QD,2015,Q4,Vomiting,,2015,Q4,4,F,20141228.0,20151110.0,20150128,20151123,EXP,,PHHO2014US017322,SANDOZ,,54.0,YR,,M,Y,87.9,KG,20151123.0,,MD,US,US,2015,Q4,Adult
108303894,10830389,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, 2X/DAY",,,,,,,,80.0,IU,INJECTION,BID,2015,Q4,Influenza,,2015,Q4,4,F,,20151027.0,20150219,20151109,PER,,US-PFIZER INC-2014318762,PFIZER,,68.0,YR,,M,Y,,,20151109.0,,MD,US,US,2015,Q4,Elderly
108553432,10855343,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Sepsis,,2015,Q4,2,F,20141017.0,20151001.0,20150223,20151013,PER,,US-CELGENEUS-USA-2014121632,CELGENE,,83.0,YR,,M,Y,74.91,KG,20151013.0,,MD,US,US,2015,Q4,Elderly
109945363,10994536,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2015,Q4,Pancreatic carcinoma,,2015,Q4,3,F,20150327.0,20151210.0,20150407,20151217,EXP,,JP-ASTRAZENECA-2015SE30940,ASTRAZENECA,,30588.0,DY,,M,Y,42.0,KG,20151217.0,,MD,JP,JP,2015,Q4,Elderly
110095322,11009532,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,18 UNITS AT BREAKFAST,,,,,,,,,,,QD,2015,Q4,Septic shock,,2015,Q4,2,F,20150323.0,20151026.0,20150410,20151103,EXP,,ES-SA-2015SA042759,AVENTIS,,44.0,YR,A,M,Y,,,20151103.0,,MD,ES,ES,2015,Q4,Adult
110216053,11021605,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, EVERY 12 HOURS (DAYS 8-10)",,,,,,,,,,,,2015,Q4,Atrial fibrillation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, EVERY 12 HOURS (DAYS 8-10)",,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, EVERY 12 HOURS (DAYS 8-10)",,,,,,,,,,,,2015,Q4,Infectious colitis,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, EVERY 12 HOURS (DAYS 8-10)",,,,,,,,,,,,2015,Q4,Leg amputation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNITS, EVERY 12 HOURS (DAYS 8-10)",,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 UNITS, EVERY 12 HOURS (DAYS 11-20)",,,,,,,,,,,,2015,Q4,Atrial fibrillation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 UNITS, EVERY 12 HOURS (DAYS 11-20)",,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 UNITS, EVERY 12 HOURS (DAYS 11-20)",,,,,,,,,,,,2015,Q4,Infectious colitis,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 UNITS, EVERY 12 HOURS (DAYS 11-20)",,,,,,,,,,,,2015,Q4,Leg amputation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 UNITS, EVERY 12 HOURS (DAYS 11-20)",,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 UNITS, EVERY 12 HOURS (DAYS 20-24)",,,,,,,,,,,,2015,Q4,Atrial fibrillation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 UNITS, EVERY 12 HOURS (DAYS 20-24)",,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 UNITS, EVERY 12 HOURS (DAYS 20-24)",,,,,,,,,,,,2015,Q4,Infectious colitis,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 UNITS, EVERY 12 HOURS (DAYS 20-24)",,,,,,,,,,,,2015,Q4,Leg amputation,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110216053,11021605,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 UNITS, EVERY 12 HOURS (DAYS 20-24)",,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,3,F,,20151130.0,20150413,20151207,EXP,,US-GLENMARK GENERICS INC.-2015GMK015723,GLENMARK,"HAHN L, HAHN M.. CARVEDILOL-INDUCED HYPERKALEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE.. JOURNAL OF PHARMACY PRACTICE. 2015?28(1):107-11",69.0,YR,,M,Y,68.0,KG,20151207.0,,PH,US,US,2015,Q4,Elderly
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Blood albumin decreased,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Blood creatinine increased,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Blood sodium decreased,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Hyperglycaemia,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Hyperkalaemia,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110308812,11030881,11,C,GLARGINE,,2,Subcutaneous,,,,,,,,,25.0,DF,,BID,2015,Q4,Renal impairment,,2015,Q4,2,F,20150122.0,20151027.0,20150415,20151105,EXP,,AU-ABBVIE-15P-008-1347033-00,ABBVIE,,64.0,YR,,M,Y,93.0,KG,20151105.0,,MD,COUNTRY NOT SPECIFIED,AU,2015,Q4,Adult
110475592,11047559,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,BID,2015,Q4,Fatigue,,2015,Q4,2,F,20150328.0,20151123.0,20150420,20151201,EXP,,DE-SA-2015SA049333,AVENTIS,,56.0,YR,A,M,Y,70.0,KG,20151201.0,,MD,DE,DE,2015,Q4,Adult
110475592,11047559,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,BID,2015,Q4,Fatigue,,2015,Q4,2,F,20150328.0,20151123.0,20150420,20151201,EXP,,DE-SA-2015SA049333,AVENTIS,,56.0,YR,A,M,Y,70.0,KG,20151201.0,,MD,DE,DE,2015,Q4,Adult
110475592,11047559,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2015,Q4,Fatigue,,2015,Q4,2,F,20150328.0,20151123.0,20150420,20151201,EXP,,DE-SA-2015SA049333,AVENTIS,,56.0,YR,A,M,Y,70.0,KG,20151201.0,,MD,DE,DE,2015,Q4,Adult
110839494,11083949,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Haemoglobin decreased,,2015,Q4,4,F,201504.0,20151012.0,20150501,20151019,PER,,US-CELGENEUS-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151019.0,,MD,US,US,2015,Q4,Elderly
110839494,11083949,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Plasma cell myeloma,,2015,Q4,4,F,201504.0,20151012.0,20150501,20151019,PER,,US-CELGENEUS-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151019.0,,MD,US,US,2015,Q4,Elderly
110839494,11083949,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Red blood cell count decreased,,2015,Q4,4,F,201504.0,20151012.0,20150501,20151019,PER,,US-CELGENEUS-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151019.0,,MD,US,US,2015,Q4,Elderly
111166873,11116687,3,C,Insuline Glargine,,2,,,,,,,,,,,,,,2015,Q4,Basal ganglia infarction,,2015,Q4,3,F,20150423.0,20150820.0,20150515,20151029,EXP,,US-ARIAD-2015US004933,ARIAD,,77.0,YR,,M,Y,99.0,KG,20151029.0,,CN,US,US,2015,Q4,Elderly
111490314,11149031,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Cerebral haemorrhage,,2015,Q4,4,F,20140331.0,20150922.0,20150529,20151007,EXP,,US-JNJFOC-20150515062,JANSSEN,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
111490314,11149031,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Death,,2015,Q4,4,F,20140331.0,20150922.0,20150529,20151007,EXP,,US-JNJFOC-20150515062,JANSSEN,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
111490314,11149031,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Haematuria,,2015,Q4,4,F,20140331.0,20150922.0,20150529,20151007,EXP,,US-JNJFOC-20150515062,JANSSEN,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
111490314,11149031,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,4,F,20140331.0,20150922.0,20150529,20151007,EXP,,US-JNJFOC-20150515062,JANSSEN,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Anxiety,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Arthralgia,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Chest discomfort,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Chills,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Condition aggravated,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Depressed mood,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Gait disturbance,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Limb discomfort,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Myalgia,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Neuropathy peripheral,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Pain in extremity,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Peripheral swelling,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Swelling,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Vision blurred,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111820254,11182025,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intramuscular,"60 IU, 2X/DAY",,,,,,,,60.0,IU,INJECTION,BID,2015,Q4,Weight increased,,2015,Q4,4,F,20150506.0,20151013.0,20150611,20151019,PER,,US-PFIZER INC-2015192314,PFIZER,,68.0,YR,,F,Y,151.0,KG,20151019.0,,CN,US,US,2015,Q4,Elderly
111862684,11186268,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,,,,,,,,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,4,F,201505.0,20151112.0,20150612,20151120,EXP,,ES-ASTRAZENECA-2015SE56065,ASTRAZENECA,,69.0,YR,,F,Y,,,20151120.0,,MD,ES,ES,2015,Q4,Elderly
111862684,11186268,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,,,,,,,,,,,,,2015,Q4,Drug prescribing error,,2015,Q4,4,F,201505.0,20151112.0,20150612,20151120,EXP,,ES-ASTRAZENECA-2015SE56065,ASTRAZENECA,,69.0,YR,,F,Y,,,20151120.0,,MD,ES,ES,2015,Q4,Elderly
112027054,11202705,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,QD,2015,Q4,Crohn's disease,,2015,Q4,4,F,20150225.0,20151022.0,20150619,20151026,EXP,,US-ABBVIE-15P-163-1408227-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20151026.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
112027054,11202705,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,,QD,2015,Q4,Pulmonary embolism,,2015,Q4,4,F,20150225.0,20151022.0,20150619,20151026,EXP,,US-ABBVIE-15P-163-1408227-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20151026.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
112031046,11203104,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Leukocytosis,,2015,Q4,6,F,20140728.0,20151014.0,20150619,20151022,PER,,US-JNJFOC-20150609606,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20151022.0,,CN,US,US,2015,Q4,Adult
112031046,11203104,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Supraventricular tachycardia,,2015,Q4,6,F,20140728.0,20151014.0,20150619,20151022,PER,,US-JNJFOC-20150609606,JANSSEN,,59.0,YR,A,M,Y,122.93,KG,20151022.0,,CN,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Angina unstable,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Asthenia,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Back pain,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Cardiac failure congestive,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Cellulitis,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Chest pain,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Diabetic foot,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Dyspnoea,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Hyperglycaemia,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Hyponatraemia,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Mental status changes,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Oedema peripheral,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112311136,11231113,7,C,GLARGINE,,2,Subcutaneous,"30 UNITS, QAM AND QHS",,,,,,,,,,,BID,2015,Q4,Syncope,,2015,Q4,6,F,20141213.0,20151105.0,20150701,20151113,EXP,,US-ROCHE-1599568,ROCHE,,60.0,YR,,F,Y,145.28,KG,20151113.0,,MD,US,US,2015,Q4,Adult
112339652,11233965,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,58 UNIT AT BEDTIME,,,,,,,,,,INJECTION,,2015,Q4,Angina unstable,,2015,Q4,2,F,20150619.0,20151029.0,20150702,20151112,EXP,,CA-JNJFOC-20150617843,JANSSEN,,56.0,YR,A,M,Y,82.4,KG,20151112.0,,MD,CA,CA,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Abdominal neoplasm,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Drug dose omission,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Fat necrosis,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Psoriasis,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Staphylococcal infection,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112595454,11259545,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,(LANTUS) 100 UNITS/ML SOLN,,,,,,,,,,SOLUTION,,2015,Q4,Therapeutic response unexpected,,2015,Q4,4,F,201504.0,20151124.0,20150710,20151202,EXP,,US-JNJFOC-20150703889,JANSSEN,,58.0,YR,A,F,Y,104.33,KG,20151202.0,,CN,US,US,2015,Q4,Adult
112719283,11271928,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Arterial occlusive disease,,2015,Q4,3,F,20150530.0,20151117.0,20150715,20151124,EXP,,IT-PFIZER INC-2015230435,PFIZER,,79.0,YR,,M,Y,,,20151124.0,,MD,IT,IT,2015,Q4,Elderly
112813023,11281302,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Arterial occlusive disease,,2015,Q4,3,F,20150530.0,20151117.0,20150717,20151125,EXP,,IT-FRESENIUS KABI-FK201503466,FRESENIUS KABI,,79.0,YR,,M,Y,,,20151125.0,,OT,IT,IT,2015,Q4,Elderly
112831684,11283168,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Arterial occlusive disease,,2015,Q4,4,F,20150530.0,20151118.0,20150720,20151130,EXP,IT-MINISAL02-317135,IT-TEVA-577990ACC,TEVA,,79.0,YR,,M,Y,,,20151130.0,,MD,IT,IT,2015,Q4,Elderly
112831684,11283168,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Pain in extremity,,2015,Q4,4,F,20150530.0,20151118.0,20150720,20151130,EXP,IT-MINISAL02-317135,IT-TEVA-577990ACC,TEVA,,79.0,YR,,M,Y,,,20151130.0,,MD,IT,IT,2015,Q4,Elderly
112868423,11286842,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Arterial occlusive disease,,2015,Q4,3,F,20150530.0,20151118.0,20150721,20151202,EXP,317135,IT-ACCORD-032230,ACCORD,,79.0,YR,,M,Y,,,20151202.0,,MD,IT,IT,2015,Q4,Elderly
113170213,11317021,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Cerebral haemorrhage,,2015,Q4,3,F,20140331.0,20150922.0,20150728,20151007,EXP,,US-BAYER-2015-280313,BAYER,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
113170213,11317021,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Death,,2015,Q4,3,F,20140331.0,20150922.0,20150728,20151007,EXP,,US-BAYER-2015-280313,BAYER,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
113170213,11317021,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Haematuria,,2015,Q4,3,F,20140331.0,20150922.0,20150728,20151007,EXP,,US-BAYER-2015-280313,BAYER,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
113170213,11317021,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,3,F,20140331.0,20150922.0,20150728,20151007,EXP,,US-BAYER-2015-280313,BAYER,,76.0,YR,E,F,Y,,,20151007.0,,CN,US,US,2015,Q4,Elderly
113467932,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Anti-insulin antibody increased,,2015,Q4,2,F,,20151201.0,20150806,20151214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,KOBAYSHI. A CASE OF GLYCAEMIC CONTROL WHICH BECAME DIFFICULT DUE TO ANTI-INSULIN ANTIBODY APPEARED DURING THE USE OF INSULIN. THE 136TH JAPANESE SOCIETY OF INTERNAL MEDICINE SHINETSU AREA MEETING. 2015?36,75.0,YR,,M,Y,,,20151214.0,,MD,JP,JP,2015,Q4,Elderly
113467932,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,,20151201.0,20150806,20151214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,KOBAYSHI. A CASE OF GLYCAEMIC CONTROL WHICH BECAME DIFFICULT DUE TO ANTI-INSULIN ANTIBODY APPEARED DURING THE USE OF INSULIN. THE 136TH JAPANESE SOCIETY OF INTERNAL MEDICINE SHINETSU AREA MEETING. 2015?36,75.0,YR,,M,Y,,,20151214.0,,MD,JP,JP,2015,Q4,Elderly
113467932,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Vomiting,,2015,Q4,2,F,,20151201.0,20150806,20151214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,KOBAYSHI. A CASE OF GLYCAEMIC CONTROL WHICH BECAME DIFFICULT DUE TO ANTI-INSULIN ANTIBODY APPEARED DURING THE USE OF INSULIN. THE 136TH JAPANESE SOCIETY OF INTERNAL MEDICINE SHINETSU AREA MEETING. 2015?36,75.0,YR,,M,Y,,,20151214.0,,MD,JP,JP,2015,Q4,Elderly
113467932,11346793,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Weight decreased,,2015,Q4,2,F,,20151201.0,20150806,20151214,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051410,BRISTOL MYERS SQUIBB,KOBAYSHI. A CASE OF GLYCAEMIC CONTROL WHICH BECAME DIFFICULT DUE TO ANTI-INSULIN ANTIBODY APPEARED DURING THE USE OF INSULIN. THE 136TH JAPANESE SOCIETY OF INTERNAL MEDICINE SHINETSU AREA MEETING. 2015?36,75.0,YR,,M,Y,,,20151214.0,,MD,JP,JP,2015,Q4,Elderly
113626876,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Hypoxia,,2015,Q4,6,F,20150727.0,20151225.0,20150810,20151230,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20151230.0,,OT,US,US,2015,Q4,Elderly
113626876,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Myocardial infarction,,2015,Q4,6,F,20150727.0,20151225.0,20150810,20151230,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20151230.0,,OT,US,US,2015,Q4,Elderly
113626876,11362687,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Pneumonia,,2015,Q4,6,F,20150727.0,20151225.0,20150810,20151230,EXP,,US-CELGENE-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20151230.0,,OT,US,US,2015,Q4,Elderly
113655304,11365530,22,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNIT/ML,,,,,,,,,,SOLUTION,QD,2015,Q4,Cardiogenic shock,,2015,Q4,4,F,20150724.0,20151005.0,20150811,20151013,EXP,,US-CELGENE-USA-2015076834,CELGENE,,70.0,YR,,F,Y,,,20151013.0,,MD,US,US,2015,Q4,Elderly
113769003,11376900,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Haemoglobin decreased,,2015,Q4,3,F,201504.0,20151012.0,20150813,20151020,EXP,,US-CELGENE-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151020.0,,MD,US,US,2015,Q4,Elderly
113769003,11376900,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Plasma cell myeloma,,2015,Q4,3,F,201504.0,20151012.0,20150813,20151020,EXP,,US-CELGENE-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151020.0,,MD,US,US,2015,Q4,Elderly
113769003,11376900,49,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Red blood cell count decreased,,2015,Q4,3,F,201504.0,20151012.0,20150813,20151020,EXP,,US-CELGENE-USA-2015046120,CELGENE,,76.0,YR,,M,Y,113.5,KG,20151020.0,,MD,US,US,2015,Q4,Elderly
113811192,11381119,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, UNK",,,,U,,,,2.0,IU,,,2015,Q4,Drug-induced liver injury,,2015,Q4,2,F,20150612.0,20150928.0,20150814,20151007,EXP,,JP-009507513-1508JPN005051,MERCK,,67.0,YR,,M,Y,79.2,KG,20151007.0,,CN,JP,JP,2015,Q4,Elderly
113811192,11381119,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, UNK",,,,U,,,,8.0,IU,,,2015,Q4,Drug-induced liver injury,,2015,Q4,2,F,20150612.0,20150928.0,20150814,20151007,EXP,,JP-009507513-1508JPN005051,MERCK,,67.0,YR,,M,Y,79.2,KG,20151007.0,,CN,JP,JP,2015,Q4,Elderly
113811192,11381119,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, UNK",,,,U,,,,10.0,IU,,,2015,Q4,Drug-induced liver injury,,2015,Q4,2,F,20150612.0,20150928.0,20150814,20151007,EXP,,JP-009507513-1508JPN005051,MERCK,,67.0,YR,,M,Y,79.2,KG,20151007.0,,CN,JP,JP,2015,Q4,Elderly
113941313,11394131,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,,,,,,1.0,DF,INJECTION,QD,2015,Q4,Knee arthroplasty,,2015,Q4,3,F,20150727.0,20151001.0,20150819,20151016,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-053287,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,,,20151016.0,,OT,US,US,2015,Q4,Adult
113962772,11396277,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhagic erosive gastritis,,2015,Q4,2,F,20140510.0,20151001.0,20150819,20151009,EXP,,US-JNJFOC-20150805079,JANSSEN,,61.0,YR,A,F,Y,,,20151009.0,,CN,US,US,2015,Q4,Adult
113962772,11396277,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 U,,,,,,,,,,UNSPECIFIED,,2015,Q4,Internal haemorrhage,,2015,Q4,2,F,20140510.0,20151001.0,20150819,20151009,EXP,,US-JNJFOC-20150805079,JANSSEN,,61.0,YR,A,F,Y,,,20151009.0,,CN,US,US,2015,Q4,Adult
113963432,11396343,18,C,GLARGINE,,2,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,2,F,20141117.0,20150921.0,20150819,20151008,PER,,US-JNJFOC-20150803741,JANSSEN,,62.0,YR,A,M,Y,,,20151008.0,,CN,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Acute respiratory failure,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Blood creatine increased,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Cardiogenic shock,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Chronic gastrointestinal bleeding,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Chronic kidney disease,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Chronic right ventricular failure,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Clostridium difficile colitis,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Condition aggravated,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Device occlusion,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Diabetes mellitus,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Dyspnoea exertional,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Dyspnoea paroxysmal nocturnal,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Epistaxis,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Eustachian tube dysfunction,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Fluid overload,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Gastrointestinal ulcer,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Haemorrhoids,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Hiatus hernia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Hypoacusis,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Hypoxia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Iron deficiency anaemia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lung consolidation,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lung infection,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lung infiltration,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lymphadenopathy mediastinal,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Oedema peripheral,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Oxygen saturation decreased,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Palpitations,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Pericardial effusion,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Pleural effusion,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Pneumonitis,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Productive cough,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Pulmonary endarterectomy,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Right ventricular failure,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Tachycardia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Thrombocytopenia,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Thrombosis,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
113978596,11397859,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Ulcer,,2015,Q4,6,F,201506.0,20151201.0,20150819,20151211,EXP,,"US-ACTELION PHARMACEUTICALS US, INC.-A-NJ2015-122460",ACTELION,,64.0,YR,A,M,Y,,,20151211.0,,OT,US,US,2015,Q4,Adult
114044943,11404494,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114044943,11404494,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Carbuncle,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114044943,11404494,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114044943,11404494,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114044943,11404494,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Carbuncle,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114044943,11404494,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,3,F,201503.0,20151027.0,20150821,20151104,EXP,,CN-ASTRAZENECA-2015SE79396,ASTRAZENECA,,61.0,YR,,M,Y,,,20151104.0,,MD,CN,CN,2015,Q4,Adult
114240112,11424011,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Acute myocardial infarction,,2015,Q4,2,F,20100823.0,20151105.0,20150827,20151110,EXP,,US-PFIZER INC-2015284884,PFIZER,,60.0,YR,,M,Y,,,20151110.0,,LW,US,US,2015,Q4,Adult
114240112,11424011,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Atrioventricular block,,2015,Q4,2,F,20100823.0,20151105.0,20150827,20151110,EXP,,US-PFIZER INC-2015284884,PFIZER,,60.0,YR,,M,Y,,,20151110.0,,LW,US,US,2015,Q4,Adult
114240112,11424011,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Cardiomegaly,,2015,Q4,2,F,20100823.0,20151105.0,20150827,20151110,EXP,,US-PFIZER INC-2015284884,PFIZER,,60.0,YR,,M,Y,,,20151110.0,,LW,US,US,2015,Q4,Adult
114240112,11424011,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Decreased activity,,2015,Q4,2,F,20100823.0,20151105.0,20150827,20151110,EXP,,US-PFIZER INC-2015284884,PFIZER,,60.0,YR,,M,Y,,,20151110.0,,LW,US,US,2015,Q4,Adult
114240112,11424011,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Pulmonary embolism,,2015,Q4,2,F,20100823.0,20151105.0,20150827,20151110,EXP,,US-PFIZER INC-2015284884,PFIZER,,60.0,YR,,M,Y,,,20151110.0,,LW,US,US,2015,Q4,Adult
114490662,11449066,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,,,,,2015,Q4,Creatinine renal clearance decreased,,2015,Q4,2,F,20150513.0,20151109.0,20150902,20151117,EXP,,US-ASTRAZENECA-2015SE82349,ASTRAZENECA,,28701.0,DY,,M,Y,,,20151117.0,,MD,US,US,2015,Q4,Elderly
114490662,11449066,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,,,,,,,,,2015,Q4,Urinary tract infection,,2015,Q4,2,F,20150513.0,20151109.0,20150902,20151117,EXP,,US-ASTRAZENECA-2015SE82349,ASTRAZENECA,,28701.0,DY,,M,Y,,,20151117.0,,MD,US,US,2015,Q4,Elderly
114563583,11456358,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2015,Q4,Peripheral ischaemia,,2015,Q4,3,F,20141211.0,20151116.0,20150903,20151123,EXP,,"IT-ARIAD PHARMACEUTICALS, INC-2015IT005438",ARIAD,,79.0,YR,,M,Y,,,20151123.0,,MD,IT,IT,2015,Q4,Elderly
114969142,11496914,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,25 UNITS IN THE MORNING AND 30 UNITS IN THE AFTERNOON.,,,,,,,,,,UNSPECIFIED,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,2,F,20130822.0,20151012.0,20150911,20151020,EXP,,US-JNJFOC-20150810868,JANSSEN,,74.0,YR,E,M,Y,,,20151020.0,,CN,US,US,2015,Q4,Elderly
115110642,11511064,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 U, 1X A DAY",,,,,,,,,,,QD,2015,Q4,Oesophageal ulcer,,2015,Q4,2,F,20140827.0,20151103.0,20150915,20151112,EXP,,US-BAXALTA-2014BAX052801,BAXALTA,,51.0,YR,,M,Y,65.0,KG,20151112.0,,MD,US,US,2015,Q4,Adult
115112952,11511295,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"34 U, BEDTIME 1X A DAY",,,,,,,,,,,QD,2015,Q4,Diabetic gastroparesis,,2015,Q4,2,F,20140923.0,20151103.0,20150915,20151111,EXP,,US-BAXALTA-2014BAX058610,BAXALTA,,51.0,YR,,M,Y,65.0,KG,20151111.0,,MD,US,US,2015,Q4,Adult
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Anaemia,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Ascites,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Chest pain,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Chills,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Chronic kidney disease,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Crohn's disease,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Death,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Dizziness,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Haemochromatosis,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Headache,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Hepatic cirrhosis,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Hypothyroidism,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Leukocytosis,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Microalbuminuria,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Myelodysplastic syndrome,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Myelofibrosis,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Nocturia,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Oedema,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Oedema peripheral,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Rosacea,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Skin disorder,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Type 2 diabetes mellitus,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115346483,11534648,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 ML, AS NEEDED",,,,,,,,3.0,ML,,,2015,Q4,Vitamin D deficiency,,2015,Q4,3,F,,20151106.0,20150922,20151113,EXP,,US-AMGEN-USASL2015095949,AMGEN,,68.0,YR,E,M,Y,60.31,KG,20151113.0,,MD,US,US,2015,Q4,Elderly
115382293,11538229,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Drug-induced liver injury,,2015,Q4,3,F,,20151027.0,20150922,20151113,EXP,,IT-009507513-1509USA010758,MERCK,,72.0,YR,,F,Y,,,20151113.0,,OT,FR,US,2015,Q4,Elderly
115627815,11562781,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 MILLIGRAM,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Cellulitis,,2015,Q4,5,F,20150908.0,20151217.0,20150928,20151223,PER,,US-CELGENEUS-USA-2015093918,CELGENE,,80.0,YR,,M,Y,116.1,KG,20151223.0,,MD,US,US,2015,Q4,Elderly
115627815,11562781,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 MILLIGRAM,,,,,,,,25.0,IU,INJECTION,QD,2015,Q4,Gout,,2015,Q4,5,F,20150908.0,20151217.0,20150928,20151223,PER,,US-CELGENEUS-USA-2015093918,CELGENE,,80.0,YR,,M,Y,116.1,KG,20151223.0,,MD,US,US,2015,Q4,Elderly
115755602,11575560,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Chronic lymphocytic leukaemia,,2015,Q4,2,F,201506.0,20151016.0,20150930,20151029,EXP,,US-BIOGENIDEC-2015BI127884,BIOGEN,,48.0,YR,,M,Y,107.0,KG,20151029.0,,OT,US,US,2015,Q4,Adult
115755602,11575560,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Multiple sclerosis relapse,,2015,Q4,2,F,201506.0,20151016.0,20150930,20151029,EXP,,US-BIOGENIDEC-2015BI127884,BIOGEN,,48.0,YR,,M,Y,107.0,KG,20151029.0,,OT,US,US,2015,Q4,Adult
115832721,11583272,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Erectile dysfunction,,2015,Q4,1,I,,20150923.0,20151001,20151001,EXP,,US-DRREDDYS-USA/USA/15/0053007,DR REDDYS,"PANGANIBAN B, KINDER B, LITNER J. A PAINFUL UROLOGIC EMERGENCY. JAAPA. 2014?27(5):54-5.",52.0,YR,,M,Y,,,20151001.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
115832721,11583272,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Priapism,,2015,Q4,1,I,,20150923.0,20151001,20151001,EXP,,US-DRREDDYS-USA/USA/15/0053007,DR REDDYS,"PANGANIBAN B, KINDER B, LITNER J. A PAINFUL UROLOGIC EMERGENCY. JAAPA. 2014?27(5):54-5.",52.0,YR,,M,Y,,,20151001.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
115852071,11585207,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Priapism,,2015,Q4,1,I,,20150922.0,20151001,20151001,EXP,,US-ENDO PHARMACEUTICALS INC-2015-003027,ENDO,"PANGANIBAN B, KINDER B, LITNER J. A PAINFUL UROLOGIC EMERGENCY. JAAPA. 2014 MAY?27(5):54-55.",52.0,YR,,M,Y,,,20151001.0,,,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Aphasia,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Diabetic foot,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoaesthesia,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Ischaemic stroke,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Monoparesis,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Ophthalmoplegia,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115892141,11589214,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,VIIth nerve paralysis,,2015,Q4,1,I,20141225.0,20150327.0,20151002,20151002,EXP,,PL-SA-2015SA039938,AVENTIS,,59.0,YR,A,M,Y,85.0,KG,20151002.0,,MD,PL,PL,2015,Q4,Adult
115935081,11593508,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,1,I,20141117.0,20150731.0,20151005,20151005,EXP,,US-BAYER-2015-396279,BAYER,,62.0,YR,A,M,Y,,,20151005.0,,OT,US,US,2015,Q4,Adult
115962691,11596269,2,C,GLARGINE INSULINE,,2,,,,,,,,,,,,,,2015,Q4,Bladder spasm,,2015,Q4,1,I,20151004.0,,20151005,20151005,DIR,,,,,84.0,YR,,M,N,74.0,KG,20151004.0,N,,MX,,2015,Q4,Elderly
116125542,11612554,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Internal haemorrhage,,2015,Q4,2,F,20141114.0,20151027.0,20151008,20151105,EXP,,US-JNJFOC-20150907724,JANSSEN,,55.0,YR,A,M,Y,,,20151105.0,,CN,US,US,2015,Q4,Adult
116125542,11612554,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,2,F,20141114.0,20151027.0,20151008,20151105,EXP,,US-JNJFOC-20150907724,JANSSEN,,55.0,YR,A,M,Y,,,20151105.0,,CN,US,US,2015,Q4,Adult
116131751,11613175,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,HS,,,,,,,,20.0,IU,UNSPECIFIED,QD,2015,Q4,Serum sickness,,2015,Q4,1,I,,20150915.0,20151008,20151008,PER,,US-JNJFOC-20150917714,JANSSEN,"SNYDER DJ, MATUSIK  FB. RIVAROXABAN-INDUCED SERUM SICKNESS AFTER TOTAL KNEE ARTHROPLASTY. AM J HEALTH SYST PHARM 2015?72 (18):1567-1571.",61.0,YR,A,M,Y,103.4,KG,20151008.0,,PH,US,US,2015,Q4,Adult
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Anti-insulin antibody positive,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Blood glucose fluctuation,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Diabetes mellitus inadequate control,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Diabetic gastroenteropathy,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Lipodystrophy acquired,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Anti-insulin antibody positive,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Blood glucose fluctuation,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Diabetes mellitus inadequate control,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Diabetic gastroenteropathy,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116158081,11615808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"18 IU, QD",,,,,,,,18.0,IU,,QD,2015,Q4,Lipodystrophy acquired,,2015,Q4,1,I,20131111.0,20150929.0,20151009,20151009,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201510001946,ELI LILLY AND CO,,80.0,YR,,F,Y,76.0,KG,20151009.0,,MD,JP,JP,2015,Q4,Elderly
116171011,11617101,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Priapism,,2015,Q4,1,I,201405.0,20150925.0,20151009,20151009,EXP,,US-OSMOTICA_PHARMACEUTICAL_CORP-POI0573201500058,OSMOTICA,PANGANIBAN B. A PAINFUL UROLOGIC EMERGENCY. JAAPA JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS. 2014 MAY 01?27(5):54-55.,52.0,YR,,M,Y,,,20151009.0,,OT,US,US,2015,Q4,Adult
116172881,11617288,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Cerebrovascular accident,,2015,Q4,1,I,20150706.0,20150930.0,20151009,20151009,EXP,,US-ABBVIE-15P-163-1473996-00,ABBVIE,,49.0,YR,,F,Y,,,20151009.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116173924,11617392,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,,QD,2015,Q4,Blood creatinine increased,,2015,Q4,4,F,,20151103.0,20151009,20151113,PER,,US-GILEAD-2015-0175990,GILEAD,,68.0,YR,E,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116173924,11617392,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,,QD,2015,Q4,Haemoglobin decreased,,2015,Q4,4,F,,20151103.0,20151009,20151113,PER,,US-GILEAD-2015-0175990,GILEAD,,68.0,YR,E,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116180091,11618009,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Cerebrovascular accident,,2015,Q4,1,I,,20150927.0,20151010,20151010,EXP,,PL-ACCORD-034359,ACCORD,"SZYMALISKA-GARBATSCH E, CZUPRYNIAK L .CLINICAL PRACTICE - DIABETOLOGY: PROBLEMS IN THE TREATMENT OF DIABETES - PART. 14: LONG TERM OR INFIRM OLD AGE - A PATIENT OF DIABETES OVER 80 YEARS OF AGE. MED.PRAKT., 2015? 7-8: 96-102.",85.0,YR,,F,Y,,,20151010.0,,MD,PL,PL,2015,Q4,Elderly
116204791,11620479,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Cardiac failure congestive,,2015,Q4,1,I,20150122.0,20150123.0,20151012,20151012,EXP,,US-ASTRAZENECA-2015SE09817,ASTRAZENECA,,27409.0,DY,,F,Y,,,20151012.0,,MD,US,US,2015,Q4,Elderly
116263091,11626309,10,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Sepsis,,2015,Q4,1,I,20150206.0,20150929.0,20151013,20151013,PER,,US-CELGENEUS-USA-2015100111,CELGENE,,60.0,YR,,F,Y,74.0,KG,20151013.0,,OT,US,US,2015,Q4,Adult
116279401,11627940,8,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Pancreatitis necrotising,,2015,Q4,1,I,20151004.0,,20151013,20151013,DIR,,,,,41.0,YR,,M,N,152.0,KG,20151009.0,Y,PH,US,,2015,Q4,Adult
116293091,11629309,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Rash,,2015,Q4,1,I,20150911.0,,20151013,20151013,DIR,,,,,51.0,YR,,F,N,202.0,LBS,20151012.0,Y,MD,US,,2015,Q4,Adult
116295851,11629585,43,C,INSULIN GLARGINE(LANTUS) SOLUTION,,2,,,,,,,,,,,,,,2015,Q4,Hypotension,,2015,Q4,1,I,20151007.0,,20151013,20151013,DIR,,,,,82.0,YR,,M,N,90.5,KG,20151009.0,Y,,COUNTRY NOT SPECIFIED,,2015,Q4,Elderly
116295851,11629585,43,C,INSULIN GLARGINE(LANTUS) SOLUTION,,2,,,,,,,,,,,,,,2015,Q4,Hypothermia,,2015,Q4,1,I,20151007.0,,20151013,20151013,DIR,,,,,82.0,YR,,M,N,90.5,KG,20151009.0,Y,,COUNTRY NOT SPECIFIED,,2015,Q4,Elderly
116295851,11629585,43,C,INSULIN GLARGINE(LANTUS) SOLUTION,,2,,,,,,,,,,,,,,2015,Q4,Tachycardia,,2015,Q4,1,I,20151007.0,,20151013,20151013,DIR,,,,,82.0,YR,,M,N,90.5,KG,20151009.0,Y,,COUNTRY NOT SPECIFIED,,2015,Q4,Elderly
116295851,11629585,43,C,INSULIN GLARGINE(LANTUS) SOLUTION,,2,,,,,,,,,,,,,,2015,Q4,Tachypnoea,,2015,Q4,1,I,20151007.0,,20151013,20151013,DIR,,,,,82.0,YR,,M,N,90.5,KG,20151009.0,Y,,COUNTRY NOT SPECIFIED,,2015,Q4,Elderly
116334485,11633448,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"25 IU, QD (EVENING)",,,,,,,,25.0,IU,,QD,2015,Q4,Cardiac failure,,2015,Q4,5,F,20151008.0,20151016.0,20151015,20151027,EXP,,PHHO2015FR015306,SANDOZ,,92.0,YR,,M,Y,72.0,KG,20151027.0,,OT,FR,FR,2015,Q4,Elderly
116334485,11633448,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"25 IU, QD (EVENING)",,,,,,,,25.0,IU,,QD,2015,Q4,Sepsis,,2015,Q4,5,F,20151008.0,20151016.0,20151015,20151027,EXP,,PHHO2015FR015306,SANDOZ,,92.0,YR,,M,Y,72.0,KG,20151027.0,,OT,FR,FR,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Biopsy skin abnormal,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Chronic papillomatous dermatitis,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Erythema,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Iodine overload,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Papule,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Pruritus,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Skin disorder,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Skin exfoliation,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116369302,11636930,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Skin lesion,,2015,Q4,2,F,,20151105.0,20151016,20151113,EXP,,US-PFIZER INC-2015341406,PFIZER,"KHETARPAL, S.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA DERMATOL.. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151113.0,,MD,US,US,2015,Q4,Elderly
116376204,11637620,52,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,80 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Abdominal pain,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116376204,11637620,52,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,80 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Oral candidiasis,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116376204,11637620,52,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,80 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Skin candida,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116376204,11637620,53,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,60 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Abdominal pain,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116376204,11637620,53,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,60 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Oral candidiasis,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116376204,11637620,53,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,60 UNITS,,,,,,,,,,INJECTION,QD,2015,Q4,Skin candida,,2015,Q4,4,F,20150921.0,20151125.0,20151016,20151208,EXP,,US-CELGENE-USA-2015102288,CELGENE,,47.0,YR,,F,Y,,,20151208.0,,MD,US,US,2015,Q4,Adult
116411061,11641106,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20130818.0,20151013.0,20151019,20151019,EXP,,IT-SA-2015SA162090,AVENTIS,,79.0,YR,E,F,Y,,,20151019.0,,PH,IT,IT,2015,Q4,Elderly
116411061,11641106,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20130818.0,20151013.0,20151019,20151019,EXP,,IT-SA-2015SA162090,AVENTIS,,79.0,YR,E,F,Y,,,20151019.0,,PH,IT,IT,2015,Q4,Elderly
116411061,11641106,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Medication error,,2015,Q4,1,I,20130818.0,20151013.0,20151019,20151019,EXP,,IT-SA-2015SA162090,AVENTIS,,79.0,YR,E,F,Y,,,20151019.0,,PH,IT,IT,2015,Q4,Elderly
116434901,11643490,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q4,Liver injury,,2015,Q4,1,I,20150921.0,20151013.0,20151020,20151020,EXP,,GB-ASTELLAS-2015US037756,ASTELLAS,,59.0,YR,,M,Y,,,20151020.0,,OT,GB,GB,2015,Q4,Adult
116443672,11644367,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Affect lability,,2015,Q4,2,F,2015.0,20151208.0,20151020,20151215,PER,,US-CELGENEUS-USA-2015101475,CELGENE,,80.0,YR,,M,Y,110.6,KG,20151215.0,,MD,US,US,2015,Q4,Elderly
116443672,11644367,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Confusional state,,2015,Q4,2,F,2015.0,20151208.0,20151020,20151215,PER,,US-CELGENEUS-USA-2015101475,CELGENE,,80.0,YR,,M,Y,110.6,KG,20151215.0,,MD,US,US,2015,Q4,Elderly
116443672,11644367,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Dysarthria,,2015,Q4,2,F,2015.0,20151208.0,20151020,20151215,PER,,US-CELGENEUS-USA-2015101475,CELGENE,,80.0,YR,,M,Y,110.6,KG,20151215.0,,MD,US,US,2015,Q4,Elderly
116443672,11644367,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Hallucination,,2015,Q4,2,F,2015.0,20151208.0,20151020,20151215,PER,,US-CELGENEUS-USA-2015101475,CELGENE,,80.0,YR,,M,Y,110.6,KG,20151215.0,,MD,US,US,2015,Q4,Elderly
116474131,11647413,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151013.0,,20151019,20151019,DIR,,,,,66.0,YR,,F,N,81.3,KG,20151016.0,N,,US,,2015,Q4,Elderly
116491031,11649103,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,1,I,20130828.0,20150803.0,20151021,20151021,EXP,,US-BAYER-2015-397431,BAYER,,62.0,YR,A,F,Y,,,20151021.0,,CN,US,US,2015,Q4,Adult
116508792,11650879,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 U IN THE MORNING,,,,,,,,,,,,2015,Q4,Diabetes mellitus,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116508792,11650879,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 U IN THE MORNING,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116508792,11650879,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 U/ DAY,,,,,,,,,,,,2015,Q4,Diabetes mellitus,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116508792,11650879,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,28 U/ DAY,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116508792,11650879,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,34 U/ DAY,,,,,,,,,,,,2015,Q4,Diabetes mellitus,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116508792,11650879,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,34 U/ DAY,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,2,F,,20151009.0,20151021,20151022,EXP,,BR-ASTRAZENECA-2015SE99369,ASTRAZENECA,,61.0,YR,,M,Y,,,20151021.0,,MD,BR,BR,2015,Q4,Adult
116515431,11651543,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Condition aggravated,,2015,Q4,1,I,20150929.0,,20151021,20151021,DIR,,,,,50.0,YR,,F,N,88.45,KG,20151020.0,N,,US,,2015,Q4,Adult
116515431,11651543,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,20150929.0,,20151021,20151021,DIR,,,,,50.0,YR,,F,N,88.45,KG,20151020.0,N,,US,,2015,Q4,Adult
116515431,11651543,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Somnolence,,2015,Q4,1,I,20150929.0,,20151021,20151021,DIR,,,,,50.0,YR,,F,N,88.45,KG,20151020.0,N,,US,,2015,Q4,Adult
116515431,11651543,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vertigo positional,,2015,Q4,1,I,20150929.0,,20151021,20151021,DIR,,,,,50.0,YR,,F,N,88.45,KG,20151020.0,N,,US,,2015,Q4,Adult
116531981,11653198,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,1,I,20130822.0,20150813.0,20151022,20151022,EXP,,US-BAYER-2015-402520,BAYER,,74.0,YR,E,M,Y,,,20151022.0,,OT,US,US,2015,Q4,Elderly
116534441,11653444,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,, 4B062A,,,10.0,IU,INFUSION,QD,2015,Q4,Asthenia,,2015,Q4,1,I,20150216.0,20151012.0,20151022,20151022,EXP,,CN-BAYER-2015-444810,BAYER,,58.0,YR,A,F,Y,50.0,KG,20151022.0,,OT,CN,CN,2015,Q4,Adult
116534441,11653444,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,, 4B062A,,,10.0,IU,INFUSION,QD,2015,Q4,Chromaturia,,2015,Q4,1,I,20150216.0,20151012.0,20151022,20151022,EXP,,CN-BAYER-2015-444810,BAYER,,58.0,YR,A,F,Y,50.0,KG,20151022.0,,OT,CN,CN,2015,Q4,Adult
116534441,11653444,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,, 4B062A,,,10.0,IU,INFUSION,QD,2015,Q4,Dizziness,,2015,Q4,1,I,20150216.0,20151012.0,20151022,20151022,EXP,,CN-BAYER-2015-444810,BAYER,,58.0,YR,A,F,Y,50.0,KG,20151022.0,,OT,CN,CN,2015,Q4,Adult
116534441,11653444,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,, 4B062A,,,10.0,IU,INFUSION,QD,2015,Q4,Haemolytic anaemia,,2015,Q4,1,I,20150216.0,20151012.0,20151022,20151022,EXP,,CN-BAYER-2015-444810,BAYER,,58.0,YR,A,F,Y,50.0,KG,20151022.0,,OT,CN,CN,2015,Q4,Adult
116534441,11653444,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,, 4B062A,,,10.0,IU,INFUSION,QD,2015,Q4,Jaundice acholuric,,2015,Q4,1,I,20150216.0,20151012.0,20151022,20151022,EXP,,CN-BAYER-2015-444810,BAYER,,58.0,YR,A,F,Y,50.0,KG,20151022.0,,OT,CN,CN,2015,Q4,Adult
116553981,11655398,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,17.0,IU,,,2015,Q4,Cardio-respiratory arrest,,2015,Q4,1,I,20151014.0,20151019.0,20151023,20151023,EXP,,CO-BAXTER-2015BAX056877,BAXTER,,58.0,YR,,F,Y,53.1,KG,20151023.0,,OT,CO,CO,2015,Q4,Adult
116553981,11655398,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,17.0,IU,,,2015,Q4,Cystitis,,2015,Q4,1,I,20151014.0,20151019.0,20151023,20151023,EXP,,CO-BAXTER-2015BAX056877,BAXTER,,58.0,YR,,F,Y,53.1,KG,20151023.0,,OT,CO,CO,2015,Q4,Adult
116553981,11655398,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,17.0,IU,,,2015,Q4,Syncope,,2015,Q4,1,I,20151014.0,20151019.0,20151023,20151023,EXP,,CO-BAXTER-2015BAX056877,BAXTER,,58.0,YR,,F,Y,53.1,KG,20151023.0,,OT,CO,CO,2015,Q4,Adult
116553981,11655398,5,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,17.0,IU,,,2015,Q4,Urinary tract infection,,2015,Q4,1,I,20151014.0,20151019.0,20151023,20151023,EXP,,CO-BAXTER-2015BAX056877,BAXTER,,58.0,YR,,F,Y,53.1,KG,20151023.0,,OT,CO,CO,2015,Q4,Adult
116565021,11656502,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2015,Q4,Gastritis,,2015,Q4,1,I,20140916.0,20141125.0,20151023,20151023,EXP,,CN-ASTRAZENECA-2014SE90788,ASTRAZENECA,,26008.0,DY,,F,Y,,,20151023.0,,MD,CN,CN,2015,Q4,Elderly
116568781,11656878,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Drug-induced liver injury,,2015,Q4,1,I,,20150909.0,20151023,20151023,EXP,,IT-009507513-1510DEU010575,MERCK,,71.0,YR,,F,Y,,,20151023.0,,OT,IT,DE,2015,Q4,Elderly
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Abdominal pain,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Anaemia,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Contusion,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dehydration,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dizziness,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dysuria,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Epistaxis,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Escherichia test positive,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Faeces discoloured,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Haematemesis,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Headache,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypophagia,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Leukopenia,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Somnolence,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Thrombocytopenia,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Urinary tract infection,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vertigo positional,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116580311,11658031,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vulvovaginal mycotic infection,,2015,Q4,1,I,,20151019.0,20151023,20151023,EXP,,US-ABBVIE-15P-163-1485968-00,ABBVIE,,50.0,YR,,F,Y,88.45,KG,20151023.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
116585832,11658583,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Injection site erythema,,2015,Q4,2,F,20151008.0,20151015.0,20151026,20151108,PER,,US-009507513-1510USA008242,MERCK,,63.0,YR,,M,Y,,,20151108.0,,CN,CH,US,2015,Q4,Adult
116585832,11658583,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Injection site swelling,,2015,Q4,2,F,20151008.0,20151015.0,20151026,20151108,PER,,US-009507513-1510USA008242,MERCK,,63.0,YR,,M,Y,,,20151108.0,,CN,CH,US,2015,Q4,Adult
116585832,11658583,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Overdose,,2015,Q4,2,F,20151008.0,20151015.0,20151026,20151108,PER,,US-009507513-1510USA008242,MERCK,,63.0,YR,,M,Y,,,20151108.0,,CN,CH,US,2015,Q4,Adult
116585832,11658583,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Product use issue,,2015,Q4,2,F,20151008.0,20151015.0,20151026,20151108,PER,,US-009507513-1510USA008242,MERCK,,63.0,YR,,M,Y,,,20151108.0,,CN,CH,US,2015,Q4,Adult
116605351,11660535,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Foot fracture,,2015,Q4,1,I,20150531.0,,20151023,20151023,DIR,,,,,64.0,YR,,M,N,86.2,KG,20151022.0,Y,CN,US,,2015,Q4,Adult
116605351,11660535,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hepatic encephalopathy,,2015,Q4,1,I,20150531.0,,20151023,20151023,DIR,,,,,64.0,YR,,M,N,86.2,KG,20151022.0,Y,CN,US,,2015,Q4,Adult
116605351,11660535,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Renal impairment,,2015,Q4,1,I,20150531.0,,20151023,20151023,DIR,,,,,64.0,YR,,M,N,86.2,KG,20151022.0,Y,CN,US,,2015,Q4,Adult
116670901,11667090,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Upper gastrointestinal haemorrhage,,2015,Q4,1,I,20141124.0,20150906.0,20151027,20151027,EXP,,US-BAYER-2015-421045,BAYER,,80.0,YR,E,M,Y,,,20151027.0,,OT,US,US,2015,Q4,Elderly
116674982,11667498,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2015,Q4,Bradycardia,,2015,Q4,2,F,20150923.0,20151020.0,20151027,20151027,EXP,,CO-BAXTER-2015BAX057150,BAXTER,,70.0,YR,,M,Y,66.0,KG,20151027.0,,OT,CO,CO,2015,Q4,Elderly
116674982,11667498,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2015,Q4,Cardio-respiratory arrest,,2015,Q4,2,F,20150923.0,20151020.0,20151027,20151027,EXP,,CO-BAXTER-2015BAX057150,BAXTER,,70.0,YR,,M,Y,66.0,KG,20151027.0,,OT,CO,CO,2015,Q4,Elderly
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Device leakage,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Headache,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Injection site discharge,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Injection site mass,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Needle issue,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116726801,11672680,9,C,TOUJEO INSULIN GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Product reconstitution issue,,2015,Q4,1,I,20151025.0,,20151027,20151027,DIR,,,,,49.0,YR,,F,N,200.0,LBS,20151026.0,N,,US,,2015,Q4,Adult
116761962,11676196,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2015,Q4,Pleural effusion,,2015,Q4,2,F,20151013.0,20151106.0,20151028,20151111,EXP,,CO-BAXTER-2015BAX057235,BAXTER,,62.0,YR,,M,Y,93.0,KG,20151111.0,,OT,CO,CO,2015,Q4,Adult
116801211,11680121,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Blood osmolarity decreased,,2015,Q4,1,I,20150927.0,20151020.0,20151029,20151029,EXP,,PHHY2015IT136359,SANDOZ,,86.0,YR,,F,Y,,,20151029.0,,OT,IT,IT,2015,Q4,Elderly
116801211,11680121,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,1,I,20150927.0,20151020.0,20151029,20151029,EXP,,PHHY2015IT136359,SANDOZ,,86.0,YR,,F,Y,,,20151029.0,,OT,IT,IT,2015,Q4,Elderly
116801211,11680121,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Dysphagia,,2015,Q4,1,I,20150927.0,20151020.0,20151029,20151029,EXP,,PHHY2015IT136359,SANDOZ,,86.0,YR,,F,Y,,,20151029.0,,OT,IT,IT,2015,Q4,Elderly
116801211,11680121,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Haematemesis,,2015,Q4,1,I,20150927.0,20151020.0,20151029,20151029,EXP,,PHHY2015IT136359,SANDOZ,,86.0,YR,,F,Y,,,20151029.0,,OT,IT,IT,2015,Q4,Elderly
116801211,11680121,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20150927.0,20151020.0,20151029,20151029,EXP,,PHHY2015IT136359,SANDOZ,,86.0,YR,,F,Y,,,20151029.0,,OT,IT,IT,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Bradycardia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Electrocardiogram P wave abnormal,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemic unconsciousness,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Nausea,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus arrest,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Vomiting,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Bradycardia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Electrocardiogram P wave abnormal,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemic unconsciousness,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Nausea,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus arrest,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Vomiting,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Bradycardia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Electrocardiogram P wave abnormal,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Hypoglycaemic unconsciousness,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Nausea,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus arrest,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835012,11683501,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Vomiting,,2015,Q4,2,F,2010.0,20151113.0,20151029,20151125,EXP,,JP-SA-2015SA170136,AVENTIS,,80.0,YR,E,F,Y,55.0,KG,20151125.0,,MD,JP,JP,2015,Q4,Elderly
116835171,11683517,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BEFORE BREAKFAST DOSE:24 UNIT(S),,,,, UNK,,21081.0,,,,QD,2015,Q4,Haemorrhage,,2015,Q4,1,I,,20151021.0,20151029,20151029,EXP,,JP-SA-2015SA170134,AVENTIS,"OGURA M, HARASHIMA S, INAGAKI N, NISHIMURA A. TWO CASES OF SEVERE HYPOGLYCEMIA IN DIABETIC PATIENTS TREATED WITH INSULIN DEGLUDEC. J JAPAN DIAB SOC. 2015 SEP?58(9)?702-6.",70.0,YR,E,M,Y,79.4,KG,20151029.0,,OT,JP,JP,2015,Q4,Elderly
116835171,11683517,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BEFORE BREAKFAST DOSE:24 UNIT(S),,,,, UNK,,21081.0,,,,QD,2015,Q4,Induration,,2015,Q4,1,I,,20151021.0,20151029,20151029,EXP,,JP-SA-2015SA170134,AVENTIS,"OGURA M, HARASHIMA S, INAGAKI N, NISHIMURA A. TWO CASES OF SEVERE HYPOGLYCEMIA IN DIABETIC PATIENTS TREATED WITH INSULIN DEGLUDEC. J JAPAN DIAB SOC. 2015 SEP?58(9)?702-6.",70.0,YR,E,M,Y,79.4,KG,20151029.0,,OT,JP,JP,2015,Q4,Elderly
116835512,11683551,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,2,F,20120221.0,20151030.0,20151029,20151106,EXP,,IT-AUROBINDO-AUR-APL-2015-09680,AUROBINDO,,66.0,YR,,F,Y,,,20151106.0,,OT,IT,IT,2015,Q4,Elderly
116835512,11683551,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,20120221.0,20151030.0,20151029,20151106,EXP,,IT-AUROBINDO-AUR-APL-2015-09680,AUROBINDO,,66.0,YR,,F,Y,,,20151106.0,,OT,IT,IT,2015,Q4,Elderly
116843071,11684307,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,QD,2015,Q4,Angina unstable,,2015,Q4,1,I,20150803.0,20151023.0,20151029,20151029,EXP,,CN-ASTRAZENECA-2015SF03185,ASTRAZENECA,,71.0,YR,,F,Y,,,20151029.0,,MD,CN,CN,2015,Q4,Elderly
116857231,11685723,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Blood osmolarity decreased,,2015,Q4,1,I,20150927.0,20151021.0,20151030,20151030,EXP,IT-MINISAL02-330575,IT-TEVA-603904ACC,TEVA,,86.0,YR,,F,Y,,,20151030.0,,MD,IT,IT,2015,Q4,Elderly
116857231,11685723,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,1,I,20150927.0,20151021.0,20151030,20151030,EXP,IT-MINISAL02-330575,IT-TEVA-603904ACC,TEVA,,86.0,YR,,F,Y,,,20151030.0,,MD,IT,IT,2015,Q4,Elderly
116857231,11685723,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dysphagia,,2015,Q4,1,I,20150927.0,20151021.0,20151030,20151030,EXP,IT-MINISAL02-330575,IT-TEVA-603904ACC,TEVA,,86.0,YR,,F,Y,,,20151030.0,,MD,IT,IT,2015,Q4,Elderly
116857231,11685723,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Haematemesis,,2015,Q4,1,I,20150927.0,20151021.0,20151030,20151030,EXP,IT-MINISAL02-330575,IT-TEVA-603904ACC,TEVA,,86.0,YR,,F,Y,,,20151030.0,,MD,IT,IT,2015,Q4,Elderly
116857231,11685723,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20150927.0,20151021.0,20151030,20151030,EXP,IT-MINISAL02-330575,IT-TEVA-603904ACC,TEVA,,86.0,YR,,F,Y,,,20151030.0,,MD,IT,IT,2015,Q4,Elderly
116864861,11686486,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2015,Q4,Pruritus generalised,,2015,Q4,1,I,,20151016.0,20151030,20151030,EXP,,FR-009507513-1510FRA013898,MERCK,,77.0,YR,,F,Y,,,20151030.0,,OT,FR,FR,2015,Q4,Elderly
116864861,11686486,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2015,Q4,Urticaria,,2015,Q4,1,I,,20151016.0,20151030,20151030,EXP,,FR-009507513-1510FRA013898,MERCK,,77.0,YR,,F,Y,,,20151030.0,,OT,FR,FR,2015,Q4,Elderly
116893662,11689366,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,2,F,20120221.0,20151103.0,20151102,20151113,EXP,IT-MINISAL02-330858,IT-TEVA-604514ACC,TEVA,,66.0,YR,,F,Y,,,20151113.0,,MD,IT,IT,2015,Q4,Elderly
116893662,11689366,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,20120221.0,20151103.0,20151102,20151113,EXP,IT-MINISAL02-330858,IT-TEVA-604514ACC,TEVA,,66.0,YR,,F,Y,,,20151113.0,,MD,IT,IT,2015,Q4,Elderly
116896902,11689690,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q4,Patella fracture,,2015,Q4,2,F,201510.0,20151226.0,20151102,20151231,EXP,,US-ASTELLAS-2015US040086,ASTELLAS,,69.0,YR,,F,Y,,,20151231.0,,PH,US,US,2015,Q4,Elderly
116896902,11689690,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q4,Postoperative ileus,,2015,Q4,2,F,201510.0,20151226.0,20151102,20151231,EXP,,US-ASTELLAS-2015US040086,ASTELLAS,,69.0,YR,,F,Y,,,20151231.0,,PH,US,US,2015,Q4,Elderly
116896902,11689690,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,U,,,,,,FORMULATION UNKNOWN,,2015,Q4,Road traffic accident,,2015,Q4,2,F,201510.0,20151226.0,20151102,20151231,EXP,,US-ASTELLAS-2015US040086,ASTELLAS,,69.0,YR,,F,Y,,,20151231.0,,PH,US,US,2015,Q4,Elderly
116897261,11689726,11,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116897261,11689726,11,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,,2015,Q4,Hyperglycaemia,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116897261,11689726,11,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,,,2015,Q4,Loss of consciousness,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116897261,11689726,12,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116897261,11689726,12,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2015,Q4,Hyperglycaemia,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116897261,11689726,12,C,glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,,,2015,Q4,Loss of consciousness,,2015,Q4,1,I,20151021.0,20151023.0,20151102,20151102,EXP,,CO-BAXTER-2015BAX058224,BAXTER,,58.0,YR,,F,Y,61.4,KG,20151102.0,,OT,CO,CO,2015,Q4,Adult
116930261,11693026,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 UNIT, QD",32.0,DF,,, 4B038A,,,8.0,DF,,QD,2015,Q4,Hepatic function abnormal,,2015,Q4,1,I,20150131.0,20151019.0,20151103,20151103,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-073184,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,60.0,KG,20151103.0,,CN,CN,CN,2015,Q4,Adult
116934653,11693465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,24.0,IU,,QD,2015,Q4,Hypoglycaemia,,2015,Q4,3,F,20151027.0,20151110.0,20151103,20151113,EXP,,CO-BAXTER-2015BAX059060,BAXTER,,72.0,YR,,M,Y,62.0,KG,20151113.0,,OT,CO,CO,2015,Q4,Elderly
116934653,11693465,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,24.0,IU,,QD,2015,Q4,Loss of consciousness,,2015,Q4,3,F,20151027.0,20151110.0,20151103,20151113,EXP,,CO-BAXTER-2015BAX059060,BAXTER,,72.0,YR,,M,Y,62.0,KG,20151113.0,,OT,CO,CO,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Acidosis,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Colitis,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Confusional state,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dehydration,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dry skin,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Electrolyte imbalance,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Fatigue,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hyperglycaemia,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Pyrexia,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116939551,11693955,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Renal failure,,2015,Q4,1,I,2015.0,20151005.0,20151103,20151103,EXP,,US-GILEAD-2015-0175898,GILEAD,,70.0,YR,E,F,Y,88.9,KG,20151103.0,,OT,US,US,2015,Q4,Elderly
116947482,11694748,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,2,F,20120221.0,20151030.0,20151103,20151113,EXP,,IT-SA-2015SA169760,AVENTIS,,66.0,YR,E,F,Y,,,20151113.0,,MD,IT,IT,2015,Q4,Elderly
116947482,11694748,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,21081.0,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,20120221.0,20151030.0,20151103,20151113,EXP,,IT-SA-2015SA169760,AVENTIS,,66.0,YR,E,F,Y,,,20151113.0,,MD,IT,IT,2015,Q4,Elderly
116960371,11696037,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Hypokalaemia,,2015,Q4,1,I,,20150611.0,20151104,20151104,EXP,,IL-WATSON-2015-12334,WATSON,"EYAL A, SUEISSA A, BRAUN E, NAFFAA ME. FROM HYPOMAGNESAEMIA TO ZOLLINGER-ELLISON SYNDROME: AN ADVERSE EFFECT OF A PROTON PUMP INHIBITOR. BMJ CASE REP. 2014?-:-",53.0,YR,,M,Y,,,20151104.0,,OT,IL,IL,2015,Q4,Adult
116960371,11696037,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Hypomagnesaemia,,2015,Q4,1,I,,20150611.0,20151104,20151104,EXP,,IL-WATSON-2015-12334,WATSON,"EYAL A, SUEISSA A, BRAUN E, NAFFAA ME. FROM HYPOMAGNESAEMIA TO ZOLLINGER-ELLISON SYNDROME: AN ADVERSE EFFECT OF A PROTON PUMP INHIBITOR. BMJ CASE REP. 2014?-:-",53.0,YR,,M,Y,,,20151104.0,,OT,IL,IL,2015,Q4,Adult
116960371,11696037,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Unmasking of previously unidentified disease,,2015,Q4,1,I,,20150611.0,20151104,20151104,EXP,,IL-WATSON-2015-12334,WATSON,"EYAL A, SUEISSA A, BRAUN E, NAFFAA ME. FROM HYPOMAGNESAEMIA TO ZOLLINGER-ELLISON SYNDROME: AN ADVERSE EFFECT OF A PROTON PUMP INHIBITOR. BMJ CASE REP. 2014?-:-",53.0,YR,,M,Y,,,20151104.0,,OT,IL,IL,2015,Q4,Adult
116981202,11698120,3,C,INSULINE GLARGINE,,2,Unknown,,,,,,,,,,,,,2015,Q4,Blood osmolarity decreased,,2015,Q4,2,F,20150927.0,20151102.0,20151104,20151116,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-072879,BRISTOL MYERS SQUIBB,,86.0,YR,,F,Y,,,20151116.0,,CN,IT,IT,2015,Q4,Elderly
116981202,11698120,3,C,INSULINE GLARGINE,,2,Unknown,,,,,,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,2,F,20150927.0,20151102.0,20151104,20151116,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-072879,BRISTOL MYERS SQUIBB,,86.0,YR,,F,Y,,,20151116.0,,CN,IT,IT,2015,Q4,Elderly
116981202,11698120,3,C,INSULINE GLARGINE,,2,Unknown,,,,,,,,,,,,,2015,Q4,Dysphagia,,2015,Q4,2,F,20150927.0,20151102.0,20151104,20151116,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-072879,BRISTOL MYERS SQUIBB,,86.0,YR,,F,Y,,,20151116.0,,CN,IT,IT,2015,Q4,Elderly
116981202,11698120,3,C,INSULINE GLARGINE,,2,Unknown,,,,,,,,,,,,,2015,Q4,Haematemesis,,2015,Q4,2,F,20150927.0,20151102.0,20151104,20151116,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-072879,BRISTOL MYERS SQUIBB,,86.0,YR,,F,Y,,,20151116.0,,CN,IT,IT,2015,Q4,Elderly
116981202,11698120,3,C,INSULINE GLARGINE,,2,Unknown,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,2,F,20150927.0,20151102.0,20151104,20151116,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-072879,BRISTOL MYERS SQUIBB,,86.0,YR,,F,Y,,,20151116.0,,CN,IT,IT,2015,Q4,Elderly
116995592,11699559,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNK, UNK",,,,,,,,,,,,2015,Q4,Cardiac failure congestive,,2015,Q4,2,F,20150311.0,20151123.0,20151105,20151128,EXP,,US-AMGEN-USACT2015038028,AMGEN,,64.0,YR,A,F,Y,,,20151128.0,,MD,US,US,2015,Q4,Adult
116995592,11699559,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNK, UNK",,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,2,F,20150311.0,20151123.0,20151105,20151128,EXP,,US-AMGEN-USACT2015038028,AMGEN,,64.0,YR,A,F,Y,,,20151128.0,,MD,US,US,2015,Q4,Adult
117005241,11700524,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, QHS; 20 UNITS AT NIGHT OR AS DIRECTED BY THE NURSE",,,,,,,,20.0,IU,,QD,2015,Q4,Joint swelling,,2015,Q4,1,I,20150714.0,20151028.0,20151105,20151105,EXP,GB-MHRA-TPP6523035C753016YC1444926770249,GB-WATSON-2015-23633,WATSON,,75.0,YR,,M,Y,87.0,KG,20151105.0,,CN,GB,GB,2015,Q4,Elderly
117005241,11700524,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 IU, QHS; 20 UNITS AT NIGHT OR AS DIRECTED BY THE NURSE",,,,,,,,20.0,IU,,QD,2015,Q4,Oedema peripheral,,2015,Q4,1,I,20150714.0,20151028.0,20151105,20151105,EXP,GB-MHRA-TPP6523035C753016YC1444926770249,GB-WATSON-2015-23633,WATSON,,75.0,YR,,M,Y,87.0,KG,20151105.0,,CN,GB,GB,2015,Q4,Elderly
117008102,11700810,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD (13-0-12)",,,,U, UNKNOWN,,,25.0,DF,,QD,2015,Q4,Bradycardia,,2015,Q4,2,F,2010.0,20151104.0,20151105,20151113,EXP,,JP-NOVOPROD-468979,NOVO NORDISK,"MASAHIRO ASAKAWA, ET.AL.,. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY: AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. J.JAPAN DIAB. SOC.,. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151113.0,,MD,JP,JP,2015,Q4,Elderly
117008102,11700810,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD (13-0-12)",,,,U, UNKNOWN,,,25.0,DF,,QD,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,2010.0,20151104.0,20151105,20151113,EXP,,JP-NOVOPROD-468979,NOVO NORDISK,"MASAHIRO ASAKAWA, ET.AL.,. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY: AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. J.JAPAN DIAB. SOC.,. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151113.0,,MD,JP,JP,2015,Q4,Elderly
117008102,11700810,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD (13-0-12)",,,,U, UNKNOWN,,,25.0,DF,,QD,2015,Q4,Sinus node dysfunction,,2015,Q4,2,F,2010.0,20151104.0,20151105,20151113,EXP,,JP-NOVOPROD-468979,NOVO NORDISK,"MASAHIRO ASAKAWA, ET.AL.,. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY: AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. J.JAPAN DIAB. SOC.,. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151113.0,,MD,JP,JP,2015,Q4,Elderly
117020111,11702011,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20130818.0,20151021.0,20151105,20151105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-074557,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,,,20151105.0,,CN,IT,IT,2015,Q4,Elderly
117020111,11702011,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20130818.0,20151021.0,20151105,20151105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-074557,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,,,20151105.0,,CN,IT,IT,2015,Q4,Elderly
117020111,11702011,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Medication error,,2015,Q4,1,I,20130818.0,20151021.0,20151105,20151105,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-074557,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,,,20151105.0,,CN,IT,IT,2015,Q4,Elderly
117028803,11702880,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,3,F,20120221.0,20151106.0,20151105,20151120,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-075020,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,,,20151120.0,,CN,IT,IT,2015,Q4,Elderly
117028803,11702880,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,3,F,20120221.0,20151106.0,20151105,20151120,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-075020,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,,,20151120.0,,CN,IT,IT,2015,Q4,Elderly
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Alanine aminotransferase increased,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Constipation,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Dyspnoea,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Fatigue,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Haemorrhoids,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Headache,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Hyperglycaemia,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Insomnia,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Oral candidiasis,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Seizure,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117030462,11703046,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"20 (UNITS) OT, UNK",,,,,,,,,,,,2015,Q4,Visual impairment,,2015,Q4,2,F,20140821.0,20151120.0,20151105,20151125,EXP,,PHFR2015GB008326,NOVARTIS,,35.0,YR,,F,Y,62.6,KG,20151125.0,,OT,GB,GB,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Anhedonia,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Asthenia,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Blood glucose decreased,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Blood glucose increased,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Confusional state,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Decreased appetite,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Disorientation,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Energy increased,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Fatigue,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Gait disturbance,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Hallucination,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Impaired driving ability,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Incorrect dose administered,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Malaise,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Mental status changes,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Somnolence,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Speech disorder,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Therapeutic response unexpected,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117033092,11703309,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 U, UNK",,,,, 5F066A,,,16.0,DF,,,2015,Q4,Weight decreased,,2015,Q4,2,F,20151015.0,20151217.0,20151105,20151223,EXP,,GXBR2015US002437,SANDOZ,,36.0,YR,,M,Y,77.98,KG,20151223.0,,CN,COUNTRY NOT SPECIFIED,US,2015,Q4,Adult
117041631,11704163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Internal haemorrhage,,2015,Q4,1,I,20141114.0,20150906.0,20151106,20151106,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20151106.0,,OT,US,US,2015,Q4,Adult
117041631,11704163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,1,I,20141114.0,20150906.0,20151106,20151106,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20151106.0,,OT,US,US,2015,Q4,Adult
117054602,11705460,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Hyperkalaemia,,2015,Q4,2,F,20120221.0,20151022.0,20151106,20151110,EXP,,IT-WATSON-2015-22962,WATSON,,66.0,YR,,F,Y,,,20151110.0,,CN,IT,IT,2015,Q4,Elderly
117054602,11705460,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,20120221.0,20151022.0,20151106,20151110,EXP,,IT-WATSON-2015-22962,WATSON,,66.0,YR,,F,Y,,,20151110.0,,CN,IT,IT,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Blood glucose decreased,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Loss of consciousness,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Sinus arrest,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Blood glucose decreased,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Loss of consciousness,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Sinus arrest,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,13-0-12,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Blood glucose decreased,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Loss of consciousness,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Sinus arrest,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Sinus node dysfunction,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117072261,11707226,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,ADJUST THE INSULIN DOSAGE REGIMEN BASED ON CONTINUOUS GLUCOSE MONITORING,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,2010.0,20151027.0,20151106,20151106,EXP,,JP-BAYER-2015-455763,BAYER,"ASAKAWA M, SEKINE T, NIITSU Y, KOBAYASHI A, MIYAKE A, KAWAMURA M, ET AL.. DIFFICULT MEDICAL MANAGEMENT IN ELDERLY DIABETIC PATIENTS WITH POLYPHARMACY? AN ANALYSIS OF CASES ACCOMPANIED BY FREQUENT CONSCIOUSNESS LOSS AND ASYMPTOMATIC HYPOGLYCEMIA. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2015?58(9):688-694",80.0,YR,E,F,Y,55.0,KG,20151106.0,,MD,JP,JP,2015,Q4,Elderly
117165914,11716591,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 UNIT, DAILY",,,,U,,,,44.0,DF,,,2015,Q4,Penile exfoliation,,2015,Q4,4,F,20151017.0,20151203.0,20151109,20151214,EXP,,CN-NAPPMUNDI-GBR-2015-0031944,PURDUE,,58.0,YR,,M,Y,,,20151214.0,,MD,CN,CN,2015,Q4,Adult
117217192,11721719,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhage,,2015,Q4,2,F,20141222.0,20151201.0,20151111,20151210,EXP,,US-JNJFOC-20151003404,JANSSEN,,78.0,YR,E,F,Y,,,20151210.0,,CN,US,US,2015,Q4,Elderly
117217192,11721719,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,2,F,20141222.0,20151201.0,20151111,20151210,EXP,,US-JNJFOC-20151003404,JANSSEN,,78.0,YR,E,F,Y,,,20151210.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Acute kidney injury,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Epistaxis,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhage urinary tract,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhagic arteriovenous malformation,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Rectal haemorrhage,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Acute kidney injury,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Epistaxis,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhage urinary tract,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Haemorrhagic arteriovenous malformation,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117217562,11721756,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Rectal haemorrhage,,2015,Q4,2,F,20140622.0,20151214.0,20151111,20151224,PER,,US-JNJFOC-20151014059,JANSSEN,,73.0,YR,E,M,Y,,,20151224.0,,CN,US,US,2015,Q4,Elderly
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Cerebral infarction,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Confusional state,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Headache,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Hemiparesis,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Hypertension,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117222321,11722232,9,C,INSULIN GLARGINE (LANTUS SOLOSTAR),,2,,,,,,,,,,,,,,2015,Q4,Hypoaesthesia,,2015,Q4,1,I,20151104.0,,20151110,20151110,DIR,,,,,54.0,YR,,M,N,173.0,LBS,20151109.0,N,MD,US,,2015,Q4,Adult
117227501,11722750,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 U,,,,,,,,,,,,2015,Q4,Angina unstable,,2015,Q4,1,I,2009.0,20151103.0,20151111,20151111,EXP,,BR-ASTRAZENECA-2015SF08206,ASTRAZENECA,,68.0,YR,,F,Y,83.5,KG,20151111.0,,MD,BR,BR,2015,Q4,Elderly
117227501,11722750,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 U,,,,,,,,,,,,2015,Q4,Hyperglycaemia,,2015,Q4,1,I,2009.0,20151103.0,20151111,20151111,EXP,,BR-ASTRAZENECA-2015SF08206,ASTRAZENECA,,68.0,YR,,F,Y,83.5,KG,20151111.0,,MD,BR,BR,2015,Q4,Elderly
117227501,11722750,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,50 U,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,1,I,2009.0,20151103.0,20151111,20151111,EXP,,BR-ASTRAZENECA-2015SF08206,ASTRAZENECA,,68.0,YR,,F,Y,83.5,KG,20151111.0,,MD,BR,BR,2015,Q4,Elderly
117392561,11739256,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Erythema,,2015,Q4,1,I,,20151102.0,20151113,20151113,EXP,,MK-SA-2015SA175878,AVENTIS,"NELOSKA L., DAMEVSKA K., PAVLESKA L., ENOXAPARIN-INDUCED SKIN NECROSIS, ACTA DERMATOVENEROL. CROAT.. 2015? 23(3):222-223.",78.0,YR,E,F,Y,,,20151113.0,,OT,MK,MK,2015,Q4,Elderly
117392561,11739256,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Injection site erythema,,2015,Q4,1,I,,20151102.0,20151113,20151113,EXP,,MK-SA-2015SA175878,AVENTIS,"NELOSKA L., DAMEVSKA K., PAVLESKA L., ENOXAPARIN-INDUCED SKIN NECROSIS, ACTA DERMATOVENEROL. CROAT.. 2015? 23(3):222-223.",78.0,YR,E,F,Y,,,20151113.0,,OT,MK,MK,2015,Q4,Elderly
117392561,11739256,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Multi-organ failure,,2015,Q4,1,I,,20151102.0,20151113,20151113,EXP,,MK-SA-2015SA175878,AVENTIS,"NELOSKA L., DAMEVSKA K., PAVLESKA L., ENOXAPARIN-INDUCED SKIN NECROSIS, ACTA DERMATOVENEROL. CROAT.. 2015? 23(3):222-223.",78.0,YR,E,F,Y,,,20151113.0,,OT,MK,MK,2015,Q4,Elderly
117392561,11739256,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Skin necrosis,,2015,Q4,1,I,,20151102.0,20151113,20151113,EXP,,MK-SA-2015SA175878,AVENTIS,"NELOSKA L., DAMEVSKA K., PAVLESKA L., ENOXAPARIN-INDUCED SKIN NECROSIS, ACTA DERMATOVENEROL. CROAT.. 2015? 23(3):222-223.",78.0,YR,E,F,Y,,,20151113.0,,OT,MK,MK,2015,Q4,Elderly
117411991,11741199,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, (AT NIGHT) QD",,,,,,,,20.0,DF,,QD,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20151019.0,20151103.0,20151116,20151116,EXP,,PHHO2015US018884,SANDOZ,,73.0,YR,,M,Y,103.0,KG,20151116.0,,OT,US,US,2015,Q4,Elderly
117411991,11741199,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, (AT NIGHT) QD",,,,,,,,20.0,DF,,QD,2015,Q4,Atrial flutter,,2015,Q4,1,I,20151019.0,20151103.0,20151116,20151116,EXP,,PHHO2015US018884,SANDOZ,,73.0,YR,,M,Y,103.0,KG,20151116.0,,OT,US,US,2015,Q4,Elderly
117411991,11741199,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, (AT NIGHT) QD",,,,,,,,20.0,DF,,QD,2015,Q4,Coagulopathy,,2015,Q4,1,I,20151019.0,20151103.0,20151116,20151116,EXP,,PHHO2015US018884,SANDOZ,,73.0,YR,,M,Y,103.0,KG,20151116.0,,OT,US,US,2015,Q4,Elderly
117411991,11741199,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 U, (AT NIGHT) QD",,,,,,,,20.0,DF,,QD,2015,Q4,Encephalopathy,,2015,Q4,1,I,20151019.0,20151103.0,20151116,20151116,EXP,,PHHO2015US018884,SANDOZ,,73.0,YR,,M,Y,103.0,KG,20151116.0,,OT,US,US,2015,Q4,Elderly
117437202,11743720,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,, UNK,,21081.0,10.0,IU,,QD,2015,Q4,Dyspnoea,,2015,Q4,2,F,20150916.0,20151104.0,20151116,20151118,EXP,,IT-SA-2015SA177890,AVENTIS,,84.0,YR,E,M,Y,,,20151118.0,,MD,IT,IT,2015,Q4,Elderly
117437202,11743720,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,, UNK,,21081.0,10.0,IU,,QD,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,20150916.0,20151104.0,20151116,20151118,EXP,,IT-SA-2015SA177890,AVENTIS,,84.0,YR,E,M,Y,,,20151118.0,,MD,IT,IT,2015,Q4,Elderly
117437202,11743720,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,, UNK,,21081.0,10.0,IU,,QD,2015,Q4,Incorrect route of drug administration,,2015,Q4,2,F,20150916.0,20151104.0,20151116,20151118,EXP,,IT-SA-2015SA177890,AVENTIS,,84.0,YR,E,M,Y,,,20151118.0,,MD,IT,IT,2015,Q4,Elderly
117441101,11744110,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,70.0,IU,,QD,2015,Q4,Chest pain,,2015,Q4,1,I,20151101.0,20151110.0,20151116,20151116,EXP,,US-ASTRAZENECA-2015SF09444,ASTRAZENECA,,53.0,YR,,F,Y,,,20151116.0,,MD,US,US,2015,Q4,Adult
117446441,11744644,2,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q4,Dyspnoea,,2015,Q4,1,I,20150916.0,20151104.0,20151116,20151116,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201511001805,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20151110.0,,CN,IT,IT,2015,Q4,Elderly
117446441,11744644,2,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20150916.0,20151104.0,20151116,20151116,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201511001805,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20151110.0,,CN,IT,IT,2015,Q4,Elderly
117475492,11747549,6,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100E/ML INJFL; 1X10IE AND 1X AS MUCH AS NECESSARY/ACCORDING SCHEDULE,,,,,,,,,,,,2015,Q4,Blood glucose fluctuation,,2015,Q4,2,F,201508.0,20151127.0,20151117,20151207,EXP,,NL-ABBVIE-15P-114-1499113-00,ABBVIE,,68.0,YR,,M,Y,66.0,KG,20151204.0,,CN,COUNTRY NOT SPECIFIED,NL,2015,Q4,Elderly
117475492,11747549,6,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100E/ML INJFL; 1X10IE AND 1X AS MUCH AS NECESSARY/ACCORDING SCHEDULE,,,,,,,,,,,,2015,Q4,Herpes zoster,,2015,Q4,2,F,201508.0,20151127.0,20151117,20151207,EXP,,NL-ABBVIE-15P-114-1499113-00,ABBVIE,,68.0,YR,,M,Y,66.0,KG,20151204.0,,CN,COUNTRY NOT SPECIFIED,NL,2015,Q4,Elderly
117529831,11752983,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Death,,2015,Q4,1,I,20151015.0,20151117.0,20151119,20151119,EXP,,US-ABBVIE-15K-163-1502618-00,ABBVIE,,84.0,YR,,M,Y,113.5,KG,20151119.0,,OT,COUNTRY NOT SPECIFIED,US,2015,Q4,Elderly
117557201,11755720,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20150702.0,20151108.0,20151119,20151119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201511003808,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20151119.0,,CN,CN,CN,2015,Q4,Adult
117557201,11755720,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Skin ulcer,,2015,Q4,1,I,20150702.0,20151108.0,20151119,20151119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201511003808,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20151119.0,,CN,CN,CN,2015,Q4,Adult
117557201,11755720,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,1,I,20150702.0,20151108.0,20151119,20151119,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201511003808,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20151119.0,,CN,CN,CN,2015,Q4,Adult
117589921,11758992,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100E/ML PEN,,,,,,,,,,,,2015,Q4,Death,,2015,Q4,1,I,20151027.0,20151116.0,20151120,20151120,EXP,,NL-ABBVIE-15P-114-1501604-00,ABBVIE,,67.0,YR,,M,Y,,,20151120.0,,CN,COUNTRY NOT SPECIFIED,NL,2015,Q4,Elderly
117661631,11766163,3,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Anxiety,,2015,Q4,1,I,20150727.0,20150826.0,20151122,20151122,PER,GB-MHRA-EYC 00126998,GB-LUPIN PHARMACEUTICALS INC.-E2B_00004142,LUPIN,,65.0,YR,,M,Y,53.97,KG,20151120.0,,,GB,GB,2015,Q4,Elderly
117661631,11766163,3,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Suicidal ideation,,2015,Q4,1,I,20150727.0,20150826.0,20151122,20151122,PER,GB-MHRA-EYC 00126998,GB-LUPIN PHARMACEUTICALS INC.-E2B_00004142,LUPIN,,65.0,YR,,M,Y,53.97,KG,20151120.0,,,GB,GB,2015,Q4,Elderly
117696703,11769670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Dermatitis bullous,,2015,Q4,3,F,,20151127.0,20151123,20151208,EXP,,JP-SA-2015SA184623,AVENTIS,"NAGAI K, AOYAGI Y, YAMADA T, TOMIYAMA K. STUDY OF A CASE OF SKIN ERUPTION ASSOCIATED WITH THE ONSET OF TYPE 1 DIABETES MELLITUS. THE 4TH ANNUAL MEETING OF JAPAN PHARMACEUTICAL AND DIABETES SOCIETY? 2015 SEP 26-27? NIIGATA CITY, NIIGATA PREFECTURE. PHARMACEUTICALS AND DIABETES 2015 SEP?137.",20.0,YR,A,M,Y,,,20151208.0,,OT,JP,JP,2015,Q4,Youth
117696703,11769670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Pruritus,,2015,Q4,3,F,,20151127.0,20151123,20151208,EXP,,JP-SA-2015SA184623,AVENTIS,"NAGAI K, AOYAGI Y, YAMADA T, TOMIYAMA K. STUDY OF A CASE OF SKIN ERUPTION ASSOCIATED WITH THE ONSET OF TYPE 1 DIABETES MELLITUS. THE 4TH ANNUAL MEETING OF JAPAN PHARMACEUTICAL AND DIABETES SOCIETY? 2015 SEP 26-27? NIIGATA CITY, NIIGATA PREFECTURE. PHARMACEUTICALS AND DIABETES 2015 SEP?137.",20.0,YR,A,M,Y,,,20151208.0,,OT,JP,JP,2015,Q4,Youth
117696703,11769670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNK,,21081.0,,,,,2015,Q4,Rash,,2015,Q4,3,F,,20151127.0,20151123,20151208,EXP,,JP-SA-2015SA184623,AVENTIS,"NAGAI K, AOYAGI Y, YAMADA T, TOMIYAMA K. STUDY OF A CASE OF SKIN ERUPTION ASSOCIATED WITH THE ONSET OF TYPE 1 DIABETES MELLITUS. THE 4TH ANNUAL MEETING OF JAPAN PHARMACEUTICAL AND DIABETES SOCIETY? 2015 SEP 26-27? NIIGATA CITY, NIIGATA PREFECTURE. PHARMACEUTICALS AND DIABETES 2015 SEP?137.",20.0,YR,A,M,Y,,,20151208.0,,OT,JP,JP,2015,Q4,Youth
117729711,11772971,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Acute myocardial infarction,,2015,Q4,1,I,20151113.0,20151117.0,20151124,20151124,EXP,,CO-BAXTER-2015BAX062432,BAXTER,,76.0,YR,,M,Y,69.0,KG,20151124.0,,OT,CO,CO,2015,Q4,Elderly
117750981,11775098,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2015,Q4,Pancytopenia,,2015,Q4,1,I,20151009.0,20151117.0,20151124,20151124,PER,,US-CELGENEUS-USA-2015115716,CELGENE,,60.0,YR,,M,Y,83.9,KG,20151124.0,,MD,US,US,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Abnormal weight gain,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Feeling abnormal,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Intentional self-injury,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Irritability,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Personality change,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Self-injurious ideation,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117770351,11777035,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Violence-related symptom,,2015,Q4,1,I,20140813.0,20151116.0,20151125,20151125,EXP,GB-MHRA-EYC 00130625,GB-TEVA-609943ACC,TEVA,,57.0,YR,,F,Y,75.0,KG,20151125.0,,CN,GB,GB,2015,Q4,Adult
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Confusional state,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Crying,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Delirium,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Delusion,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Dementia,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Depressed mood,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Disturbance in attention,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Faecal incontinence,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Fatigue,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,"Hallucinations, mixed",,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Herpes zoster,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Lethargy,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Pain in extremity,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Pyrexia,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Somnolence,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Urinary tract infection,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117792841,11779284,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100IU/ML, 6 UNITS IN MORNING",,,,U,,,,,,,,2015,Q4,Wrong technique in product usage process,,2015,Q4,1,I,20150315.0,20151117.0,20151125,20151125,EXP,,AU-PURDUE PHARMA-GBR-2015-0032300,PURDUE,,84.0,YR,,F,Y,45.7,KG,20151125.0,,OT,AU,AU,2015,Q4,Elderly
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Anxiety,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose decreased,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Drug ineffective,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dyslipidaemia,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dysuria,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Haemoglobin increased,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Off label use,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Proteinuria,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Tachycardia,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117818652,11781865,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,White blood cell count increased,,2015,Q4,2,F,201511.0,20151214.0,20151126,20151222,PER,,US-ASTRAZENECA-2015SF12959,ASTRAZENECA,,53.0,YR,,F,Y,78.5,KG,20151222.0,,MD,US,US,2015,Q4,Adult
117830292,11783029,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Abdominal pain,,2015,Q4,2,F,20151115.0,20151201.0,20151127,20151210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080951,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20151210.0,,OT,US,US,2015,Q4,Adult
117830292,11783029,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Malignant neoplasm progression,,2015,Q4,2,F,20151115.0,20151201.0,20151127,20151210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080951,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20151210.0,,OT,US,US,2015,Q4,Adult
117830292,11783029,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Pulmonary embolism,,2015,Q4,2,F,20151115.0,20151201.0,20151127,20151210,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080951,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20151210.0,,OT,US,US,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Abnormal weight gain,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Feeling abnormal,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Intentional self-injury,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Irritability,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Personality change,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Self-injurious ideation,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117848331,11784833,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Violence-related symptom,,2015,Q4,1,I,20140813.0,20151116.0,20151130,20151130,EXP,,GB-APOTEX-2015AP014657,APOTEX,,57.0,YR,,F,Y,75.0,KG,20151130.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Abnormal weight gain,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Drug ineffective,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Feeling abnormal,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Intentional self-injury,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Irritability,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Personality change,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Self-injurious ideation,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117891201,11789120,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Violence-related symptom,,2015,Q4,1,I,20140813.0,20151116.0,20151201,20151201,EXP,,GB-AUROBINDO-AUR-APL-2015-10504,AUROBINDO,,57.0,YR,,F,Y,75.0,KG,20151127.0,,CN,GB,GB,2015,Q4,Adult
117899861,11789986,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Accidental overdose,,2015,Q4,1,I,20151102.0,,20151130,20151130,DIR,,,,,79.0,YR,,F,N,80.1,KG,20151125.0,N,PH,US,,2015,Q4,Elderly
117899861,11789986,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20151102.0,,20151130,20151130,DIR,,,,,79.0,YR,,F,N,80.1,KG,20151125.0,N,PH,US,,2015,Q4,Elderly
117899861,11789986,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Incorrect dose administered,,2015,Q4,1,I,20151102.0,,20151130,20151130,DIR,,,,,79.0,YR,,F,N,80.1,KG,20151125.0,N,PH,US,,2015,Q4,Elderly
117899861,11789986,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Product use issue,,2015,Q4,1,I,20151102.0,,20151130,20151130,DIR,,,,,79.0,YR,,F,N,80.1,KG,20151125.0,N,PH,US,,2015,Q4,Elderly
117970531,11797053,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypersensitivity vasculitis,,2015,Q4,1,I,20151109.0,,20151202,20151202,DIR,,,,,76.0,YR,,M,N,87.0,KG,20151201.0,N,OT,US,,2015,Q4,Elderly
117974041,11797404,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2015,Q4,General physical health deterioration,,2015,Q4,1,I,20151108.0,20151124.0,20151203,20151203,EXP,,CO-BAXTER-2015BAX063792,BAXTER,,75.0,YR,,F,Y,,,20151203.0,,OT,CO,CO,2015,Q4,Elderly
117974041,11797404,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2015,Q4,Groin abscess,,2015,Q4,1,I,20151108.0,20151124.0,20151203,20151203,EXP,,CO-BAXTER-2015BAX063792,BAXTER,,75.0,YR,,F,Y,,,20151203.0,,OT,CO,CO,2015,Q4,Elderly
117974041,11797404,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2015,Q4,Hypersomnia,,2015,Q4,1,I,20151108.0,20151124.0,20151203,20151203,EXP,,CO-BAXTER-2015BAX063792,BAXTER,,75.0,YR,,F,Y,,,20151203.0,,OT,CO,CO,2015,Q4,Elderly
117974041,11797404,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2015,Q4,Septic shock,,2015,Q4,1,I,20151108.0,20151124.0,20151203,20151203,EXP,,CO-BAXTER-2015BAX063792,BAXTER,,75.0,YR,,F,Y,,,20151203.0,,OT,CO,CO,2015,Q4,Elderly
117974041,11797404,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,50.0,IU,,QD,2015,Q4,Somnolence,,2015,Q4,1,I,20151108.0,20151124.0,20151203,20151203,EXP,,CO-BAXTER-2015BAX063792,BAXTER,,75.0,YR,,F,Y,,,20151203.0,,OT,CO,CO,2015,Q4,Elderly
118012121,11801212,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Hypomagnesaemia,,2015,Q4,1,I,,20151123.0,20151204,20151204,EXP,GB-MHRA-EYC 00131042,GB-WATSON-2015-26135,WATSON,,51.0,YR,,F,Y,,,20151204.0,,CN,GB,GB,2015,Q4,Adult
118051181,11805118,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,INJECTION,QD,2015,Q4,Gastritis,,2015,Q4,1,I,20140805.0,20141125.0,20151206,20151206,EXP,,CN-ASTRAZENECA-2014SE90793,ASTRAZENECA,,25966.0,DY,,F,Y,,,20151206.0,,MD,CN,CN,2015,Q4,Elderly
118082261,11808226,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Drug eruption,,2015,Q4,1,I,,20150929.0,20151207,20151207,PER,,US-APOTEX-2015AP013438,APOTEX,"KHETARPAL S, KOVALYSHYN I, FERNANDEZ AP.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA-DERMATOL. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151207.0,,MD,US,US,2015,Q4,Elderly
118082261,11808226,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Iodine overload,,2015,Q4,1,I,,20150929.0,20151207,20151207,PER,,US-APOTEX-2015AP013438,APOTEX,"KHETARPAL S, KOVALYSHYN I, FERNANDEZ AP.. ERYTHEMATOUS PAPULES ON THE FOREARMS.. JAMA-DERMATOL. 2015?151(8):891-892",72.0,YR,,M,Y,,,20151207.0,,MD,US,US,2015,Q4,Elderly
118111091,11811109,15,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2015,Q4,Acute myocardial infarction,,2015,Q4,1,I,20151122.0,20151201.0,20151208,20151208,EXP,,CO-BAXTER-2015BAX065045,BAXTER,,61.0,YR,,F,Y,67.0,KG,20151208.0,,OT,CO,CO,2015,Q4,Adult
118111091,11811109,15,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2015,Q4,Cardiac failure congestive,,2015,Q4,1,I,20151122.0,20151201.0,20151208,20151208,EXP,,CO-BAXTER-2015BAX065045,BAXTER,,61.0,YR,,F,Y,67.0,KG,20151208.0,,OT,CO,CO,2015,Q4,Adult
118155301,11815530,14,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2015,Q4,Acute myocardial infarction,,2015,Q4,1,I,20151109.0,20151202.0,20151209,20151209,EXP,,CO-BAXTER-2015BAX065190,BAXTER,,53.0,YR,,M,Y,87.0,KG,20151209.0,,OT,CO,CO,2015,Q4,Adult
118155361,11815536,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Diabetic foot,,2015,Q4,1,I,,20151202.0,20151209,20151209,EXP,,CO-BAXTER-2015BAX065188,BAXTER,,78.0,YR,,F,Y,73.0,KG,20151209.0,,OT,CO,CO,2015,Q4,Elderly
118155361,11815536,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Sepsis,,2015,Q4,1,I,,20151202.0,20151209,20151209,EXP,,CO-BAXTER-2015BAX065188,BAXTER,,78.0,YR,,F,Y,73.0,KG,20151209.0,,OT,CO,CO,2015,Q4,Elderly
118232051,11823205,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Cardiac failure,,2015,Q4,1,I,2015.0,20151204.0,20151210,20151210,EXP,,CO-BAXTER-2015BAX066231,BAXTER,,53.0,YR,,M,Y,64.4,KG,20151210.0,,OT,CO,CO,2015,Q4,Adult
118232051,11823205,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Diabetic metabolic decompensation,,2015,Q4,1,I,2015.0,20151204.0,20151210,20151210,EXP,,CO-BAXTER-2015BAX066231,BAXTER,,53.0,YR,,M,Y,64.4,KG,20151210.0,,OT,CO,CO,2015,Q4,Adult
118232051,11823205,8,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Disease complication,,2015,Q4,1,I,2015.0,20151204.0,20151210,20151210,EXP,,CO-BAXTER-2015BAX066231,BAXTER,,53.0,YR,,M,Y,64.4,KG,20151210.0,,OT,CO,CO,2015,Q4,Adult
118270231,11827023,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Acute myocardial infarction,,2015,Q4,1,I,20151204.0,20151204.0,20151211,20151211,EXP,,CO-BAXTER-2015BAX066230,BAXTER,,63.0,YR,,M,Y,72.0,KG,20151211.0,,OT,CO,CO,2015,Q4,Adult
118270231,11827023,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Disease complication,,2015,Q4,1,I,20151204.0,20151204.0,20151211,20151211,EXP,,CO-BAXTER-2015BAX066230,BAXTER,,63.0,YR,,M,Y,72.0,KG,20151211.0,,OT,CO,CO,2015,Q4,Adult
118270231,11827023,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Peripheral arterial occlusive disease,,2015,Q4,1,I,20151204.0,20151204.0,20151211,20151211,EXP,,CO-BAXTER-2015BAX066230,BAXTER,,63.0,YR,,M,Y,72.0,KG,20151211.0,,OT,CO,CO,2015,Q4,Adult
118389941,11838994,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypersensitivity vasculitis,,2015,Q4,1,I,,20151207.0,20151216,20151216,EXP,,US-GE HEALTHCARE MEDICAL DIAGNOSTICS-TCGN-PR-1512L-0006,GE HEALTHCARE,"HUSSAIN N,USMAN M,DAVIS J,THAKKAR S,ALI A,MIRRAKHIMOV A,BARBARYAN A,ROWLEY G. INDOMETHACIN-RELATED LEUKOCYTOCLASTIC VASCULITIS: A CASE REPORT AND REVIEW OF LITERATURE. CASE REPORTS IN DERMATOLOGY. 2013 FEB 16?5:33-37.",50.0,YR,,M,Y,131.66,KG,20151216.0,,OT,US,US,2015,Q4,Adult
118404451,11840445,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hypotension,,2015,Q4,1,I,20151207.0,,20151215,20151215,DIR,,,,,69.0,YR,,M,N,169.0,LBS,20151213.0,N,,US,,2015,Q4,Elderly
118404451,11840445,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,1,I,20151207.0,,20151215,20151215,DIR,,,,,69.0,YR,,M,N,169.0,LBS,20151213.0,N,,US,,2015,Q4,Elderly
118438371,11843837,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 UNIT BEFORE MEALS,,,,,,,,,,,,2015,Q4,Drug hypersensitivity,,2015,Q4,1,I,,20111020.0,20151217,20151217,PER,,US-ASTRAZENECA-2011SE63790,ASTRAZENECA,,60.0,YR,,F,Y,,,20151217.0,,CN,US,US,2015,Q4,Adult
118438371,11843837,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 UNIT BEFORE MEALS,,,,,,,,,,,,2015,Q4,Gastrooesophageal reflux disease,,2015,Q4,1,I,,20111020.0,20151217,20151217,PER,,US-ASTRAZENECA-2011SE63790,ASTRAZENECA,,60.0,YR,,F,Y,,,20151217.0,,CN,US,US,2015,Q4,Adult
118443074,11844307,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,4,F,20151127.0,20151211.0,20151217,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-WATSON-2015-27663,ACTAVIS,,76.0,YR,,F,Y,,,20151223.0,,CN,GB,GB,2015,Q4,Elderly
118443074,11844307,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,4,F,20151127.0,20151211.0,20151217,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-WATSON-2015-27663,ACTAVIS,,76.0,YR,,F,Y,,,20151223.0,,CN,GB,GB,2015,Q4,Elderly
118443074,11844307,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,4,F,20151127.0,20151211.0,20151217,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-WATSON-2015-27663,ACTAVIS,,76.0,YR,,F,Y,,,20151223.0,,CN,GB,GB,2015,Q4,Elderly
118443074,11844307,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,4,F,20151127.0,20151211.0,20151217,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-WATSON-2015-27663,ACTAVIS,,76.0,YR,,F,Y,,,20151223.0,,CN,GB,GB,2015,Q4,Elderly
118541091,11854109,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151127.0,20151211.0,20151220,20151220,EXP,,GB-DEXPHARM-20153112,DEXCEL,,76.0,YR,E,F,Y,,,20151220.0,,OT,GB,GB,2015,Q4,Elderly
118541091,11854109,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20151127.0,20151211.0,20151220,20151220,EXP,,GB-DEXPHARM-20153112,DEXCEL,,76.0,YR,E,F,Y,,,20151220.0,,OT,GB,GB,2015,Q4,Elderly
118541091,11854109,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,1,I,20151127.0,20151211.0,20151220,20151220,EXP,,GB-DEXPHARM-20153112,DEXCEL,,76.0,YR,E,F,Y,,,20151220.0,,OT,GB,GB,2015,Q4,Elderly
118541091,11854109,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,20151211.0,20151220,20151220,EXP,,GB-DEXPHARM-20153112,DEXCEL,,76.0,YR,E,F,Y,,,20151220.0,,OT,GB,GB,2015,Q4,Elderly
118552411,11855241,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q4,Coma scale abnormal,,2015,Q4,1,I,,20150729.0,20151221,20151221,EXP,GB-MHRA-EYC 00126010,GB-ACTAVIS-2015-15940,ACTAVIS,,85.0,YR,,M,Y,,,20151221.0,,CN,GB,GB,2015,Q4,Elderly
118561681,11856168,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151127.0,20151211.0,20151221,20151221,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-TEVA-617952ACC,TEVA,,76.0,YR,,F,Y,,,20151221.0,,PH,GB,GB,2015,Q4,Elderly
118561681,11856168,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20151127.0,20151211.0,20151221,20151221,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-TEVA-617952ACC,TEVA,,76.0,YR,,F,Y,,,20151221.0,,PH,GB,GB,2015,Q4,Elderly
118561681,11856168,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,1,I,20151127.0,20151211.0,20151221,20151221,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-TEVA-617952ACC,TEVA,,76.0,YR,,F,Y,,,20151221.0,,PH,GB,GB,2015,Q4,Elderly
118561681,11856168,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,20151211.0,20151221,20151221,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-TEVA-617952ACC,TEVA,,76.0,YR,,F,Y,,,20151221.0,,PH,GB,GB,2015,Q4,Elderly
118571821,11857182,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40UNITS/DAY,,,,U,,,,,,,,2015,Q4,Renal tubular necrosis,,2015,Q4,1,I,,20151207.0,20151221,20151221,EXP,,US-APOTEX-2015AP015326,APOTEX,"WOODRUFF AE, MEANEY CJ, HANSEN EA, PRESCOTT GM.. AZITHROMYCIN-INDUCED, BIOPSY-PROVEN ACUTE INTERSTITIAL NEPHRITIS IN AN ADULT SUCCESSFULLY TREATED WITH LOW-DOSE CORTICOSTEROIDS.. PHARMACOTHERAPY. 2015?35(11):E169-74",59.0,YR,,M,Y,100.0,KG,20151221.0,,OT,US,US,2015,Q4,Adult
118571821,11857182,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40UNITS/DAY,,,,U,,,,,,,,2015,Q4,Tubulointerstitial nephritis,,2015,Q4,1,I,,20151207.0,20151221,20151221,EXP,,US-APOTEX-2015AP015326,APOTEX,"WOODRUFF AE, MEANEY CJ, HANSEN EA, PRESCOTT GM.. AZITHROMYCIN-INDUCED, BIOPSY-PROVEN ACUTE INTERSTITIAL NEPHRITIS IN AN ADULT SUCCESSFULLY TREATED WITH LOW-DOSE CORTICOSTEROIDS.. PHARMACOTHERAPY. 2015?35(11):E169-74",59.0,YR,,M,Y,100.0,KG,20151221.0,,OT,US,US,2015,Q4,Adult
118627071,11862707,20,C,INSULIN GLARGINE (LANTUS 100 UNITS/ML SUBCUTANEOUS SOLUTION),,2,,,,,,,,,,,,,,2015,Q4,Anaemia,,2015,Q4,1,I,,,20151222,20151222,DIR,,,,,75.0,YR,,M,N,230.0,LBS,20151214.0,Y,,US,,2015,Q4,Elderly
118638321,11863832,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-FRI-1000081791,FOREST,,76.0,YR,,F,Y,,,20151223.0,,OT,DK,GB,2015,Q4,Elderly
118638321,11863832,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-FRI-1000081791,FOREST,,76.0,YR,,F,Y,,,20151223.0,,OT,DK,GB,2015,Q4,Elderly
118638321,11863832,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-FRI-1000081791,FOREST,,76.0,YR,,F,Y,,,20151223.0,,OT,DK,GB,2015,Q4,Elderly
118638321,11863832,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,GB-FRI-1000081791,FOREST,,76.0,YR,,F,Y,,,20151223.0,,OT,DK,GB,2015,Q4,Elderly
118660121,11866012,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,PHHY2015GB163688,SANDOZ,,76.0,YR,,F,Y,,,20151223.0,,OT,GB,GB,2015,Q4,Elderly
118660121,11866012,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,PHHY2015GB163688,SANDOZ,,76.0,YR,,F,Y,,,20151223.0,,OT,GB,GB,2015,Q4,Elderly
118660121,11866012,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Malaise,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,PHHY2015GB163688,SANDOZ,,76.0,YR,,F,Y,,,20151223.0,,OT,GB,GB,2015,Q4,Elderly
118660121,11866012,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,20151211.0,20151223,20151223,EXP,GB-MHRA-MIDB-694E8A93-0D95-4E0F-A885-F320C84FE6C8,PHHY2015GB163688,SANDOZ,,76.0,YR,,F,Y,,,20151223.0,,OT,GB,GB,2015,Q4,Elderly
118668521,11866852,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151127.0,20151211.0,20151224,20151224,EXP,,GB-AUROBINDO-AUR-APL-2015-11714,AUROBINDO,,76.0,YR,,F,Y,,,20151224.0,,PH,GB,GB,2015,Q4,Elderly
118668521,11866852,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20151127.0,20151211.0,20151224,20151224,EXP,,GB-AUROBINDO-AUR-APL-2015-11714,AUROBINDO,,76.0,YR,,F,Y,,,20151224.0,,PH,GB,GB,2015,Q4,Elderly
118668521,11866852,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Malaise,,2015,Q4,1,I,20151127.0,20151211.0,20151224,20151224,EXP,,GB-AUROBINDO-AUR-APL-2015-11714,AUROBINDO,,76.0,YR,,F,Y,,,20151224.0,,PH,GB,GB,2015,Q4,Elderly
118668521,11866852,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,20151211.0,20151224,20151224,EXP,,GB-AUROBINDO-AUR-APL-2015-11714,AUROBINDO,,76.0,YR,,F,Y,,,20151224.0,,PH,GB,GB,2015,Q4,Elderly
118681161,11868116,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,AT MORNING,,,,,,,,8.0,DF,,,2015,Q4,Cardio-respiratory arrest,,2015,Q4,1,I,20151128.0,20151223.0,20151224,20151224,EXP,,CO-ABBVIE-15P-036-1527274-00,ABBVIE,,58.0,YR,,M,Y,68.5,KG,20151224.0,,CN,COUNTRY NOT SPECIFIED,CO,2015,Q4,Adult
118682321,11868232,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (AS DIRECTED),,,,,,,,,,,,2015,Q4,Tendon rupture,,2015,Q4,1,I,20151210.0,20151217.0,20151224,20151224,EXP,GB-MHRA-TPP14753810C1521891YC1449743372512,GB-WATSON-2015-28148,WATSON,,80.0,YR,,F,Y,74.0,KG,20151224.0,,CN,GB,GB,2015,Q4,Elderly
118706621,11870662,11,C,INSUL GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Haematochezia,,2015,Q4,1,I,20150902.0,,20151224,20151224,DIR,,,,,68.0,YR,,M,N,,,20150904.0,N,PH,US,,2015,Q4,Elderly
118706621,11870662,11,C,INSUL GLARGINE,,2,,,,,,,,,,,,,,2015,Q4,Hypotension,,2015,Q4,1,I,20150902.0,,20151224,20151224,DIR,,,,,68.0,YR,,M,N,,,20150904.0,N,PH,US,,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Accidental underdose,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Glycosylated haemoglobin increased,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Medication error,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Treatment noncompliance,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Accidental underdose,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Glycosylated haemoglobin increased,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Medication error,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708081,11870808,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,30 UNITS DAILY,,,,U,,,,,,,,2015,Q4,Treatment noncompliance,,2015,Q4,1,I,,20151118.0,20151228,20151228,EXP,,US-AUROBINDO-AUR-APL-2015-10780,AUROBINDO,"ARMOR BL, ET AL. IBUPROFEN/INSULIN GLARGINE/NAPROXEN ACUTE RENAL INSUFFICIENCY AND INSULIN GLARGINE NONADHERENCE: CASE REPORT. REACTION WEEKLY. 2015?1577:135",71.0,YR,,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118708201,11870820,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Brain neoplasm,,2015,Q4,1,I,20150802.0,,20151224,20151224,DIR,,,,,62.0,YR,,F,N,,,20150826.0,N,PH,US,,2015,Q4,Adult
118708201,11870820,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Cerebral haemorrhage,,2015,Q4,1,I,20150802.0,,20151224,20151224,DIR,,,,,62.0,YR,,F,N,,,20150826.0,N,PH,US,,2015,Q4,Adult
118708201,11870820,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Disorientation,,2015,Q4,1,I,20150802.0,,20151224,20151224,DIR,,,,,62.0,YR,,F,N,,,20150826.0,N,PH,US,,2015,Q4,Adult
118708201,11870820,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Mental status changes,,2015,Q4,1,I,20150802.0,,20151224,20151224,DIR,,,,,62.0,YR,,F,N,,,20150826.0,N,PH,US,,2015,Q4,Adult
118710901,11871090,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Epistaxis,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Haemorrhage urinary tract,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Haemorrhagic arteriovenous malformation,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Rectal haemorrhage,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Epistaxis,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Haemorrhage urinary tract,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Haemorrhagic arteriovenous malformation,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118710901,11871090,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Rectal haemorrhage,,2015,Q4,1,I,20140622.0,20151015.0,20151228,20151228,EXP,,US-BAYER-2015-448453,BAYER,,73.0,YR,E,M,Y,,,20151228.0,,OT,US,US,2015,Q4,Elderly
118712241,11871224,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20150704.0,,20151224,20151224,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q4,Young Adult
118712241,11871224,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q4,Hypotension,,2015,Q4,1,I,20150704.0,,20151224,20151224,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q4,Young Adult
118712241,11871224,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q4,Loss of consciousness,,2015,Q4,1,I,20150704.0,,20151224,20151224,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q4,Young Adult
118712241,11871224,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q4,Sepsis,,2015,Q4,1,I,20150704.0,,20151224,20151224,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q4,Young Adult
118712241,11871224,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,N,Y,,,,14.0,IU,,HS,2015,Q4,Syncope,,2015,Q4,1,I,20150704.0,,20151224,20151224,DIR,,,,,33.0,YR,,F,N,,,20150717.0,N,PH,US,,2015,Q4,Young Adult
118712691,11871269,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Dyspnoea,,2015,Q4,1,I,20151106.0,,20151224,20151224,DIR,,,,,74.0,YR,,M,N,,,20151106.0,N,PH,US,,2015,Q4,Elderly
118712691,11871269,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Fatigue,,2015,Q4,1,I,20151106.0,,20151224,20151224,DIR,,,,,74.0,YR,,M,N,,,20151106.0,N,PH,US,,2015,Q4,Elderly
118712691,11871269,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Pleural effusion,,2015,Q4,1,I,20151106.0,,20151224,20151224,DIR,,,,,74.0,YR,,M,N,,,20151106.0,N,PH,US,,2015,Q4,Elderly
118713771,11871377,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2015,Q4,Cardiac tamponade,,2015,Q4,1,I,20151022.0,,20151224,20151224,DIR,,,,,58.0,YR,,M,N,,,20151123.0,N,PH,US,,2015,Q4,Adult
118714871,11871487,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,26.0,IU,,HS,2015,Q4,Brain mass,,2015,Q4,1,I,20151002.0,,20151224,20151224,DIR,,,,,52.0,YR,,F,N,,,20151012.0,N,PH,US,,2015,Q4,Adult
118714871,11871487,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,26.0,IU,,HS,2015,Q4,Headache,,2015,Q4,1,I,20151002.0,,20151224,20151224,DIR,,,,,52.0,YR,,F,N,,,20151012.0,N,PH,US,,2015,Q4,Adult
118714871,11871487,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,Y,,,,26.0,IU,,HS,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,20151002.0,,20151224,20151224,DIR,,,,,52.0,YR,,F,N,,,20151012.0,N,PH,US,,2015,Q4,Adult
118764201,11876420,8,C,Glargine insulin,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,36.0,IU,,QD,2015,Q4,Acute myocardial infarction,,2015,Q4,1,I,20151210.0,20151222.0,20151229,20151229,EXP,,CO-BAXTER-2015BAX069657,BAXTER,,55.0,YR,,F,Y,65.0,KG,20151229.0,,OT,CO,CO,2015,Q4,Adult
118788071,11878807,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU, UNK",,,,,,,,38.0,IU,INJECTION,,2015,Q4,Gastrointestinal stromal tumour,,2015,Q4,1,I,20151002.0,20151217.0,20151230,20151230,EXP,,KR-OTSUKA-2015_017220,OTSUKA,,57.0,YR,,M,Y,,,20151230.0,,OT,KR,KR,2015,Q4,Adult
72863002,7286300,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Coagulopathy,,2015,Q4,2,F,,20150820.0,20100219,20151201,EXP,,ES-WATSON-2010-01817,WATSON,,73.0,YR,,F,Y,,,20151201.0,,CN,GB,ES,2015,Q4,Elderly
72863002,7286300,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Hepatic failure,,2015,Q4,2,F,,20150820.0,20100219,20151201,EXP,,ES-WATSON-2010-01817,WATSON,,73.0,YR,,F,Y,,,20151201.0,,CN,GB,ES,2015,Q4,Elderly
72863002,7286300,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Lactic acidosis,,2015,Q4,2,F,,20150820.0,20100219,20151201,EXP,,ES-WATSON-2010-01817,WATSON,,73.0,YR,,F,Y,,,20151201.0,,CN,GB,ES,2015,Q4,Elderly
72863002,7286300,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2015,Q4,Renal failure,,2015,Q4,2,F,,20150820.0,20100219,20151201,EXP,,ES-WATSON-2010-01817,WATSON,,73.0,YR,,F,Y,,,20151201.0,,CN,GB,ES,2015,Q4,Elderly
82162652,8216265,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,IU,INJECTION,QD,2015,Q4,Blood insulin increased,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,IU,INJECTION,QD,2015,Q4,Blood potassium decreased,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,IU,INJECTION,QD,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,IU,INJECTION,QD,2015,Q4,Intentional overdose,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",,,,,,,,10.0,IU,INJECTION,QD,2015,Q4,Suicide attempt,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"900 U, QD",,,,,,,,900.0,IU,INJECTION,QD,2015,Q4,Blood insulin increased,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"900 U, QD",,,,,,,,900.0,IU,INJECTION,QD,2015,Q4,Blood potassium decreased,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"900 U, QD",,,,,,,,900.0,IU,INJECTION,QD,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"900 U, QD",,,,,,,,900.0,IU,INJECTION,QD,2015,Q4,Intentional overdose,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
82162652,8216265,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"900 U, QD",,,,,,,,900.0,IU,INJECTION,QD,2015,Q4,Suicide attempt,,2015,Q4,2,F,,20151021.0,20111031,20151102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201110005844,ELI LILLY AND CO,,46.0,YR,,F,Y,59.2,KG,20151029.0,,MD,JP,JP,2015,Q4,Adult
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Blood glucose increased,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Bone marrow failure,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Heart rate increased,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Humerus fracture,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Injury,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Neutrophil count increased,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Pelvic fracture,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Platelet count increased,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Pseudomonas infection,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Road traffic accident,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,Sepsis,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
95217938,9521793,39,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, QD",,,,,,,,6.0,IU,INJECTION,QD,2015,Q4,White blood cell count increased,,2015,Q4,8,F,20130116.0,20151007.0,20130913,20151013,EXP,,PHHY2013JP100462,NOVARTIS,,65.0,YR,,F,Y,,,20151013.0,,,JP,JP,2015,Q4,Elderly
98394472,9839447,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SC QHS,,,,,,,,,,,,2015,Q4,Acute respiratory distress syndrome,,2015,Q4,2,F,20140101.0,20150929.0,20140124,20151005,EXP,,US-ROCHE-1338480,ROCHE,,56.0,YR,,F,Y,,,20151005.0,,PH,US,US,2015,Q4,Adult
98394472,9839447,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SC QHS,,,,,,,,,,,,2015,Q4,Acute respiratory failure,,2015,Q4,2,F,20140101.0,20150929.0,20140124,20151005,EXP,,US-ROCHE-1338480,ROCHE,,56.0,YR,,F,Y,,,20151005.0,,PH,US,US,2015,Q4,Adult
98394472,9839447,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SC QHS,,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,2,F,20140101.0,20150929.0,20140124,20151005,EXP,,US-ROCHE-1338480,ROCHE,,56.0,YR,,F,Y,,,20151005.0,,PH,US,US,2015,Q4,Adult
98394472,9839447,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SC QHS,,,,,,,,,,,,2015,Q4,Pneumonia influenzal,,2015,Q4,2,F,20140101.0,20150929.0,20140124,20151005,EXP,,US-ROCHE-1338480,ROCHE,,56.0,YR,,F,Y,,,20151005.0,,PH,US,US,2015,Q4,Adult
